Pills

This is the text extract for Section H - effective 1 March 2013, browse documents here.


Pharmaceutical Management Agency

Section H

for Hospital Pharmaceuticals

Effective 1 March 2013 New Zealand Pharmaceutical Schedule


Hospital Pharmaceuticals March 2013

Editors Sarah Le Leu & Donna Jennings email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer Street PO Box 10 254 Wellington 6143 Freephone Information Line 0800 66 00 50 (9am – 5pm weekdays) Circulation Published each March, July and November. Changes to the contents are published in monthly updates. Accessible in an electronic format at no cost from the Health Professionals section of the PHARMAC website www.pharmac.govt.nz You can register to have an electronic version of the Pharmaceutical Schedule (link to PDF copy) emailed to your nominated email address each month. Alternatively there is a nominal charge for an annual subscription to the printed Schedule publications. To access either of these subscriptions visit our subscription website www.schedule.co.nz. Production Typeset automatically from XML and TEX. See www.pharmac.govt.nz/schedule/archive/ for the XML version of this Schedule. Programmers Anrik Drenth & John Geering email: texschedule@pharmac.govt.nz c Pharmaceutical Management Agency ISSN 1179-3708 pdf ISSN 1172-9694 print This work is licensed under the Creative Commons Attribution 3.0 New Zealand licence. In essence, you are free to copy, distribute and adapt it, as long as you attribute the work to PHARMAC and abide by the other licence terms. To view a copy of this licence, visit: creativecommons.org/licenses/by/3.0/nz/. Attribution to PHARMAC should be in written form and not by reproduction of the PHARMAC logo. While care has been taken in compiling this Schedule, PHARMAC takes no responsibility for any errors or omissions, and shall not be liable for any consequences arising there from.

Contents

Introducing PHARMAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Members of the PHARMAC Board . . . . . . . . . . . . . . . . . . . . . . . . . 2 Decision Criteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 PHARMAC and Section H of the Pharmaceutical Schedule . . . . 3 The PHARMAC Hospital Team . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 PHARMAC’s clinical advisors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Pharmacology and Therapeutics Advisory Committee (PTAC) . . . 4 Hospital Pharmaceuticals Subcommittee of PTAC . . . . . . . . . . . . . 4 Purpose of the Pharmaceutical Schedule . . . . . . . . . . . . . . . . . . . 5 Finding Information in the Pharmaceutical Schedule . . . . . . . . . . . 5 Community Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Hospital Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Explaining Hospital Pharmaceutical Entries . . . . . . . . . . . . . . . . . . 6 Glossary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Treatment Costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 PHARMAC website . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Named Patient Pharmaceutical Assessment (NPPA) . . . . . . . . . . . 8 Unusual Clinical Circumstance (UCC) . . . . . . . . . . . . . . . . . . . . . . . 8 Urgent Assessment (UA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Hospital Pharmaceuticals in the Community (HPC) . . . . . . . . . . . . 9 Part I – General Rules for Hospital Pharmaceuticals . . . . . . . . . 10 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 1. Interpretation and Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2. Current Hospital Pharmaceutical Contracts . . . . . . . . . . . . . . . 11 3. National Contract Pharmaceutical Price . . . . . . . . . . . . . . . . . . 12 4. Hospital Supply Status (HSS) . . . . . . . . . . . . . . . . . . . . . . . . . . 12 5. Collection of rebates and payment of financial compensation . 12 6. Price and Volume Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 7. Discretionary Community Supply Pharmaceuticals . . . . . . . . . 13 8. Pharmaceuticals Cancer Treatment . . . . . . . . . . . . . . . . . . . . . 14 9. Practitioners Prescribing Unapproved Pharmaceuticals . . . . . 14 Part II – Pharmaceuticals Under National Contracts . . . . . . . . . 15 Part III – Discretionary Community Supply Pharmaceuticals . . 68 Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73


Introducing PHARMAC

PHARMAC, the Pharmaceutical Management Agency, is a Crown entity established pursuant to the New Zealand Public Health and Disability Act 2000 (The Act). The primary objective of PHARMAC is to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided. The PHARMAC Board consists of up to six members appointed by the Minister of Health. All decisions relating to PHARMAC’s operation are made by or under the authority of the Board. In particular, Board members decide on the strategic direction of PHARMAC and may decide which community pharmaceuticals should be subsidised and at what levels, and determine national prices for some pharmaceuticals to be purchased by and used in DHB Hospitals, and whether or not special conditions are to be applied to such purchases. Members of the PHARMAC Board Stuart McLauchlan Kura Denness David Kerr Anne Kolbe Jens Mueller Jan White Decisions taken by the PHARMAC Board members, or made under the authority of the Board, incorporate a balanced view of the needs of prescribers and patients. The aim is to achieve long-term gains and efficient ways of making pharmaceuticals available to the community and for DHB Hospitals to purchase them. The functions of PHARMAC are to perform the following, within the amount of funding provided to it in the Pharmaceutical Budget or to DHBs from their own budgets for the use of pharmaceuticals in their hospitals, as applicable, and in accordance with its annual plan and any directions given by the Minister (Section 103 of the Crown Entities Act): a) to maintain and manage a pharmaceutical schedule that applies consistently throughout New Zealand, including determining eligibility and criteria for the provision of subsidies; b) to manage incidental matters arising out of (a), including in exceptional circumstances providing for subsidies for the supply of pharmaceuticals not on the pharmaceutical schedule; c) to engage as it sees fit, but within its operational budget, in research to meet its objectives as set out in Section 47(a) of the Act; d) to promote the responsible use of pharmaceuticals; e) to manage the purchasing of any or all pharmaceuticals, whether used either in a hospital or outside it, on behalf of DHBs; f) any other functions given to PHARMAC by or under any enactment or authorised by the Minister. The policies and criteria set out in the Pharmaceutical Schedule and PHARMAC’s Operating Policies and Procedures arise out of, and are designed to help PHARMAC achieve and perform, PHARMAC’s objective and functions under the Act. However PHARMAC may, having regard to its public law obligations, depart from the strict application of those policies and criteria in certain exceptional cases where it considers this necessary or appropriate in the proper exercise of its statutory discretion and to give effect to its objective and functions, particularly with respect to: G Determining eligibility and criteria for the provision of subsidies; and G In exceptional circumstances providing for subsidies for the supply of pharmaceuticals not on the Pharmaceutical Schedule. Decision Criteria PHARMAC updates the Pharmaceutical Schedule at regular intervals to notify prescribers, pharmacists, hospital managers and patients of changes to Community Pharmaceutical subsidies and the prices for Hospital Pharmaceuticals. In making decisions about amendments to the Pharmaceutical Schedule, PHARMAC is guided by its Operating Policies and Procedures, as amended or supplemented from time to time. PHARMAC takes into account the following criteria when considering proposed amendments to the Schedule: a) the health needs of all eligible people within New Zealand; b) the particular health needs of M¯ ori and Pacific peoples; a c) the availability and suitability of existing medicines, therapeutic medical devices and related products and related things; d) the clinical benefits and risks of pharmaceuticals; e) the cost-effectiveness of meeting health needs by funding pharmaceuticals rather than using other publicly funded health and disability support services; f) the budgetary impact (in terms of the pharmaceutical budget and the Government’s overall health budget) of any changes to the Schedule; g) the direct cost to health service users; h) the Government’s priorities for health funding, as set out in any objectives notified by the Crown to PHARMAC, or in PHARMAC’s Funding Agreement, or elsewhere; and i) such other criteria as PHARMAC thinks fit. PHARMAC will carry out appropriate consultation when it intends to take any such “other criteria” into account.

2


The Operating Policies and Procedures, including any supplements, also describe the way in which PHARMAC determines the level of subsidy or purchase price payable for each Community Pharmaceutical or Hospital Pharmaceutical, respectively. Copies of PHARMAC’s Operating Policies and Procedures and of any applicable supplements are available on the PHARMAC website (www.pharmac.govt.nz), or on request.

PHARMAC and Section H of the Pharmaceutical Schedule:

PHARMAC manages the national Pharmaceutical Schedule, which lists: G Pharmaceuticals available in the community and subsidised by the Government with funding from the Pharmaceutical Budget; and G some Pharmaceuticals purchased by DHBs for use in their hospitals, and includes those Hospital Pharmaceuticals for which national prices have been negotiated by PHARMAC. In the community approximately 1848 Pharmaceuticals are subsidised by the Government. Most are available to all eligible people within New Zealand on prescription by a medical doctor. Some are listed with guidelines or conditions such as ‘only if prescribed for a dialysis patient’ or ‘Special Authority - Retail Pharmacy’, to ensure that Pharmaceuticals are used by those people who are most likely to benefit from them. Pharmaceuticals provided to patients for use while in DHB Hospitals are not covered by Sections A to G of the Pharmaceutical Schedule. Section H of the Pharmaceutical Schedule is not a comprehensive list of pharmaceuticals that are used within DHB Hospitals. Section H of the Pharmaceutical Schedule includes Pharmaceuticals that can be purchased at a national price by DHBs for use in their hospitals. These are referred to as National Contract Pharmaceuticals. Section H of the Pharmaceutical Schedule also identifies Pharmaceutical Cancer Treatments that DHBs have been directed to fund for use in their hospitals and/or in association with services provided in their hospitals, as well as new Pharmaceuticals used in hospitals, which have been or are being assessed by PHARMAC, the results of that analysis being available to DHB Hospitals via PHARMAC’s website. A list of Discretionary Community Supply Pharmaceuticals, in Section H of the Pharmaceutical Schedule, identifies those products that currently are not subsidised from the Pharmaceutical Budget as Community Pharmaceuticals in Sections A to G of the Pharmaceutical Schedule but which DHBs can at their discretion fund for use in the community from their own budgets without specific Hospital Pharmaceuticals in the Community approval.

3


The PHARMAC Hospital Team Andrew Davies Acting Manager, Funding and Procurement Anne Glennie Panel Co-ordinator Katie Appleby Panel Co-ordinator PHARMAC’s clinical advisors Pharmacology and Therapeutics Advisory Committee (PTAC) PHARMAC works closely with the Pharmacology and Therapeutics Advisory Committee (PTAC), an expert medical committee which provides independent advice to PHARMAC on health needs and the clinical benefits of particular pharmaceuticals for use in the community and/or in DHB Hospitals. The committee members are all senior, practising clinicians. The chair of PTAC sits with the PHARMAC Board in an advisory capacity. PTAC helps decide which pharmaceuticals are to be subsidised from public monies by making recommendations to PHARMAC. Part of the role of PTAC is to review whether Pharmaceuticals already listed on the Schedule should continue to receive Government funds. The resources freed up can be used to subsidise other Pharmaceuticals with a greater therapeutic worth. PHARMAC may obtain clinical advice from PTAC in relation to national purchasing strategies for Hospital Pharmaceuticals. There may be additional specialist hospital representatives on PTAC subcommittees, or additional PTAC subcommittees, where PHARMAC considers this necessary. PTAC members are: Sisira Jayathissa Howard Wilson Chris Cameron Melissa Copland Stuart Dalziel Ian Hosford George Laking Dee Mangin Graham Mills Mark Weatherall Jane Thomas Marius Rademaker Sean Hanna MMedSc (Clin Epi), MMBS, MD, MRCP (UK), FRCP (Edin), FRACP, FAFPHM, Dip Clin Epi, Dip OHP, Dip HSM, MBS, Chair BSc, PhD, MB, BS, Dip Obst, FRNZCGP, FRAGCP Deputy Chair MBChB, FRACP, MClin Pharm PhD, BPharm(Hons), RegPharmNZ, FNZCP MBChB, PhD, FRACP MBChB, FRANZCP, psychiatrist PhD, MD, FRACP MBChB, DPH, RNZCGP MBChB, MTropHlth, MD, FRACP, infectious disease specialist and general physician BA, MBChB, MApplStats, FRACP MBChB, FANZCA BM (Soton), FRCP (Edin), FRACP DM MBChB, FRNZCGP, FRACGP, PGDipGP

Contact PTAC C/-PTAC Secretary, Pharmaceutical Management Agency, PO Box 10 254, WELLINGTON 6143, Email: PTAC@pharmac.govt.nz Hospital Pharmaceuticals Subcommittee of PTAC The Hospital Pharmaceuticals Subcommittee of PTAC is a subcommittee made up of representatives from DHB hospitals to provide PTAC and PHARMAC with advice in relation to our role in relation to hospital pharmaceuticals. The PHARMAC Board has appointed the following members to the Hospital Pharmaceuticals Subcommittee of PTAC: Assoc. Prof. Mark Weatherall Physician Wellington Dr Matthew Dawes Clinical Pharmacologist Auckland Dr Andrew Stanley Respiratory Physician Rotorua Dr Andrew Herbert Gastroenterologist Palmerston North Prof. Murray Barclay Clinical Pharmacologist Christchurch Dr Paul Tomlinson Paediatrician Invercargill Sarah Fitt Pharmacist Auckland Marilyn Crawley Pharmacist Auckland Jan Goddard Pharmacist Hamilton Billy Allen Pharmacist Hastings Chris Jay Pharmacist Wellington

4


Purpose of the Pharmaceutical Schedule

The purpose of the Schedule is to list: G the Community Pharmaceuticals that are subsidised by the Government and to show the amount of the subsidy paid to contractors, as well as the manufacturer’s price and any access conditions that may apply; and G some Hospital Pharmaceuticals that are purchased and used by DHB Hospitals, including those for which national prices have been negotiated by PHARMAC. The purpose of the Schedule is not to show the final cost to Government of subsidising each Community Pharmaceutical or to DHBs in purchasing each Hospital Pharmaceutical since that will depend on any rebate and other arrangements PHARMAC has with the supplier and, for some Hospital Pharmaceuticals, on any logistics arrangements put in place by individual DHB Hospitals. Finding Information in the Pharmaceutical Schedule Community Pharmaceuticals For Community Pharmaceuticals, the Schedule is organised in a way to help the reader find Community Pharmaceuticals, which may be used to treat similar conditions. To do this, Community Pharmaceuticals are first classified anatomically, originally based on the Anatomical Therapeutic Chemical (ATC) system, and then further classified under section headings structured for the New Zealand medical system. G Section A lists the General Rules in relation to Community Pharmaceuticals and related products. G Section B lists Community Pharmaceuticals and related products by anatomical classification, which are further divided into one or more therapeutic headings. Community Pharmaceuticals used to treat similar conditions are grouped together. G Section C lists the rules in relation to Extemporaneously Compounded Products (ECPs) and Community Pharmaceuticals that will be subsidised when extemporaneously compounded. G Section D lists the rules in relation to Special Foods and the Special Foods that are subsidised. G Section E Part I lists the Community Pharmaceuticals that are subsidised on a Practitioner’s Supply Order (PSO) and Wholesale Supply Order (WSO). G Section E Part II lists rural areas for the purpose of PSOs. G Section F lists the Community Pharmaceuticals dispensing period exemptions. G Section G lists the Community Pharmaceuticals eligible for reimbursement of safety cap and related rules. The listings are displayed alphabetically (where practical) within each level of the classification system. Each anatomical section contains a series of therapeutic headings, some of which may contain a further classification level. Where a Community Pharmaceutical is used in more than one therapeutic area, they may be cross-referenced. The therapeutic headings in the Pharmaceutical Schedule do not necessarily correspond to the therapeutic groups and therapeutic subgroups, which PHARMAC establishes for the separate purpose of determining the level of subsidy to be paid for each Community Pharmaceutical. The index located at the back of the book in which Sections A-G of the Pharmaceutical Schedule are published can be used to find page numbers for generic chemical entities, or product brand names. Hospital Pharmaceuticals Section H lists Pharmaceuticals that DHBs fund from their own budgets. The Hospital Pharmaceuticals are grouped into the following Parts in Section H: G Part I lists the rules in relation to Hospital Pharmaceuticals. G Part II lists Hospital Pharmaceuticals for which national contracts exist (National Contract Pharmaceuticals). These are listed alphabetically by generic chemical entity name and line item, the relevant Price negotiated by PHARMAC and, if applicable, an indication of whether it has Hospital Supply Status (HSS) and any associated DV Limit. G Part III lists Discretionary Community Supply Pharmaceuticals, which are not Community Pharmaceuticals, but which a DHB Hospital can, in its discretion, fund for use in the community from its own budget. The index located at the back of the Section H can be used to find page numbers for generic chemical entities, or product brand names, for Hospital Pharmaceuticals.

5


Explaining Hospital Pharmaceutical Entries Section H of the Pharmaceutical Schedule lists National Contract Pharmaceuticals and Discretionary Community Supply Pharmaceuticals that are available to be purchased by DHBs. Where applicable, the listing of the Hospital Pharmaceutical may have an indication of whether it has HSS (if the brand name is in bold), its Price and any associated DV Limit. Example

Pharmaceuticals Under National Contracts

Price (ex man. excl GST) $ Brand or Generic Manufacturer

Per

CHEMICAL Presentation A ............................................................10.00 Generic name listed alphabetically From 1 January 2010 to 30 June 2012, at least 99% of the total volume of this item purchased must be Brand C Presentation B - 1% DV Limit Jan-10 to 2012 ...........15.00 Presentation C ............................................................18.00

100

Brand A Brand B Brand C Brand D Brand or manufacturer’s name Product with Hospital Supply Status (HSS)

50 250 ml

CHEMICAL Presentation D ............................................................26 26.53 Form and strength

100

Brand E

Quantity the Price applies to Standard national price excluding GST

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

In the case of presentation B, Brand C is the Pharmaceutical with HSS. While the price indicated applies from the date on which it was listed, it does not have HSS until the date indicated in the DV Limit. The 1% DV Limit means that at least 99% of the total volume of all brands of that presentation purchased by DHB Hospitals from the date HSS effective indicated must be the HSS brand. Subject to clause 4 of the General Rules for Hospital Pharmaceuticals, DHB Hospitals may only purchase up to the DV Limit of other brands. The brand E of Presentation D, does not have HSS or any DV Limit. Accordingly, DHB Hospitals are able to buy that brand at the listed Price if they choose, but may also buy any other brand of the presentation in any quantity required, at whatever price the DHB Hospital negotiates with the relevant supplier.

6


Glossary

Units of Measure gram ..................................................g kilogram...........................................kg international unit ...............................iu microgram....................................... µg milligram .........................................mg millilitre.............................................ml millimole......................................mmol unit.....................................................u

Abbreviations Ampoule ...................................... Amp Granules ......................................Gran Suppository ................................ Supp Capsule ........................................ Cap Infusion............................................Inf Tablet .............................................Tab Cream...........................................Crm Injection ...........................................Inj Tincture.........................................Tinc Device........................................... Dev Linctus .......................................... Linc Trans Dermal Delivery Dispersible................................... Disp Liquid..............................................Liq System.................................. TDDS Effervescent.................................... Eff Long Acting..................................... LA Emulsion..................................... Emul Ointment....................................... Oint Enteric Coated................................EC Sachet ........................................ Sach Gelatinous ..................................... Gel Solution........................................ Soln HSS Hospital Supply Status, the status of being the brand of the relevant Hospital Pharmaceutical listed in Section H Part II as HSS, that DHBs are obliged to purchase subject to any DV Limit for that Hospital Pharmaceutical for the period of hospital supply, as awarded under an agreement between PHARMAC and the relevant pharmaceutical supplier. S29 This medicine is an unapproved medication supplied under Section 29 of the Medicines Act 1981. Practitioners prescribing this medication should: a) be aware of and comply with their obligations under Section 29 of the Medicines Act 1981 and otherwise under that Act and the Medicines Regulations 1984; b) be aware of and comply with their obligations under the Health and disability Commissioner’s Code of Consumer Rights, including the requirement to obtain informed consent from the patient (PHARMAC recommends that Practitioners obtain written consent); and c) exercise their own skill, judgement, expertise and discretions, and make their own prescribing decisions with respect to the use of an unapproved Pharmaceutical or a Pharmaceutical for an indication for which it is not approved. Note: Where medicines supplied under Section 29 that are used for emergency situations, patient details required under Section 29 of the Medicines Act may be retrospectively provided to the supplier.

7


Hospital Pharmaceutical and Pharmaceutical Cancer Treatment Costs The cost of purchasing Hospital Pharmaceuticals (for use in DHB hospitals and/or in association with Outpatient services provided in DHB hospitals) is met by the relevant DHB hospital from its own budget. Pharmaceutical Cancer Treatments (for use in DHB hospitals and/or in association with Outpatient services provided in DHB hospitals) are funded through the Pharmaceutical budget. As required by section 23(7) of the Act, in performing any of their functions in relation to the supply of Pharmaceuticals, including Pharmaceutical Cancer Treatments, DHBs must not act inconsistently with the Pharmaceutical Schedule. PHARMAC website Information about PHARMAC is available on its website at http://www.pharmac.govt.nz. The website includes copies of the Annual Review, Annual Report and Annual Plan, as well as information such as the Pharmaceutical Schedule, Pharmaceutical Schedule Updates, other publications and recent press releases. Copies of the February 2002 National Hospital Pharmaceutical Strategy can be found on the website. Also, for details about hospital pharmaceuticals that have been assessed by PHARMAC and further information about assessments undertaken by DHB Hospitals, please refer to http://www.pharmac.govt.nz/hpad

Named Patient Pharmaceutical Assessment policy

The Named Patient Pharmaceutical Assessment (NPPA) Policy is PHARMAC’s process for considering applications about named patients seeking funding for treatments not listed on the Schedule, either at all or for the named patient’s clinical circumstances. For PHARMAC to perform its legislative function of maintaining and managing a Schedule that applies consistently throughout New Zealand, the NPPA Policy will, and must, operate in a way that does not undermine the Schedule decision making process. Together, the Schedule process and the NPPA Policy, ensure there is a pathway for consideration of an individual’s clinical circumstances. If an individual has a set of clinical circumstances not covered by the NPPA Policy, the Schedule decision making process is available. It is not the purpose of the NPPA Policy to provide access to every treatment not listed on the Schedule. There are three main pathways by which named patients can be considered for funding under the NPPA Policy. PHARMAC will exercise its discretion to determine the most appropriate pathway for an application under the NPPA Policy based on the information that is provided. PHARMAC will assess applications that meet the prerequisites described below according to its Decision Criteria before deciding whether to approve applications for funding. The Decision Criteria will be used to assess both the individual clinical circumstances of each NPPA applicant, and the implications of each NPPA funding decision on PHARMAC’s ability to carry out its legislative functions. For more information on NPPA, or to apply, visit the PHARMAC website at http://www.pharmac.govt.nz/nppa, or call the Panel Coordinators at (04) 9167553 or (04) 9167521. Unusual Clinical Circumstance (UCC) The purpose of the Unusual Clinical Circumstances (UCC) pathway is to provide a process for consideration for funding for named patients whose clinical circumstances are so unusual that PHARMAC is unlikely, for administrative reasons, to consider listing treatments for these circumstances on the Schedule. The prerequisite requirements for UCC consideration are: G The patient has reasonably tried and failed all alternative funded treatments (or alternative treatments have been contraindicated, or there are no other treatments available), or the patient has experienced such serious side effects with all other relevant funded treatments that treatment has been ceased or cannot reasonably be continued; and G The patient is experiencing an indication or set of clinical circumstances that are so unusual that PHARMAC is unlikely to consider listing treatments for these on the Schedule; and G Generally, PHARMAC has not already considered/is not considering, through the Schedule decision making process, the treatment for the patient’s clinical circumstances, or has not considered the treatment at all. Urgent Assessment (UA) The purpose of the Urgent Assessment (UA) pathway is to provide a process for PHARMAC to consider funding treatments for named patients where PHARMAC is also considering or is likely to consider the treatment for Schedule listing, but the patient’s clinical circumstances justify urgent assessment, prior to a decision on Schedule listing. The prerequisite requirements for UA are: G The patient has reasonably tried and failed all alternative funded treatments (or alternative treatments have been contraindicated, or there are no other treatments available), or the patient has experienced such serious side effects with all other relevant funded treatments that treatment has been ceased or cannot reasonably be continued; and G The patient is experiencing an indication or set of clinical circumstances that may be experienced by a population group (either currently or over time); and G The patient has serious clinical circumstances and not receiving the treatment within six to 12 months would lead to either a significant deterioration in a serious clinical condition or the patient would miss the opportunity for significant improvement in clinical outcome (length or quality of life); and G The treatment has either not been prioritised by PHARMAC, or if it has, PHARMAC has funded the treatment under the NPPA Policy for the same clinical circumstances prior to prioritisation. G PHARMAC has not declined to list, on the Schedule, this treatment for these clinical circumstances.

8


Hospital Pharmaceuticals in the Community (HPC) The purpose of the Hospital Pharmaceuticals in the Community (HPC) pathway is to allow District Health Board hospitals to fund a medicine for a patient in the community if it would be more affordable for the DHB than paying for the treatment that would otherwise need to be provided. PHARMAC’s approval is required for any such funding, given DHBs’ legislative obligation to act consistently with the Schedule. The prerequisite requirements for HPC are: G The patient has reasonably tried and failed all alternative cheaper funded treatments (or these alternative treatments have been contraindicated) or the patient has experienced such serious side effects with all other cheaper relevant funded treatments that treatment has been ceased or cannot reasonably be continued; and G The application is for a DHB hospital to fund a treatment for use in the community for a patient under the care of a DHB hospital clinician (in-patient or out-patient); and G The treatment is not being used to treat a cancer; and G The treatment costs less for the DHB than the most likely alternative intervention or outcome; and G The treatment is being sought for a short-term episode of care (usually a maximum of three months) and is not generally for the treatment of a chronic condition.

9


Part I: General Rules for Hospital Pharmaceuticals

INTRODUCTION

Section H contains general rules that apply, and other information relating, to Hospital Pharmaceuticals. The amounts payable by a DHB to the relevant pharmaceutical supplier are based on the contractual arrangements between PHARMAC and the relevant pharmaceutical supplier for a national price for that National Contract Pharmaceutical. The Pharmaceutical Schedule shows the national price at which the National Contract Pharmaceutical can be purchased by DHBs, providers of logistics services, wholesalers or other such distributors, or Contract Manufacturers directly from the pharmaceutical supplier. As required by section 23(7) of the Act, in performing any of its functions in relation to the supply of Pharmaceuticals, DHBs must not act inconsistently with the Schedule. 1 Interpretation and Definitions 1.1 In this Schedule, unless the context otherwise requires: “Act” means the New Zealand Public Health and Disability Act 2000. “Community Pharmaceutical” means a Pharmaceutical listed in Sections A to G of the Pharmaceutical Schedule that is subsidised by the Funder from the Pharmaceutical Budget for use in the community. “Contract Manufacturer” means a manufacturer or a supplier that is a party to a contract with the relevant DHB Hospital to compound Hospital Pharmaceuticals, on request from that DHB Hospital. “Designated Delivery Point” means at a DHB Hospital’s discretion: a) a delivery point agreed between a pharmaceutical supplier and the relevant DHB Hospital, to which delivery point that pharmaceutical supplier must supply the Pharmaceutical directly at the Price; and/or b) any delivery point designated by the relevant DHB Hospital or PHARMAC, such delivery point being within 30 km of the relevant pharmaceutical supplier’s national distribution centre. “DHB” means an organisation established as a District Health Board by or under Section 19 of the Act. “DHB Hospital” means a DHB, including its hospital or associated provider unit that the DHB purchases Hospital Pharmaceuticals for. “Discretionary Community Supply Pharmaceutical” means the list of Pharmaceuticals set out in Section H Part III of the Schedule, which may be funded by a DHB Hospital from its own budget for use in the community. “DV Limit” means, for a particular Hospital Pharmaceutical with HSS, the National DV Limit or the Individual DV Limit. “DV Pharmaceutical” means a discretionary variance Pharmaceutical that does not have HSS but is used in place of one that does. Usually this means it is the same chemical entity, at the same strength, and in the same or a similar presentation or form, as the relevant Hospital Pharmaceutical with HSS. Where this is not the case, a note will be included with the listing of the HSS pharmaceutical. “Funder” means the body or bodies responsible, pursuant to the Act, for the funding of Pharmaceuticals listed on the Schedule (which may be one or more DHBs and/or the Ministry of Health) and their successors. “GST” means goods and services tax under the Goods and Services Tax Act 1985. “Hospital Pharmaceuticals” means National Contract Pharmaceuticals, DV Pharmaceuticals and Discretionary Community Supply Pharmaceuticals. “Hospital Pharmaceuticals in the Community (HPC)” means the pathway under the Named Patient Pharmaceutical Assessment policy to allow District Health Board hospitals to fund a medicine for a patient in the community if this is more affordable for the DHB than paying for the treatment that would otherwise need to be provided. “HSS” means hospital supply status, the status of being the brand of the relevant Hospital Pharmaceutical listed in Section H Part II as HSS, that DHBs are obliged to purchase subject to any DV Limit for that Hospital Pharmaceutical for the period of hospital supply, as awarded under an agreement between PHARMAC and the relevant pharmaceutical supplier. Pharmaceuticals with HSS are listed in Section H Part II in bold text. “Individual DV Limit” means, for a particular Hospital Pharmaceutical with HSS and a particular DHB Hospital, the discretionary variance limit, being the specified percentage of that DHB Hospital’s Total Market Volume up to which that DHB Hospital may purchase DV Pharmaceuticals of that Hospital Pharmaceutical. “Named Patient Pharmaceutical Assessment Advisory Panel” means the panel of clinicians, appointed by the PHARMAC Board, that is responsible for advising, within its Terms of Reference, on Named Patient Pharmaceutical Assessment applications and Exceptional Circumstances renewal applications submitted after 1 March 2012 (EC renewal application form located at http://www.pharmac.govt.nz/healthpros/EC/ECForms) “National Contract Pharmaceutical” means a Hospital Pharmaceutical for which PHARMAC has negotiated a national contract and the Price. “National DV Limit” means, for a particular Hospital Pharmaceutical with HSS, the discretionary variance limit, being the

10


Part I: General Rules for Hospital Pharmaceuticals

specified percentage of the Total Market Volume up to which all DHB Hospitals may collectively purchase DV Pharmaceuticals of that Hospital Pharmaceutical. “Outpatient” in relation to a Community Pharmaceutical, means a person who, as part of treatment at a hospital or other institution under the control of a DHB, is prescribed the Community Pharmaceutical for consumption or use in the person’s home. “PHARMAC” means the Pharmaceutical Management Agency established by Section 46 of the Act (PHARMAC). “Pharmacode” means the six or seven digit identifier assigned to a Pharmaceutical and notified to a pharmaceutical supplier by the Pharmacy Guild. “Pharmaceutical” means a medicine, therapeutic medical device, or related product or related thing listed in Sections B to H of the Schedule. “Pharmaceutical Budget” means the pharmaceutical budget set for PHARMAC by the Crown for the subsidised supply of Community Pharmaceuticals and Pharmaceutical Cancer Treatments including for named patients in exceptional circumstances. “Pharmaceutical Cancer Treatment” means Pharmaceuticals for the treatment of cancer, listed in Sections A to G of the Schedule and identified therein as a “PCT” or “PCT only” Pharmaceutical that DHBs must provide access to for use in their hospitals, and/or in association with Outpatient services provided in their DHB Hospitals, in relation to the treatment of cancers. “Price” means the standard national price, and, unless agreed otherwise between PHARMAC and the pharmaceutical supplier, includes any costs associated with the supply of a National Contract Pharmaceutical listed in Section H Part II of the Pharmaceutical Schedule to, at a DHB Hospital’s discretion, any Designated Delivery Point, or to a Contract Manufacturer (expressly for the purpose of compounding). “Schedule” means this Pharmaceutical Schedule and all its sections and appendices. “Total Market Volume” means, for a particular Hospital Pharmaceutical with HSS in any given period, in accordance with the data available to PHARMAC, the sum of: a) the total number of Units of the relevant Hospital Pharmaceutical with HSS purchased by all DHB Hospitals, or by a particular DHB Hospital in the case of the Individual DV Limit; and b) the total number of Units of all the relevant DV Pharmaceuticals purchased by all DHB Hospitals, or by a particular DHB Hospital in the case of the Individual DV Limit. “Unapproved Indication” means, for a Pharmaceutical, an indication for which it is not approved under the Medicines Act 1981. Practitioners prescribing Pharmaceuticals for Unapproved Indications should be aware of, and comply with, their obligations under Section 25 and/or Section 29 of the Medicines Act 1981 and as set out in Part I: General Rules for Hospital Pharmaceuticals, rule 9. “Unit” means an individual unit of a Pharmaceutical (e.g. tablet, 1 ml of an oral liquid, amp, syringe). “Unusual Clinical Circumstances (UCC)” means the pathway under the Named Patient Pharmaceutical Assessment policy for funding consideration for named patients whose clinical circumstances are so unusual that PHARMAC is unlikely, for administrative reasons, to consider listing treatments for these circumstances on the Schedule. “Urgent Assessment (UA)” means the pathway under the Named Patient P harmaceutical Assessment policy for funding consideration for treatments for named patients where PHARMAC is also considering or is likely to consider the treatment for Schedule listing, but the patient’s clinical circumstances justify urgent assessment, prior to a decision on Schedule listing. 1.2 In addition to the above interpretations and definitions, unless the content requires otherwise, a reference in the Schedule to: a) the singular includes the plural; and b) any legislation includes a modification and re-enactment of, legislation enacted in substitution for, and a regulation, Order in Council, and other instrument from time to time issued or made under, that legislation, where that legislation, regulation, Order in Council or other instrument has an effect on the prescribing, dispensing or subsidising of Pharmaceuticals. 2 Current Hospital Pharmaceutical Contracts 2.1 A DHB Hospital may enter into a contract for the purchase of any Pharmaceutical that is not a National Contract Pharmaceutical, provided that such contract: a) does not oblige the relevant DHB Hospital to purchase a volume of that Pharmaceutical, if that Pharmaceutical is a DV Pharmaceutical, that is greater than the relevant DV Limit; b) enables PHARMAC to access and use future price and volume data in respect of that Pharmaceutical; and c) enables the relevant DHB Hospital to terminate the contract or relevant parts of the contract in order to give full effect to the national contract on 3 months’ written notice to the pharmaceutical supplier.

11


Part I: General Rules for Hospital Pharmaceuticals

2.2 From the day after a DHB Hospital’s current supply contract for a chemical entity that is a National Contract Pharmaceutical expires, that DHB Hospital is to purchase the relevant National Contract Pharmaceutical listed in Section H Part II at the Price, and is to comply with the DV Limits for the National Contract Pharmaceutical where it has HSS. 2.3 Following written notification from PHARMAC that a Pharmaceutical is a National Contract Pharmaceutical, either through Section H updates or otherwise, DHB Hospitals are to take any steps available to them to terminate current contracts, and are not to enter into any new contracts or extend the period of any current contracts, for the supply of that National Contract Pharmaceutical listed in Section H Part II or the relevant chemical entity, unless PHARMAC expressly notifies otherwise. 3 National Contract Pharmaceutical Price 3.1 DHB Hospitals must take all necessary steps to enable any contracts between PHARMAC and a pharmaceutical supplier in relation to National Contract Pharmaceuticals to be given full effect. 3.2 National Contract Pharmaceuticals that can be purchased by DHBs at the relevant Price, as agreed between PHARMAC and the relevant pharmaceutical supplier, are hereby deemed to include every medicine, therapeutic medical device, or related product or related thing listed in Section H Part II of the Schedule except DV Pharmaceuticals. 3.3 A National Contract Pharmaceutical is to be made available by the relevant pharmaceutical supplier for purchase at the relevant Price by any or all of the following: a) DHB Hospitals at Designated Delivery Points; and/or b) Contract Manufacturers (expressly for the purpose of compounding). 4 Hospital Supply Status (HSS) 4.1 The DV Limit for any National Contract Pharmaceutical which has HSS is set out beside the listing of the relevant National Contract Pharmaceutical in Section H Part II of the Schedule and may be amended from time to time. 4.2 If a National Contract Pharmaceutical is listed in Section H Part II as having HSS, DHB Hospitals: a) are expected to use up any existing stocks of DV Pharmaceuticals during the First Transition Period; b) must not purchase DV Pharmaceuticals in volumes exceeding their usual requirements, or in volumes exceeding those which they reasonably expect to use, within the First Transition Period; and c) must purchase the Hospital Pharmaceutical with HSS except: i) to the extent that the DHB Hospital may use its discretion to purchase a DV Pharmaceutical within the DV Limit, provided that (subject to subclause (iii) below) the DV Limit has not been exceeded nationally; ii) if the pharmaceutical supplier fails to supply that Hospital Pharmaceutical, in which case the relevant DHB Hospital does not have to comply with the DV Limit for that Hospital Pharmaceutical during that period of non-supply (and any such month(s) included in a period of non-supply will be excluded in any review of the DV Limit in accordance with clause 4.3 below); iii) that where the DV Limit has been exceeded nationally, the DHB Hospital may negotiate with the pharmaceutical supplier who supplies the National Contract Pharmaceutical with HSS for written permission to vary the application of that DHB Hospital’s Individual DV Limit for any patient whose exceptional needs require a DV Pharmaceutical. 4.3 PHARMAC may, in its discretion, for any period or part period: a) review usage by DHB Hospitals of the National Contract Pharmaceutical and DV Pharmaceuticals to determine whether the DV Limit has been exceeded; and b) audit compliance by DHBs with the DV Limits and related requirements. 4.4 PHARMAC will address any issues of non-compliance by any individual DHB with a DV Limit by: a) obtaining the relevant DHB’s assurance that it will comply with the DV Limit for that National Contract Pharmaceutical with HSS in the remainder of the applicable period and any subsequent periods; and b) informing the relevant supplier of the HSS Pharmaceutical of any individual DHB’s non-compliance with the DV Limit for that HSS Pharmaceutical. 4.5 In addition to the steps taken by PHARMAC under clause 4.4 above to address any issues of non-compliance by any individual DHB with a DV Limit, the relevant pharmaceutical supplier may require, in its discretion, financial compensation from the relevant DHB: a) an amount representing its contribution towards exceeding the DV Limit (where PHARMAC is able to quantify this based on the information available to it); or b) the sum of $1,000 or $5,000 (depending on the terms of the applicable national contract applying to the HSS Pharmaceutical), whichever is the greater as between sub-paragraphs (a) and (b) within the number of business days specified in the notice requiring such payment to be made.

12


Part I: General Rules for Hospital Pharmaceuticals

5 Collection of rebates and payment of financial compensation 5.1 Following the receipt of any rebates from a pharmaceutical supplier in respect of a particular Hospital Pharmaceutical, PHARMAC will notify each relevant DHB and DHB Hospital of the amount of the rebate owing to it, being a portion of the total rebate determined by PHARMAC on the basis of that DHB Hospital’s usage of that Hospital Pharmaceutical, where this is able to be determined. Where data to determine individual DHB Hospitals’ usage is not available, PHARMAC will apportion rebates on the basis of an alternative method agreed between the relevant DHBs and PHARMAC. 5.2 PHARMAC will pay each DHB Hospital the rebate amounts (if any) owing to it, no less frequently than once each calendar quarter in respect of rebates received quarterly (or more often). 6 Price and Volume Data 6.1 DHB Hospitals are to provide to PHARMAC, on a monthly basis in accordance with PHARMAC’s requirements, any volume data and, unless it would result in a breach of an existing contract, price data held by those DHB Hospitals in respect of any Hospital Pharmaceuticals listed in Section H of the Schedule. 6.2 All price and volume data provided to PHARMAC under clause 6.1 above should identify the relevant Hospital Pharmaceutical by using a Pharmacode or some other unique numerical identifier, and the date (month and year) on which the DHB Hospital incurred a cost for the purchase of that Pharmaceutical. Volume is to be measured in units (that being the smallest possible whole unit – e.g. a capsule, a vial, a millilitre etc). 7 Discretionary Community Supply Pharmaceuticals 7.1 Discretionary Community Supply Pharmaceuticals are deemed to include every medicine, therapeutic medical device, or related product or related thing listed in Section H Part III of the Schedule. 7.2 PHARMAC may, in its discretion, list any pharmaceutical that is not a Community Pharmaceutical as a Discretionary Community Supply Pharmaceutical, including a pharmaceutical that PHARMAC is made aware of by HPAC, the Named Patient Pharmaceutical Assessment Advisory Panel, a DHB Hospital or relevant hospital personnel. 7.3 A DHB Hospital may use its discretion to purchase Discretionary Community Supply Pharmaceuticals for use in the community, provided that, if the patient being treated with a Discretionary Community Supply Pharmaceutical usually resides in a district other than that within the jurisdiction of the DHB initiating the treatment, then the DHB initiating the treatment must either agree to fund any on-going treatment required once the patient has returned to his/her usual DHB, or obtain written consent from the DHB or DHBs in which the patient will reside following the commencement of treatment. 7.4 The funding of a Discretionary Community Supply Pharmaceutical for use in the community will be sourced from the relevant DHB’s own budget. For the avoidance of doubt, the Discretionary Community Supply Pharmaceutical is not a Community Pharmaceutical and funding is not available for Discretionary Community Supply Pharmaceuticals from the Pharmaceutical Budget. 7.5 Subject to rule 7.6 and 7.7, DHB Hospitals must not fund for use in the community, any pharmaceuticals that are not Discretionary Community Supply Pharmaceuticals unless they have been approved under Hospital Pharmaceuticals in the community (HPC). 7.6 DHB Hospitals may fund from their own budgets, any Pharmaceutical that is listed in Sections A-G of the Pharmaceutical Schedule without Hospital Hospital Pharmaceuticals in the community (HPC) approval provided that: a) the quantity supplied does not exceed that sufficient for: i) up to 5 days treatment, or one original pack, (where inappropriate to provide less); or ii) more than 5 days treatment, provided that the relevant DHB Hospital has a dispensing for discharge policy and the quantity supplied is in accordance with that policy; and b) the Pharmaceutical is supplied consistent with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule. Note dispensing for discharge as described in rule 7.6 is at the discretion of individual DHBs. 7.7 DHB Hospitals may fund from their own budgets any Pharmaceutical without Hospital Exceptional Circumstances approval provided that the Pharmaceutical is only being supplied to the patient for them to use in the 24 hours leading up to a procedure to be performed in a DHB Hospital.

13


Part I: General Rules for Hospital Pharmaceuticals

8 Pharmaceutical Cancer Treatments 8.1 DHBs must provide access to Pharmaceutical Cancer Treatments for the treatment of cancers in their DHB hospitals, and/or in association with Outpatient services provided in their DHB hospitals. 8.2 Pharmaceutical Cancer Treatments may be used in combination with each other, including where such combinations result in admixtures or dilutions that differ from those specified. 8.3 DHBs must only provide access to Pharmaceuticals for the treatment of cancer that are listed as Pharmaceutical Cancer Treatments in Sections A to G of the Schedule, provided that DHBs may provide access to an unlisted pharmaceutical for the treatment of cancer where that unlisted pharmaceutical: a) has Named Patient Pharmaceutical Assessment (NPPA) approval; b) is being used as part of a bona fideclinical trial which has Ethics Committee approval; c) is being used and funded as part of a paediatric oncology service; or d) was being used to treat the patient in question prior to 1 July 2005. 8.4 Some indications for Pharmaceutical Cancer Treatments listed in the Schedule are Unapproved Indications. Some of these formed part of the October 2001 decision by the Minister of Health as to pharmaceuticals and indications for which DHBs must provide funding. As far as reasonably practicable, these Unapproved Indications are marked in the Schedule. However, PHARMAC makes no representation and gives no guarantee as to the accuracy of this information. Practitioners prescribing Pharmaceutical Cancer Treatments for Unapproved Indications should: a) be aware of and comply with their obligations under sections 25 and 29 of the Medicines Act 1981, as applicable, and otherwise under that Act and the Medicines Regulations 1984; b) be aware of and comply with their obligations under the Health and Disability Commissioner’s Code of Consumer Rights, including the requirement to obtain informed consent from the patient (PHARMAC recommends that Practitioners obtain written consent); and c) exercise their own skill, judgment, expertise and discretion, and make their own prescribing decisions with respect to the use of an unapproved Pharmaceutical Cancer Treatment or a Pharmaceutical Cancer Treatment for an Unapproved Indication. 8.5 Applications to add pharmaceuticals, and add or amend indications for Pharmaceutical Cancer Treatments, may be made in writing by pharmaceutical suppliers and/or clinicians to PHARMAC. Applications should follow the Guidelines for Funding Applications to PHARMAC 2010, copies of which are available from PHARMAC or PHARMAC’s website. 9 Practitioners prescribing unapproved Pharmaceuticals Practitioners should, where possible, prescribe Pharmaceuticals that are approved under the Medicines Act 1981. However, the access criteria under which a Pharmaceutical is listed on the Pharmaceutical Schedule may: a) in some case, explicitly permit Government funded access to a Pharmaceutical that is not approved under the Medicines Act 1981 or for an Unapproved Indication; or b) not explicitly preclude Government funded access to a Pharmaceutical when it is used for an Unapproved Indication. Accordingly, if Practitioners are planning on prescribing an unapproved Pharmaceutical or a Pharmaceutical for an Unapproved Indication, Practitioners should: a) be aware of and comply with their obligations under sections 25 and 29 of the Medicines Act 1981, as applicable, and otherwise under that Act and the Medicines Regulations 1984; b) be aware of and comply with their obligations under the Health and Disability Commissioner’s Code of Consumer Rights, including the requirement to obtain informed consent from the patient (PHARMAC recommends that Practitioners obtain written consent); and c) exercise their own skill, judgment, expertise and discretion, and make their own prescribing decisions with respect to the use of an unapproved Pharmaceutical or a Pharmaceutical for an Unapproved Indication. Practitioners should be aware that simply by listing a Pharmaceutical on the Pharmaceutical Schedule PHARMAC makes no representations about whether that Pharmaceutical has any form of approval or consent under, or whether the supply or use of the Pharmaceutical otherwise complies with, the Medicines Act 1981. Further, the Pharmaceutical Schedule does not constitute an advertisement, advertising material or a medical advertisement as defined in the Medicines Act or otherwise.

14


Part II: Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ABACAVIR SULPHATE Tab 300 mg – 1% DV Jul-11 to 2014 ...........................................................229.00 Oral liq 20 mg per ml – 1% DV Jul-11 to 2014 ..............................................50.00 ABACAVIR SULPHATE WITH LAMIVUDINE Tab 600 mg with lamivudine 300 mg ............................................................630.00 ABCIXIMAB Inj 10 mg .......................................................................................................579.53 ACARBOSE Tab 50 mg – 1% DV Dec-12 to 2015 ...............................................................9.82 Tab 100 mg – 1% DV Dec-12 to 2015 ...........................................................15.83 ACETAZOLAMIDE Tab 250 mg – 1% DV Nov-11 to 2014 ...........................................................17.03 ACETYLCYSTEINE Inj 200 mg per ml, 10 ml – 1% DV Jul-12 to 2015 .......................................178.00 Inj 200 mg per ml, 30 ml ...............................................................................219.00 ACICLOVIR Tab dispersible 200 mg – 1% DV Dec-10 to 2013 ...........................................1.98 Tab dispersible 400 mg – 1% DV Dec-10 to 2013 ...........................................6.64 Tab dispersible 800 mg – 1% DV Dec-10 to 2013 ...........................................7.38 Inj 250 mg – 1% DV Mar-13 to 2015..............................................................14.09 ACITRETIN Cap 10 mg ......................................................................................................38.66 35.95 Cap 25 mg ......................................................................................................83.11 85.40 ACTIVATED CHARCOAL Oral liq 50 g per 250 ml ..................................................................................43.50 ADALIMUMAB Inj 40 mg per 0.8 ml prefilled pen ..............................................................1,799.92 Inj 40 mg per 0.8 ml prefilled syringe ........................................................1,799.92 ADEFOVIR DIPIVOXIL Tab 10 mg .....................................................................................................670.00 ADRENALINE Inj 1 in 1,000, 1 ml ............................................................................................4.98 5.25 Inj 1 in 10,000, 10 ml ......................................................................................27.00 49.00 ALENDRONATE SODIUM Tab 40 mg .....................................................................................................133.00 Tab 70 mg .......................................................................................................22.90 ALENDRONATE SODIUM WITH CHOLECALCIFEROL Tab 70 mg with cholecalciferol 5,600 iu ..........................................................22.90 ALFACALCIDOL Cap 0.25 µg ....................................................................................................26.32 Cap 1 µg .........................................................................................................87.98

60 240 ml 30 1 90 90 100 10 4 25 56 35 5 60 100 60 100 250 ml 2 2 30 5 5 10 30 4 4 100 100

Ziagen Ziagen Kivexa ReoPro Accarb Accarb Diamox Martindale Acetylcysteine Acetadote Lovir Lovir Lovir Zovirax IV Novatretin Neotigason Novatretin Neotigason Carbosorb-X HumiraPen Humira Hepsera Aspen Adrenaline Mayne Mayne Aspen Adrenaline Fosamax Fosamax Fosamax Plus One-Alpha One-Alpha

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

15


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ALLOPURINOL Tab 100 mg – 1% DV Dec-11 to 2014 ...........................................................15.90 Tab 300 mg – 1% DV Dec-11 to 2014 ...........................................................16.75 ALPROSTADIL Inj 0.5 mg per ml, 1 ml – 1% DV Oct-12 to 2015 ......................................1,417.50 AMANTADINE HYDROCHLORIDE Cap 100 mg – 1% DV Sep-11 to 2014...........................................................38.24 AMBRISENTAN Tab 5 mg ....................................................................................................4,585.00 Tab 10 mg ..................................................................................................4,585.00 AMIKACIN SULPHATE Inj 5 mg per ml, 5 ml – 1% DV Nov-12 to 2014............................................176.00 AMILORIDE Oral liq 1 mg per ml ........................................................................................30.00 AMINO ACID FORMULA Powder (unflavoured) .......................................................................................6.00 53.00 56.00 Powder (vanilla) ..............................................................................................53.00 56.00 AMINOACID WITHOUT PHENYLALANINE Liquid (berry) ..................................................................................................13.10 Liquid (orange) ...............................................................................................13.10 Liquid (unflavoured) ........................................................................................13.10 AMINOPHYLLINE Inj 25 mg per ml, 10 ml – 1% DV Nov-11 to 2014..........................................53.75 AMISULPRIDE Tab 100 mg .....................................................................................................22.52 Tab 200 mg .....................................................................................................97.03 Tab 400 mg ...................................................................................................185.44 Oral liq 100 mg per ml ....................................................................................55.44 AMITRIPTYLINE Tab 10 mg – 1% DV Jan-13 to 2014................................................................3.32 Tab 25 mg – 1% DV Jun-11 to 2014................................................................1.85 Tab 50 mg – 1% DV Jun-11 to 2014................................................................3.60 AMLODIPINE Tab 2.5 mg – 1% DV Mar-12 to 2014...............................................................2.45 Tab 5 mg – 1% DV Oct-11 to 2014 ..................................................................2.65 Tab 10 mg – 1% DV Oct-11 to 2014 ................................................................4.15

1,000 500 5 60 30 30 10 25 ml 48.5 g 400 g

Apo-Allopurinol Apo-Allopurinol Prostin VR Symmetrel Volibris Volibris Biomed Biomed Vivonex Paediatric Elecare Elecare LCP Neocate Gold Elecare Neocate Advance PKU Anamix Junior LQ PKU Anamix Junior LQ PKU Anamix Junior LQ DBL Aminophylline Solian Solian Solian Solian Arrow-Amitriptyline Amitrip Amitrip Apo-Amlodipine Apo-Amlodipine Apo-Amlodipine

400 g

125 ml 125 ml 125 ml 5 30 60 60 60 ml 100 100 100 100 100 100

16

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

AMOXYCILLIN Cap 250 mg – 1% DV Dec-10 to 2013...........................................................16.18 Cap 500 mg – 1% DV Dec-10 to 2013...........................................................26.50 Drops 100 mg per ml ........................................................................................4.00 Grans for oral liq 125 mg per 5 ml ....................................................................1.55 Grans for oral liq 250 mg per 5 ml ....................................................................1.10 Inj 250 mg – 1% DV Nov-11 to 2014 .............................................................12.96 Inj 500 mg – 1% DV Nov-11 to 2014 .............................................................15.08 Inj 1 g – 1% DV Nov-11 to 2014 ....................................................................21.94 AMOXYCILLIN CLAVULANATE Tab amoxycillin 500 mg with potassium clavulanate 125 mg – 1% DV Aug-12 to 2014 ........................................................................................ 12.55 Grans for oral liq 125 mg with potassium clavulanate 31.25 mg per 5 ml – 1% DV Nov-12 to 2015 ..................................................................... 1.61 Grans for oral liq 250 mg with potassium clavulanate 62.5 mg per 5 ml – 1% DV Nov-12 to 2015 ........................................................................... 2.19 Inj 600 mg – 1% DV Jan-13 to 2015..............................................................10.14 Inj 1.2 g – 1% DV Jan-13 to 2015..................................................................14.03 AMPHOTERICIN B Liposomal inj 50 mg – 1% DV Oct-12 to 2015..........................................3,450.00 Lozenges 10 mg ...............................................................................................5.86 ANASTROZOLE Tab 1 mg .........................................................................................................26.55 ANTITHYMOCYTE GLOBULIN (EQUINE) Inj 50 mg per ml, 5 ml ................................................................................2,137.50 APOMORPHINE HYDROCHLORIDE Inj 10 mg per ml, 2 ml ...................................................................................110.00 APREPITANT Cap 2 × 80 mg and 1 × 125 mg ..................................................................116.00 AQUEOUS CREAM Crm 100 g – 1% DV Sep-11 to 2014 ...............................................................1.23 Note: DV Limit applies to pack sizes of 100 g or less. Crm 500 g – 1% DV Sep-11 to 2014 ...............................................................1.96 Note: DV Limit applies to pack sizes of greater than 100 g. ARIPIPRAZOLE Tab 10 mg .....................................................................................................123.54 Tab 15 mg .....................................................................................................175.28 Tab 20 mg .....................................................................................................213.42 Tab 30 mg .....................................................................................................260.07 ARSENIC TRIOXIDE Inj 10 mg ....................................................................................................4,817.00 ASCORBIC ACID Tab 100 mg – 1% DV Oct-10 to 2013 ............................................................13.80 ATAZANAVIR SULPHATE Cap 150 mg ..................................................................................................568.34 Cap 200 mg ..................................................................................................757.79

500 500 30 ml 100 ml 100 ml 10 10 10

Alphamox Alphamox Ospamox Ospamox Ospamox Ibiamox Ibiamox Ibiamox

100 100 ml 100 ml 10 10 10 20 30

Curam Duo Augmentin Augmentin m-Amoxiclav m-Amoxiclav AmBisome Fungilin Aremed DP-Anastrozole ATGAM Apomine Emend Tri-Pack AFT AFT

5 5 3 100 g 500 g

30 30 30 30 10 500 60 60

Abilify Abilify Abilify Abilify AFT Vitala-C Reyataz Reyataz

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

17


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ATENOLOL Tab 50 mg – 1% DV Oct-12 to 2015 ................................................................5.56 Tab 100 mg – 1% DV Oct-12 to 2015 ..............................................................9.12 Oral liq 25 mg per 5 ml ...................................................................................21.25 ATOMOXETINE HYDROCHLORIDE Cap 10 mg ....................................................................................................107.03 Cap 18 mg ....................................................................................................107.03 Cap 25 mg ....................................................................................................107.03 Cap 40 mg ....................................................................................................107.03 Cap 60 mg ....................................................................................................107.03 Cap 80 mg ....................................................................................................139.11 Cap 100 mg ..................................................................................................139.11 ATORVASTATIN Tab 10 mg – 1% DV Oct-12 to 2015 ................................................................2.52 Tab 20 mg – 1% DV Oct-12 to 2015 ................................................................4.17 Tab 40 mg – 1% DV Oct-12 to 2015 ................................................................7.32 Tab 80 mg – 1% DV Oct-12 to 2015 ..............................................................16.23 ATRACURIUM BESYLATE Inj 10 mg per ml, 2.5 ml – 1% DV Sep-12 to 2015...........................................6.13 Inj 10 mg per ml, 5 ml – 1% DV Sep-12 to 2015..............................................9.19 ATROPINE SULPHATE Eye drops 1% .................................................................................................17.36 Inj 600 µg, 1 ml – 1% DV Jan-13 to 2015......................................................71.00 AZATHIOPRINE Tab 50 mg – 1% DV Oct-10 to 2013 ..............................................................18.45 Inj 50 mg – 1% DV Oct-10 to 2013 ................................................................60.00 AZITHROMYCIN Tab 250 mg .....................................................................................................10.00 Tab 500 mg – 1% DV Feb-13 to 2015..............................................................1.25 Grans for oral liq 200 mg per 5 ml ....................................................................6.60 AZTREONAM Inj 1 g – 1% DV Sep-11 to 2014 ..................................................................131.00

500 500 300 ml 28 28 28 28 28 28 28 90 90 90 90 5 5 15 ml 50 100 1 30 2 15 ml 5

Mylan Atenolol Mylan Atenolol Atenolol AFT Strattera Strattera Strattera Strattera Strattera Strattera Strattera Zarator Zarator Zarator Zarator Tracrium Tracrium Atropt AstraZeneca Imuprine Imuran Imuran Apo-Azithromycin Apo-Azithromycin Zithromax Azactam

BACILLUS CALMETTE-GUERIN (BCG) VACCINE a) Note: Subsidised only for bladder cancer. b) Note: Any BCG injection containing equal to or greater than 500 million CFU is considered a DV Pharmaceutical. Inj 2-8 × 100 milliion CFU – 1% DV Jan-11 to 2013 ...................................187.37 1 OncoTICE BACLOFEN Tab 10 mg .........................................................................................................5.10 Inj 0.05 mg per ml, 1 ml – 1% DV Oct-12 to 2015 .........................................11.55 Inj 2 mg per ml, 5 ml – 1% DV Oct-12 to 2015 ............................................209.29 BARIUM SULPHATE Oral suspension 2.2%, 250 ml ......................................................................175.00 Oral suspension 2.2%, 450 ml ......................................................................220.00 BASILIXIMAB Inj 20 mg amp ............................................................................................3,200.00 100 1 1 24 24 1 Pacifen Lioresal Intrathecal Lioresal Intrathecal CT Plus+ CT Plus+ Simulect

18

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

BECLOMETHASONE DIPROPIONATE Aerosol inhaler, 50 µg per dose CFC-free ........................................................8.54 Metered aqueous nasal spray, 50 µg per dose ................................................4.85 Aerosol inhaler, 100 µg per dose CFC-free ....................................................12.50 Metered aqueous nasal spray, 100 µg per dose ..............................................5.75 Aerosol inhaler, 250 µg per dose CFC-free ....................................................22.67 BENDROFLUAZIDE Tab 2.5 mg – 1% DV Sep-11 to 2014 ..............................................................6.48 Tab 5 mg – 1% DV Sep-11 to 2014 .................................................................9.95 BENZATHINE BENZYLPENICILLIN Inj 1.2 mega u per 2.3 ml – 1% DV Sep-12 to 2015 ....................................315.00 BENZTROPINE MESYLATE Tab 2 mg ...........................................................................................................7.99 Inj 1 mg per ml, 2 ml .......................................................................................95.00 BENZYLPENICILLIN SODIUM (PENICILLIN G) Inj 600 mg – 1% DV Nov-11 to 2014 .............................................................11.50 BERACTANT Inj 25 mg per ml, 8 ml intratracheal ..............................................................550.00 BETAHISTINE DIHYDROCHLORIDE Tab 16 mg .......................................................................................................10.00 BETAMETHASONE DIPROPIONATE WITH CALCIPOTRIOL Oint 500 µg with calcipotriol 50 µg .................................................................26.12 Topical gel 500 µg with calcipotriol 50 µg ......................................................26.12 BETAMETHASONE VALERATE Scalp app 0.1% ................................................................................................7.75 BEZAFIBRATE Tab 200 mg – 1% DV Mar-13 to 2015..............................................................9.70 Tab long-acting 400 mg – 1% DV Oct-12 to 2015 ...........................................5.70 BICALUTAMIDE Tab 50 mg – 1% DV Nov-11 to 2014 .............................................................10.00 BISACODYL Tab 5 mg – 1% DV Sep-10 to 2013 .................................................................4.99 Suppos 5 mg ....................................................................................................3.00 Suppos 10 mg ..................................................................................................3.00 BISOPROLOL FUMARATE Tab 2.5 mg ........................................................................................................3.88 Tab 5 mg ...........................................................................................................4.74 Tab 10 mg .........................................................................................................9.18 BLOOD GLUCOSE DIAGNOSTIC TEST METER 1 meter with 50 lancets, a lancing device, and 10 diagnostic test strips .........20.00

200 dose 200 dose 200 dose 200 dose 200 dose 500 500 10 60 5 10 1 84 30 g 30 g 100 ml 90 30 28 200 6 6 30 30 30 1

Beclazone 50 Alanase Beclazone 100 Alanase Beclazone 250 Arrow-Bendrofluazide Arrow-Bendrofluazide Bicillin LA Benztrop Cogentin Sandoz Survanta Vergo 16 Daivobet Daivobet Beta Scalp Bezalip Bezalip Retard Bicalaccord Lax-Tabs Dulcolax Dulcolax Bosvate Bosvate Bosvate CareSens II CareSens N CareSens N POP Accu-Chek Performa FreeStyle Lite On Call Advanced

Meter ..............................................................................................................19.00 9.00

1

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

19


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

BLOOD GLUCOSE DIAGNOSTIC TEST STRIP Blood glucose test strips ................................................................................28.75 10.56 21.65 28.75 Blood glucose test strips × 50 and lancets × 5 .............................................19.10 BLOOD KETONE DIAGNOSTIC TEST METER Meter ..............................................................................................................40.00 BORTEZOMIB Inj 1 mg .........................................................................................................540.70 Inj 3.5 mg ...................................................................................................1,892.50 BOSENTAN Tab 62.5 mg ...............................................................................................4,585.00 Tab 125 mg ................................................................................................4,585.00 BRIMONIDINE TARTRATE Eye drops 0.2% – 1% DV Jul-12 to 2014 ........................................................6.45 BUDESONIDE Metered aqueous nasal spray, 50 µg per dose ................................................4.85 Metered aqueous nasal spray, 100 µg per dose ..............................................5.75 Powder for inhalation, 200 µg per dose ..........................................................15.20 Powder for inhalation, 400 µg per dose ..........................................................25.60 BUMETANIDE Tab 1 mg .........................................................................................................16.36 BUPIVACAINE HYDROCHLORIDE Inf 0.25%, 100 ml theatre pack .....................................................................150.00 Inj 0.5%, 4 ml ..................................................................................................50.00 Inj 0.5%, 8% glucose, 4 ml .............................................................................38.00 Inj 0.25%, 20 ml – 1% DV Oct-12 to 2015 .....................................................35.00 Inj 0.5%, 10 ml ................................................................................................35.00 Inj 0.5%, 10 ml theatre pack – 1% DV Oct-12 to 2015 ..................................28.00 Inj 0.5%, 20 ml theatre pack – 1% DV Oct-12 to 2015 ..................................28.00 BUPIVACAINE HYDROCHLORIDE WITH ADRENALINE Inj 0.25% with 1:400,000 adrenaline, 20 ml – 1% DV Nov-11 to 2014 .........135.00 Inj 0.5% with 1:200,000 adrenaline, 20 ml – 1% DV Nov-11 to 2014 ..........115.00 BUPIVACAINE HYDROCHLORIDE WITH FENTANYL Inf 0.125% with 2 µg fentanyl per ml, 100 ml bag – 1% DV Nov-11 to 2014 ................................................................................................... 210.00 Inf 0.125% with 2 µg fentanyl per ml, 200 ml bag – 1% DV Nov-11 to 2014 ................................................................................................... 210.00 Inj 0.125% with 2 µg fentanyl per ml, 15 ml prefilled syringe – 1% DV Nov-11 to 2014 ........................................................................................ 72.00 Inj 0.125% with 2 µg fentanyl per ml, 20 ml prefilled syringe – 1% DV Nov-11 to 2014 ........................................................................................ 92.00

50 test

50 test 1 1 1 60 60 5 ml 200 dose 200 dose 200 dose 200 dose 100 5 5 5 5 50 5 5 5 5

Accu-Chek Performa CareSens CareSens N FreeStyle Lite Freestyle Optium On Call Advanced Freestyle Optium Velcade Velcade Tracleer Tracleer Arrow-Brimonidine Butacort Aqueous Butacort Aqueous Budenocort Budenocort Burinex Marcain Marcain Isobaric Marcain Heavy Marcain Marcain Marcain Marcain Marcain with Adrenaline Marcain with Adrenaline

10 10 10 10

Bupafen Bupafen Biomed Biomed

20

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

BUPRENORPHRINE WITH NALOXONE Tab sublingual 2 mg with naloxone 0.5 mg .....................................................57.40 Tab sublingual 8 mg with naloxone 2 mg ......................................................166.00 BUPROPION HYDROCHLORIDE Tab modified-release 150 mg .........................................................................65.00 BUSPIRONE HYDROCHLORIDE Tab 5 mg .........................................................................................................28.00 Tab 10 mg .......................................................................................................17.00 BUSULPHAN Tab 2 mg .........................................................................................................59.50 CABERGOLINE Tab 0.5 mg – 1% DV Sep-12 to 2015 ..............................................................6.25 25.00 CAFFEINE CITRATE Oral liq 20 mg per ml (10 mg base per ml) .....................................................14.85 Inj 20 mg per ml (10 mg base per ml), 2.5 ml .................................................55.75 CALAMINE Crm aqueous, BP – 1% DV Mar-13 to 2015 ....................................................1.77 Lotn, BP – 1% DV Nov-12 to 2015 ................................................................13.45 CALCIPOTRIOL Crm 50 µg per g .............................................................................................45.00 Oint 50 µg per g .............................................................................................45.00 Soln 50 µg per ml ...........................................................................................16.00 CALCITONIN Inj 100 u per ml, 1 ml – 1% DV Sep-11 to 2014...........................................110.00 CALCITRIOL Cap 0.25 µg ......................................................................................................3.03 10.10 Cap 0.5 µg ........................................................................................................5.62 18.73 Oral liq 1 µg per ml .........................................................................................39.40 CALCIUM CARBONATE Tab 1.25 g (500 mg elemental) – 1% DV Feb-12 to 2014................................6.38 Tab eff 1.75 g (1 g elemental) – 1% DV Nov-11 to 2014 .................................6.21 Oral liq 1,250 mg per 5 ml (500 mg elemental per 5 ml) ................................39.00 CALCIUM FOLINATE Tab 15 mg – 1% DV Nov-11 to 2014 .............................................................82.45 Inj 50 mg – 1% DV Sep-08 to 2014 ...............................................................24.50 Inj 100 mg – 1% DV Sep-08 to 2014 ...............................................................9.75 Inj 300 mg – 1% DV Sep-08 to 2014 .............................................................30.00 Inj 1 g – 1% DV Sep-08 to 2014 ....................................................................90.00

28 28 30 100 100 100 2 8 25 ml 5 100 g 2,000 ml 100 g 100 g 30 ml 5 30 100 30 100 10 ml 250 30 500 ml 10 5 1 1 1

Suboxone Suboxone Zyban Pacific Buspirone Pacific Buspirone Myleran Dostinex Dostinex Biomed Biomed Pharmacy Health PSM Daivonex Daivonex Daivonex Miacalcic Airflow Calcitriol-AFT Airflow Calcitriol-AFT Rocaltrol Arrow-Calcium Calsource Roxane DBL Leucovorin Calcium Calcium Folinate Ebewe Calcium Folinate Ebewe Calcium Folinate Ebewe Calcium Folinate Ebewe

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

21


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CALCIUM GLUCONATE Inj 10%, 10 ml .................................................................................................21.40 Gel, 2.5%, 50 g ...............................................................................................21.00 CALCIUM POLYSTYRENE SULPHONATE Powder ..........................................................................................................169.85 CANDESARTAN Tab 4 mg – 1% DV Nov-12 to 2015 .................................................................4.13 Tab 8 mg – 1% DV Nov-12 to 2015 .................................................................6.10 Tab 16 mg – 1% DV Nov-12 to 2015 .............................................................10.18 Tab 32 mg – 1% DV Nov-12 to 2015 .............................................................17.66 CAPECITABINE Tab 150 mg ...................................................................................................115.00 Tab 500 mg ...................................................................................................705.00 CAPSAICIN Crm 0.025% .....................................................................................................9.95 Crm 0.075% ...................................................................................................12.50 CAPTOPRIL Tab 12.5 mg – 1% DV Jan-11 to 2013.............................................................2.00 Tab 25 mg – 1% DV Jan-11 to 2013................................................................2.40 Tab 50 mg – 1% DV Jan-11 to 2013................................................................3.50 Oral liq 5 mg per ml – 1% DV Nov-10 to 2013...............................................94.99 CARBOPLATIN Inj 10 mg per ml, 5 ml .....................................................................................20.00 Inj 10 mg per ml, 15 ml – 1% DV Jan-13 to 2015 ..........................................19.50 Inj 10 mg per ml, 45 ml – 1% DV Jan-13 to 2015 ..........................................48.50 Inj 10 mg per ml, 100 ml ...............................................................................105.00 CARVEDILOL Tab 6.25 mg ....................................................................................................21.00 Tab 12.5 mg ....................................................................................................27.00 Tab 25 mg .......................................................................................................33.75 CASPOFUNGIN Inj 50 mg – 1% DV Oct-12 to 2015 ..............................................................667.50 Inj 70 mg – 1% DV Oct-12 to 2015 ..............................................................862.50 CEFACLOR MONOHYDRATE Cap 250 mg ....................................................................................................24.57 Grans for oral liq 125 mg per 5 ml – 1% DV Sep-10 to 2013...........................3.53 CEFAZOLIN SODIUM Inj 500 mg – 1% DV Mar-12 to 2014................................................................3.99 Inj 1 g – 1% DV Mar-12 to 2014.......................................................................3.99 CEFEPIME HYDROCHLORIDE Inj 1 g – 1% DV Oct-12 to 2015 .......................................................................8.80 Inj 2 g – 1% DV Oct-12 to 2015 .....................................................................17.60 CEFOTAXIME Inj 500 mg – 1% DV Oct-11 to 2014 ................................................................1.90 Inj 1 g – 1% DV Nov-11 to 2014 ....................................................................15.58 Inj 2 g ................................................................................................................2.60

10 1 300 g 90 90 90 90 60 120 45 g 45 g 100 100 100 95 ml 1 1 1 1 30 30 30 1 1 100 100 ml 5 5 1 1 1 10 1

Mayne healthE Calcium Resonium Candestar Candestar Candestar Candestar Xeloda Xeloda Zostrix Zostrix HP m-Captopril m-Captopril m-Captopril Capoten Carboplatin Ebewe Carbaccord Carbaccord Carboplatin Ebewe Dilatrend Dilatrend Dilatrend Cancidas Cancidas Ranbaxy-Cefaclor Ranbaxy-Cefaclor AFT AFT DBL Cefepime DBL Cefepime Cefotaxime Sandoz DBL Cefotaxime Cefotaxime Sandoz

22

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CEFOXITIN SODIUM Powder for inj 1 g ............................................................................................55.00 CEFTAZIDIME Inj 500 mg – 1% DV Oct-11 to 2014 ................................................................2.37 Inj 1 g – 1% DV Oct-11 to 2014 .......................................................................3.25 Inj 2 g – 1% DV Oct-11 to 2014 .......................................................................6.49 CEFTRIAXONE SODIUM Inf 2 g – 1% DV Nov-10 to 2013 ......................................................................5.20 Inj 500 mg – 1% DV Nov-10 to 2013 ...............................................................2.70 Inj 1 g – 1% DV May-11 to 2013 ....................................................................10.49 CEFUROXIME AXETIL Tab 250 mg .....................................................................................................29.40 CEFUROXIME SODIUM Inj 750 mg – 1% DV Mar-12 to 2014................................................................6.96 Inj 1.5 g – 1% DV Apr-12 to 2014....................................................................2.65 CELIPROLOL Tab 200 mg .....................................................................................................19.00 CEPHALEXIN MONOHYDRATE Cap 500 mg ......................................................................................................8.90 Grans for oral liq 125 mg per 5 ml ....................................................................8.50 Grans for oral liq 250 mg per 5 ml ..................................................................11.50 CETIRIZINE HYDROCHLORIDE Tab 10 mg – 1% DV Sep-11 to 2014 ...............................................................1.59 Oral liq 1 mg per ml – 1% DV Nov-11 to 2014.................................................3.52 CETOMACROGOL Crm BP 100 g ...................................................................................................1.65 Crm BP 500 g ...................................................................................................3.50 CHLORAMPHENICOL Eye oint 1% – 1% DV Jan-13 to 2015..............................................................2.76 Eye drops 0.5% – 1% DV Sep-12 to 2015 .......................................................1.20 CHLORHEXIDINE Crm 1% obstetric – 1% DV Oct-12 to 2015 .....................................................1.24 Soln 0.02% for irrigation ...................................................................................2.92 Soln 0.05% for irrigation ...................................................................................3.02 3.63 Soln 0.1% for irrigation .....................................................................................3.10 Soln 0.5% for irrigation .....................................................................................4.69 Foaming liquid 4%, 50 ml .................................................................................1.86 Soln 5%, 500 ml .............................................................................................15.50 CHLORHEXIDINE GLUCONATE Mouthwash 0.2% – 1% DV Dec-12 to 2015.....................................................2.68 Obstetric lotion 1%, 200 ml ..............................................................................6.75

5 1 1 1 1 1 5 50 5 1 180 20 100 ml 100 ml 100 200 ml 1 1 4g 10 ml 50 g 100 ml 100 ml 500 ml 100 ml 500 ml 1 1 200 ml 1

Mayne Fortum DBL Ceftazidime DBL Ceftazidime Veracol Veracol Aspen Ceftriaxone Zinnat m-Cefuroxime Mylan Celol Cephalexin ABM Cefalexin Sandoz Cefalexin Sandoz Zetop Cetirizine - AFT healthE Pharmacy Health Chlorsig Chlorafast healthE Baxter Baxter Baxter Baxter Baxter healthE healthE healthE healthE

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

23


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CHLORHEXIDINE IN ALCOHOL Soln 0.5% with 70% alcohol, 25 ml (tinted pink) ...............................................1.55 Soln 0.5% with 70% alcohol, 100 ml (tinted pink) .............................................2.65 Soln 0.5% with 70% alcohol, 100 ml (tinted red) ..............................................2.90 Soln 0.5% with 70% alcohol, 500 ml (tinted pink) .............................................5.45 Soln 0.5% with 70% alcohol, 500 ml (tinted red) ..............................................5.90 Soln 2% with 70% alcohol, 100 ml (tinted pink) ................................................3.54 Soln 2% with 70% alcohol, 100 ml (tinted red) .................................................3.86 Soln 2% with 70% alcohol, 500 ml (tinted red) .................................................9.56 CHLORHEXIDINE WITH CETRIMIDE Soln 0.015% with 0.15% cetrimide for irrigation ...............................................3.21 3.47 4.17 Soln 0.05% with 0.5% cetrimide for irrigation ...................................................4.20 3.87 Soln 0.1% with 1% cetrimide for irrigation ........................................................4.38 5.81 CHLOROTHIAZIDE Oral liq 50 mg per ml ......................................................................................26.00 CHLORTHALIDONE Tab 25 mg .........................................................................................................4.80 8.00 CHOLECALCIFEROL Tab 50,000 iu ....................................................................................................7.76 CILAZAPRIL WITH HYDROCHLOROTHIAZIDE Tab 5 mg with 12.5 mg .....................................................................................6.30 CIPROFLOXACIN Tab 250 mg – 1% DV Dec-11 to 2014 .............................................................2.20 Tab 500 mg – 1% DV Dec-11 to 2014 .............................................................3.00 Tab 750 mg – 1% DV Dec-11 to 2014 .............................................................5.15 Inj 2 mg per ml, 100 ml – 1% DV Jun-10 to 2013 ..........................................41.00 CISPLATIN Inj 1 mg per ml, 50 ml – 1% DV Jul-10 to 2013 .............................................15.00 Inj 1 mg per ml, 100 ml – 1% DV Jul-10 to 2013 ...........................................21.00 CITALOPRAM HYDROBROMIDE Tab 20 mg – 1% DV Sep-11 to 2014 ...............................................................2.34 CLADRIBINE Inj 1 mg per ml, 10 ml ................................................................................5,249.72 CLARITHROMYCIN Tab 250 mg – 1% DV Jan-12 to 2014..............................................................4.19 Tab 500 mg – 1% DV Apr-12 to 2014 ............................................................10.95 Grans for oral liq 125 mg per 5 ml ..................................................................23.12 Inj 500 mg – 1% DV Oct-11 to 2014 ..............................................................30.00 CLINDAMYCIN Cap hydrochloride 150 mg – 1% DV May-12 to 2013......................................9.90 Inj phosphate 150 mg per ml, 4 ml – 1% DV Jul-10 to 2013 .......................160.00

1 1 1 1 1 1 1 1 100 ml 500 ml 1,000 ml 100 ml 500 ml 100 ml 500 ml 25 ml 30 50 12 28 28 28 28 10 1 1 84 7 14 14 70 ml 1 16 10

healthE healthE healthE healthE healthE healthE healthE healthE Baxter Baxter Baxter Baxter Baxter Baxter Baxter Biomed Igroton Hygroton Cal-d-Forte Inhibace Plus Cipflox Cipflox Cipflox Aspen Ciprofloxacin Cisplatin Ebewe Cisplatin Ebewe Arrow-Citalopram Leustatin Apo-Clarithromycin Apo-Clarithromycin Klacid Klacid Clindamycin ABM Dalacin C

24

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CLOBETASOL PROPIONATE Crm 0.05% .......................................................................................................3.68 Oint 0.05% ........................................................................................................3.68 Scalp app 0.05% ..............................................................................................6.96 CLOMIPHENE CITRATE Tab 50 mg .......................................................................................................29.84 CLOMIPRAMINE HYDROCHLORIDE Tab 10 mg – 1% DV Jan-13 to 2015..............................................................12.60 Tab 25 mg – 1% DV Jan-13 to 2015................................................................8.68 CLONAZEPAM Tab 500 µg .......................................................................................................6.68 Tab 2 mg .........................................................................................................12.75 Inj 1 mg per ml, 1 ml .......................................................................................19.00 CLONIDINE TDDS 2.5 mg, 100 µg per day .......................................................................23.30 TDDS 5 mg, 200 µg per day ..........................................................................32.80 TDDS 7.5 mg, 300 µg per day .......................................................................41.20 CLONIDINE HYDROCHLORIDE Tab 25 µg .......................................................................................................19.25 Tab 150 µg – 1% DV Feb-13 to 2015 ............................................................34.32 Inj 150 µg per ml, 1 ml – 1% DV Nov-12 to 2015 ..........................................16.07 CLOPIDOGREL Tab 75 mg – 1% DV Nov-10 to 2013 .............................................................16.25 CLOSTRIDUM BOTULINUM Inj 100 u ........................................................................................................467.50 Inj 500 u .....................................................................................................1,295.00 CLOTRIMAZOLE Crm 1% – 1% DV Nov-11 to 2014 ...................................................................0.54 Vaginal crm 1% with applicators – 1% DV Sep-10 to 2013 .............................1.30 Vaginal crm 2% with applicators – 1% DV Sep-10 to 2013 .............................2.50 CLOZAPINE Tab 25 mg .......................................................................................................13.37 26.74 6.69 13.37 Tab 50 mg .........................................................................................................8.67 17.33 Tab 100 mg .....................................................................................................34.65 69.30 17.33 34.65 Tab 200 mg .....................................................................................................34.65 69.30 Oral liq 50 mg per ml ......................................................................................17.33 CO-TRIMOXAZOLE Oral liq 240 mg per 5 ml ...................................................................................2.15 COCAINE Soln 4%, 2 ml .................................................................................................25.46

30 g 30 g 30 ml 10 100 100 100 100 5 4 4 4 100 100 5 90 1 2 20 g 35 g 20 g 50 100 50 100 50 100 50 100 50 100 50 100 100 ml 100 ml 1

Dermol Dermol Dermol Serophene Apo-Clomipramine Apo-Clomipramine Paxam Paxam Rivotril Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Dixarit Catapres Catapres Apo-Clopidogrel Botox Dysport Clomazol Clomazol Clomazol Clozaril Clozaril Clopine Clopine Clopine Clopine Clozaril Clozaril Clopine Clopine Clopine Clopine Clopine Deprim Biomed

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

25


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CODEINE PHOSPHATE Tab 15 mg .........................................................................................................5.39 Tab 30 mg .........................................................................................................8.25 Tab 60 mg .......................................................................................................17.76 COLASPASE (L-ASPARAGINASE) Inj 10,000 iu ..................................................................................................102.32 COLCHICINE Tab 500 µg – 1% DV Sep-10 to 2013 ..............................................................9.60 COLISTIN SULPHOMETHATE Inj 150 mg .......................................................................................................65.00 CORD ORAL FEED 1.5 KCAL/ML Liquid (vanilla) ..................................................................................................1.66 CROTAMITON Crm 10% – 1% DV Sep-12 to 2015 .................................................................3.48 CYCLIZINE HYDROCHLORIDE Tab 50 mg – 1% DV Sep-12 to 2015 ...............................................................0.59 CYCLIZINE LACTATE Inj 50 mg per ml, 1 ml .....................................................................................14.95 CYCLOPHOSPHAMIDE Tab 50 mg – 1% DV Sep-10 to 2013 .............................................................25.71 Inj 1 g – 1% DV Nov-11 to 2014 ....................................................................26.70 Inj 2 g – 1% DV Nov-11 to 2014 ....................................................................56.90 CYCLOSPORIN Cap 25 mg ......................................................................................................44.63 Cap 50 mg ......................................................................................................88.91 Cap 100 mg ..................................................................................................177.81 Oral liq 100 mg per ml – 1% DV Oct-12 to 2015..........................................198.13 Inf 50 mg per ml, 5 ml – 1% DV Oct-12 to 2015 ..........................................276.30 CYPROTERONE ACETATE Tab 50 mg – 1% DV Oct-12 to 2015 ..............................................................18.80 Tab 100 mg – 1% DV Oct-12 to 2015 ............................................................34.25 CYTARABINE Inj 100 mg – 1% DV Aug-10 to 2013 .............................................................76.00 Inj 500 mg – 1% DV Aug-10 to 2013 .............................................................18.15 Inj 1 g – 1% DV Aug-10 to 2013 ....................................................................37.00 Inj 2 g – 1% DV Aug-10 to 2013 ....................................................................31.00 DABIGATRAN Cap 75 mg ....................................................................................................148.00 Cap 110 mg ..................................................................................................148.00 Cap 150 mg ..................................................................................................148.00 DACARBAZINE Inj 200 mg – 1% DV Nov-10 to 2013 .............................................................48.00

100 100 100 1 100 1 237 ml 20 g 10 5 50 1 1 50 50 50 50 ml 10 50 50 5 1 1 1 60 60 60 1

PSM PSM PSM Leunase Colgout Colistin-Link Pulmocare Itch-Soothe Nausicalm Nausicalm Cycloblastin Endoxan Endoxan Neoral Neoral Neoral Neoral Sandimmun Siterone Siterone Pfizer Pfizer Pfizer Pfizer Pradaxa Pradaxa Pradaxa Hospira

26

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

DALTEPARIN SODIUM Inj 2,500 iu per 0.2 ml prefilled syringe ...........................................................19.97 Inj 5,000 iu per 0.2 ml prefilled syringe ...........................................................39.94 Inj 7,500 iu per 0.75 ml graduated syringe .....................................................60.03 Inj 10,000 iu per 1 ml graduated syringe ........................................................77.55 Inj 12,500 iu per 0.5 ml prefilled syringe .........................................................99.96 Inj 15,000 iu per 0.6 ml prefilled syringe .......................................................120.05 Inj 18,000 iu per 0.72 ml prefilled syringe .....................................................158.47 DANAZOL Cap 100 mg ....................................................................................................68.33 Cap 200 mg ....................................................................................................97.83 DANTHRON WITH POLAXAMER Oral liq 25 mg with poloxamer 200 mg per 5 ml .............................................21.30 Oral liq 75 mg with poloxamer 1 g per 5 ml ....................................................43.60 DANTROLENE SODIUM Cap 25 mg ......................................................................................................65.00 Cap 50 mg ......................................................................................................77.00 DANTROLENE SODIUM HEMIHEPTAHYDRATE Inj 20 mg .......................................................................................................800.00 DARUNAVIR Tab 400 mg ...................................................................................................837.50 Tab 600 mg ................................................................................................1,190.00 DASATINIB Tab 20 mg ..................................................................................................3,774.06 Tab 50 mg ..................................................................................................6,214.20 Tab 70 mg ..................................................................................................7,692.58 Tab 100 mg ................................................................................................6,214.20 DAUNORUBICIN Inj 2 mg per ml, 10 ml ...................................................................................118.72 DEFERIPRONE Tab 500 mg ...................................................................................................533.17 Oral liq 100 mg per ml ..................................................................................266.59 DESFERRIOXAMINE MESYLATE Inj 500 mg .......................................................................................................99.00 DESFLURANE Liq 240 ml bottle – 1% DV Dec-12 to 2015...............................................1,230.00 DESMOPRESSIN Tab 100 µg .....................................................................................................36.40 Nasal spray 10 µg per dose – 1% DV Sep-11 to 2014 ..................................27.48 DEXAMETHASONE Eye oint 0.1% – 1% DV Sep-11 to 2014 ..........................................................5.86 Eye drops 0.1% – 1% DV Sep-10 to 2013 .......................................................4.50 Oral liq 1 mg per ml ........................................................................................45.00 Tab 1 mg – 1% DV Aug-12 to 2015 .................................................................5.87 Tab 4 mg – 1% DV Aug-12 to 2015 .................................................................8.16

10 10 10 10 10 10 10 100 100 300 ml 300 ml 100 100 6 60 60 60 60 60 30 1 100 250 ml 10 6 30 6 ml 3.5 g 5 ml 25 ml 100 mg 100 mg

Fragmin Fragmin Fragmin Fragmin Fragmin Fragmin Fragmin Azol Azol Pinorax Pinorax Forte Dantrium Dantrium Dantrium IV Prezista Prezista Sprycel Sprycel Sprycel Sprycel Pfizer Ferriprox Ferriprox Mayne Suprane Minirin Desmopressin-PH&T Maxidex Maxidex Biomed Douglas Douglas

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

27


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

DEXAMETHASONE SODIUM PHOSPHATE Inj 4 mg per ml, 1 ml – 1% DV Aug-10 to 2013 .............................................21.50 Inj 4 mg per ml, 2 ml – 1% DV Aug-10 to 2013 .............................................31.00 DEXAMPHETAMINE SULPHATE Tab 5 mg – 1% DV Mar-13 to 2015................................................................16.50 DEXTRAN 70 WITH SODIUM CHLORIDE Inf 6% with 0.9% sodium chloride ..................................................................16.59 DEXTROSE Inj 50%, 10 ml – 1% DV Sep-11 to 2014 .......................................................19.50 Inj 50%, 90 ml – 1% DV Sep-11 to 2014 .......................................................11.25 DIABETIC ENTERAL FEED 1 KCAL/ML Liquid (vanilla) ..................................................................................................7.50 DIABETIC ORAL FEED 1 KCAL/ML Liquid (vanilla) ..................................................................................................2.10 1.88 DIAZEPAM Tab 2 mg .........................................................................................................11.44 Tab 5 mg .........................................................................................................13.71 Inj 5 mg per ml, 2 ml .........................................................................................9.24 Rectal tubes 5 mg ...........................................................................................25.05 Rectal tubes 10 mg .........................................................................................30.50 DICLOFENAC SODIUM Tab EC 25 mg – 1% DV Mar-13 to 2015..........................................................4.00 Tab EC 50 mg – 1% DV Mar-13 to 2015........................................................16.00 Tab long-acting 75 mg – 1% DV Dec-12 to 2015.............................................3.10 24.52 Tab long-acting 100 mg – 1% DV Dec-12 to 2015.........................................42.25 Eye drops 1 mg per ml – 1% DV Sep-11 to 2014 ..........................................13.80 Inj 25 mg per ml, 3 ml – 1% DV Sep-11 to 2014............................................12.00 Suppos 12.5 mg – 1% DV Sep-11 to 2014 ......................................................1.85 Suppos 25 mg – 1% DV Sep-11 to 2014 .........................................................2.22 Suppos 50 mg – 1% DV Sep-11 to 2014 .........................................................3.84 Suppos 100 mg – 1% DV Sep-11 to 2014 .......................................................6.36 DIHYDROCODEINE TARTRATE Tab long-acting 60 mg – 1% DV Jun-10 to 2013 ...........................................27.27 DILTIAZEM HYDROCHLORIDE Tab 30 mg – 5% DV Sep-12 to 2015 ...............................................................4.60 Tab 60 mg – 5% DV Sep-12 to 2015 ...............................................................8.50 Cap long-acting 120 mg – 5% DV Feb-13 to 2015 ........................................31.83 Cap long-acting 180 mg – 5% DV Feb-13 to 2015 ........................................47.67 Cap long-acting 240 mg – 5% DV Feb-13 to 2015 ........................................63.58 DINOPROSTONE Gel 1 mg, 2.5 ml .............................................................................................52.65 Gel 2 mg, 2.5 ml .............................................................................................64.60 DIPYRIDAMOLE Tab long-acting 150 mg – 1% DV Oct-11 to 2014 .........................................11.52

5 5 100 500 ml 5 1 1,000 ml 237 ml 250 ml 500 500 5 5 5 100 500 30 500 500 5 ml 5 10 10 10 10 60 100 100 500 500 500 1 1 60

Hospira Hospira PSM Baxter Biomed Biomed Glucerna Select RTH Resource Diabetic Glucerna Select Arrow-Diazepam Arrow-Diazepam Mayne Stesolid Stesolid Apo-Diclo Apo-Diclo Diclax SR Diclax SR Diclax SR Voltaren Ophtha Voltaren Voltaren Voltaren Voltaren Voltaren DHC Continus Dilzem Dilzem Apo-Diltiazem CD Apo-Diltiazem CD Apo-Diltiazem CD Prostin E2 Prostin E2 Pytazen SR

28

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

DISULFIRAM Tab 200 mg .....................................................................................................24.30 DOCETAXEL Inj 20 mg – 1% DV Sep-11 to 2014 ...............................................................48.75 Inj 80 mg – 1% DV Sep-11 to 2014 .............................................................195.00 DOCUSATE SODIUM Cap 50 mg – 1% DV Sep-11 to 2014...............................................................2.57 Cap 120 mg – 1% DV Sep-11 to 2014.............................................................3.48 DOCUSATE SODIUM WITH SENNOSIDES Tab 50 mg with total sennosides 8 mg – 1% DV Jun-10 to 2013 ....................6.38 DOMPERIDONE Tab 10 mg – 1% DV Mar-13 to 2015................................................................3.25 DONEPEZIL HYDROCHLORIDE Tab 5 mg ...........................................................................................................7.71 Tab 10 mg .......................................................................................................14.06 DOPAMINE HYDROCHLORIDE Inj 40 mg per ml, 5 ml – 1% DV Sep-12 to 2015............................................69.77 DORIPENEM Vial for infusion 500 mg ................................................................................454.50 DORNASE ALFA Nebuliser soln, 2.5 mg per 2.5 ml amp .........................................................250.00 DORZOLAMIDE HYDROCHLORIDE WITH TIMOLOL MALEATE Eye drops 2% with timolol maleate 0.5% .......................................................15.50 DOTHIEPIN HYDROCHLORIDE Tab 75 mg .......................................................................................................10.50 Cap 25 mg ........................................................................................................6.17 DOXAZOSIN MESYLATE Tab 2 mg – 1% DV Jun-11 to 2014..................................................................8.23 Tab 4 mg – 1% DV Jun-11 to 2014................................................................12.40 DOXORUBICIN Inj 50 mg – 1% DV Mar-13 to 2015................................................................17.00 Inj 200 mg – 1% DV Mar-13 to 2015..............................................................65.00 DOXYCYCLINE HYDROCHLORIDE Tab 100 mg – 1% DV Sep-11 to 2014 .............................................................7.95 EFAVIRENZ Tab 50 mg .....................................................................................................158.33 Tab 200 mg ...................................................................................................474.99 Tab 600 mg ...................................................................................................474.99 EFAVIRENZ WITH EMTRICITABINE WITH TENOFOVIR DISOPROXIL FUMARATE Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg ................................................................................... 1,313.19 EMTRICITABINE Cap 200 mg ..................................................................................................307.20 EMTRICITABINE WITH TENOFOVIR DISOPROXIL FUMARATE Tab 200 mg with tenofovir disoproxil fumarate 300 mg ................................838.20

100 1 1 100 100 200 100 90 90 10 10 6 5 ml 100 100 500 500 1 1 250 30 90 30

Antabuse Docetaxel Ebewe Docetaxel Ebewe Laxofast 50 Laxofast 120 Laxsol Prokinex Donepezil-Rex Donepezil-Rex Martindale Doribax Pulmozyme Cosopt Dopress Dopress Apo-Doxazosin Apo-Doxazosin Arrow-Doxorubicin Arrow-Doxorubicin Doxine Stocrin Stocrin Stocrin

30 30 30

Atripla Emtriva Truvada

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

29


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

EMULSIFYING OINTMENT Oint BP 100 g – 1% DV Nov-11 to 2014..........................................................1.95 Oint BP 500 g – 1% DV Sep-11 to 2014..........................................................3.04 Note: DV Limit applies to pack sizes of greater than 100 g ENALAPRIL Tab 5 mg – 1% DV Dec-12 to 2015 .................................................................1.07 Tab 10 mg – 1% DV Dec-12 to 2015 ...............................................................1.32 Tab 20 mg – 1% DV Dec-12 to 2015 ...............................................................1.72 ENFUVIRTIDE Powder for inj 90 mg per ml × 60 ..............................................................2,380.00 ENOXAPARIN SODIUM Inj 20 mg – 1% DV Sep-12 to 2015 ...............................................................37.24 Inj 40 mg – 1% DV Sep-12 to 2015 ...............................................................49.69 Inj 60 mg – 1% DV Sep-12 to 2015 ...............................................................74.91 Inj 80 mg – 1% DV Sep-12 to 2015 ...............................................................99.86 Inj 100 mg – 1% DV Sep-12 to 2015 ...........................................................125.06 Inj 120 mg – 1% DV Sep-12 to 2015 ...........................................................155.40 Inj 150 mg – 1% DV Sep-12 to 2015 ...........................................................177.60 ENTACAPONE Tab 200 mg – 1% DV Dec-12 to 2015 ...........................................................47.92 ENTECAVIR Tab 0.5 mg ....................................................................................................400.00 ENTERAL FEED 1.5 KCAL/ML Liquid ................................................................................................................7.00 ENTERAL FEED 2 KCAL/ML Liquid ................................................................................................................5.50 11.00 ENTERAL FEED 1 KCAL/ML Liquid ................................................................................................................1.24 2.65 5.29 ENTERAL FEED WITH FIBRE 1 KCAL/ML Liquid ................................................................................................................1.32 2.65 5.29 ENTERAL FEED WITH FIBRE 1.5 KCAL/ML Liquid ................................................................................................................1.75 7.00 ENTERAL/ORAL ELEMENTAL FEED 1 KCAL/ML Powder ..............................................................................................................7.50 4.40 ENTERAL/ORAL FEED 1 KCAL/ML Powder (unflavoured) .....................................................................................78.97 EPHEDRINE HYDROCHLORIDE Inj 30 mg per ml, 1 ml – 1% DV Nov-12 to 2014............................................66.00

100 g 500 g

Jaychem AFT

90 90 90 1 10 10 10 10 10 10 10 100 30 1,000 ml 500 ml 1,000 ml 250 ml 500 ml 1,000 ml 237 ml 500 ml 1,000 ml 250 ml 1,000 ml

m-Enalapril m-Enalapril m-Enalapril Fuzeon Clexane Clexane Clexane Clexane Clexane Clexane Clexane Entapone Baraclude Nutrison Energy Nutrison Concentrated Two Cal HN RTH Osmolite Osmolite Osmolite RTH Jevity Jevity RTH Jevity RTH Ensure Plus HN Ensure Plus RTH Jevity HiCal RTH Alitraq Vital HN Heparon Junior Max Health

76 g 79 g 400 g 10

30

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

EPIRUBICIN Inj 2 mg per ml, 5 ml .......................................................................................25.00 Inj 2 mg per ml, 25 ml – 1% DV Aug-12 to 2015 ...........................................39.38 Inj 2 mg per ml, 50 ml – 1% DV Aug-12 to 2015 ...........................................58.20 Inj 2 mg per ml, 100 ml – 1% DV Aug-12 to 2015 .........................................94.50 EPTIFIBATIDE Inj 2 mg per ml, 10 ml ...................................................................................111.00 Inj 0.75 mg per ml, 100 ml ............................................................................324.00 ERGOMETRINE MALEATE Inj 500 µg per ml, 1 ml – 1% DV Nov-11 to 2014 ..........................................31.00 ERLOTINIB HYDROCHLORIDE Tab 100 mg ................................................................................................3,100.00 Tab 150 mg ................................................................................................3,950.00 ERTAPENEM SODIUM Inj 1 g ..............................................................................................................70.00 ERYTHROMYCIN ETHYL SUCCINATE Tab 400 mg .....................................................................................................16.95 Grans for oral liq 200 mg per 5 ml ....................................................................4.35 Grans for oral liq 400 mg per 5 ml ....................................................................5.85 ERYTHROMYCIN LACTOBIONATE Inj 1 g ..............................................................................................................16.00 ERYTHROPOIETIN ALPHA Inj human recombinant 1,000 iu, prefilled syringe ..........................................48.68 Inj human recombinant 2,000 iu, prefilled syringe ........................................120.18 Inj human recombinant 3,000 iu, prefilled syringe ........................................166.87 Inj human recombinant 4,000 iu, prefilled syringe ........................................193.13 Inj human recombinant 5,000 iu, prefilled syringe ........................................243.26 Inj human recombinant 6,000 iu, prefilled syringe ........................................291.92 Inj human recombinant 10,000 iu, prefilled syringe ......................................395.18 ERYTHROPOIETIN BETA Inj 2,000 iu, prefilled syringe .........................................................................120.18 Inj 3,000 iu, prefilled syringe .........................................................................166.87 Inj 4,000 iu, prefilled syringe .........................................................................193.13 Inj 5,000 iu, prefilled syringe .........................................................................243.26 Inj 6,000 iu, prefilled syringe .........................................................................291.92 Inj 10,000 iu, prefilled syringe .......................................................................395.18 ESCITALOPRAM Tab 10 mg – 1% DV Feb-11 to 2013................................................................2.65 Tab 20 mg – 1% DV Feb-11 to 2013................................................................4.20 ETANERCEPT Inj 50 mg prefilled syringe .........................................................................1,899.92 Inj 25 mg .......................................................................................................949.96 Inj 50 mg autoinjector ................................................................................1,899.92

1 1 1 1

Epirubicin Ebewe DBL Epirubicin Hydrochloride DBL Epirubicin Hydrochloride DBL Epirubicin Hydrochloride Integrilin Integrilin DBL Ergometrine Tarceva Tarceva Invanz E-Mycin E-Mycin E-Mycin Erythrocin IV Eprex Eprex Eprex Eprex Eprex Eprex Eprex NeoRecormon NeoRecormon NeoRecormon NeoRecormon NeoRecormon NeoRecormon Loxalate Loxalate Enbrel Enbrel Enbrel

1 1 5 30 30 1 100 100 ml 100 ml 1 6 6 6 6 6 6 6 6 6 6 6 6 6 28 28 4 4 4

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

31


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ETHAMBUTOL HYDROCHLORIDE Tab 100 mg .....................................................................................................48.01 Tab 400 mg .....................................................................................................49.34 ETHINYLOESTRADIOL WITH LEVONORGESTREL Tab 50 µg with levonorgestrel 125 µg and 7 inert tab ......................................9.45 ETIDRONATE DISODIUM Tab 200 mg – 1% DV Sep-12 to 2015 ...........................................................15.80 ETOPOSIDE Cap 50 mg ....................................................................................................340.73 Cap 100 mg ..................................................................................................340.73 Inj 20 mg per ml, 5 ml .....................................................................................25.00 ETOPOSIDE PHOSPHATE Inj 100 mg (of etoposide base) – 1% DV Sep-11 to 2014..............................40.00 ETRAVIRINE Tab 100 mg ..................................................................................................770.00 Tab 200 mg ...................................................................................................770.00 (Intelence Tab 100 mg to be delisted 1 August 2013) EXEMESTANE Tab 25 mg – 1% DV Jun-11 to 2014..............................................................22.57 FACTOR EIGHT INHIBITORS BYPASSING AGENT Inj 500 U ....................................................................................................1,640.00 Inj 1,000 U .................................................................................................3,280.00 FAT FREE ARGININE SUPPLEMENT Powder (orange) ...............................................................................................2.15 FELODIPINE Tab long-acting 2.5 mg – 1% DV Sep-12 to 2015............................................2.90 Tab long-acting 5 mg – 1% DV Nov-12 to 2015...............................................3.10 Tab long-acting 10 mg – 1% DV Nov-12 to 2015.............................................4.60 FENTANYL Transdermal patch 12.5 µg per hour – 1% DV Aug-11 to 2013.......................8.90 Transdermal patch 25 µg per hour – 1% DV Aug-11 to 2013..........................9.15 Transdermal patch 50 µg per hour – 1% DV Aug-11 to 2013........................11.50 Transdermal patch 75 µg per hour – 1% DV Aug-11 to 2013........................13.60 Transdermal patch 100 µg per hour – 1% DV Aug-11 to 2013......................14.50 FENTANYL CITRATE Inf 10 µg per ml, 50 ml premixed bag – 1% DV Dec-11 to 2014 .................210.00 Inf 10 µg per ml, 100 ml premixed bag – 1% DV Dec-11 to 2014 ...............210.00 Inj 10 µg per ml, 50 ml prefilled syringe – 1% DV Dec-11 to 2014 ..............165.00 Inj 20 µg per ml, 50 ml prefilled syringe – 1% DV Dec-11 to 2014 ..............185.00 Inj 50 µg per ml, 2 ml – 1% DV Sep-12 to 2015 ..............................................4.50 Inj 50 µg per ml, 10 ml – 1% DV Sep-12 to 2015 ..........................................11.77 FERROUS FUMARATE Tab 200 mg (65 mg elemental) .........................................................................4.35 FERROUS FUMARATE WITH FOLIC ACID Tab 310 mg (100 mg elemental) with folic acid 350 µg ....................................4.75

56 56 84 100 20 10 1 1 120 60

Myambutol Myambutol Microgynon 50 ED Arrow-Etidronate Vepesid Vepesid Mayne Etopophos Intelence Intelence

30 1 1 9.2 g 30 30 30 5 5 5 5 5 10 10 10 10 10 10 100 60

Aromasin FEIBA FEIBA Resource Arginaid Plendil ER Plendil ER Plendil ER Mylan Fentanyl Patch Mylan Fentanyl Patch Mylan Fentanyl Patch Mylan Fentanyl Patch Mylan Fentanyl Patch Biomed Biomed Biomed Biomed Boucher and Muir Boucher and Muir Ferro-tab Ferro-F-Tabs

32

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

FERROUS SULPHATE Oral liq 30 mg per 1 ml (6 mg elemental per 1 ml) – 1% DV Sep-10 to 2013 ..................................................................................................... 10.30 FILGRASTIM Inj 300 µg per 0.5 ml prefilled syringe – 1% DV Jan-13 to 31 Dec 2015 .........540.00 Inj 300 µg per 1 ml vial .................................................................................650.00 Inj 480 µg per 0.5 ml preflled syringe – 1% DV Jan-13 to 31 Dec 2015 .........864.00 FINASTERIDE Tab 5 mg – 1% DV Nov-11 to 2014 .................................................................5.10 FLECAINIDE ACETATE Tab 50 mg .......................................................................................................45.82 Tab 100 mg .....................................................................................................80.92 Cap long-acting 100 mg .................................................................................45.82 Cap long-acting 200 mg .................................................................................80.92 Inj 10 mg per ml, 15 ml ...................................................................................52.45 FLUCLOXACILLIN SODIUM Cap 250 mg – 1% DV Oct-12 to 2015 ...........................................................22.00 Cap 500 mg – 1% DV Oct-12 to 2015 ...........................................................74.00 Grans for oral liq 125 mg per 5 ml – 1% DV Sep-12 to 2015...........................2.49 Grans for oral liq 250 mg per 5 ml – 1% DV Sep-12 to 2015...........................3.25 Inj 250 mg – 1% DV Nov-11 to 2014 .............................................................10.86 Inj 500 mg – 1% DV Nov-11 to 2014 .............................................................11.32 Inj 1 g – 1% DV Nov-11 to 2014 ....................................................................14.28 FLUCONAZOLE Cap 50 mg – 1% DV Jan-12 to 2014 ...............................................................4.77 Cap 150 mg – 1% DV Jan-12 to 2014 .............................................................0.91 Cap 200 mg – 1% DV Jan-12 to 2014 ...........................................................13.34 Powder for oral suspension 10 mg per ml ......................................................34.56 Inj 2 mg per ml, 50 ml .......................................................................................5.68 FLUDARABINE PHOSPHATE Tab 10 mg – 1% DV Jun-12 to 2015............................................................433.50 Inj 50 mg – 1% DV Sep-11 to 2014 .............................................................525.00 FLUDROCORTISONE ACETATE Tab 100 µg .....................................................................................................14.32 FLUMAZENIL Inj 0.5 mg per 5 ml amp ................................................................................170.10

500 ml 5 5 5 30 60 60 30 30 5 250 500 100 ml 100 ml 10 10 10 28 1 28 35 ml 1 20 5 100 5

Ferodan Zarzio Neupogen Zarzio Rex Medical Tambocor Tambocor Tambocor CR Tambocor CR Tambocor Staphlex Staphlex AFT AFT Flucloxin Flucloxin Flucloxin Ozole Ozole Ozole Diflucan Fluconazole-Claris Fludara Oral Fludarabine Ebewe Florinef Anexate

FLUOCORTOLONE CAPROATE WITH FLUOCORTOLONE PIVALATE AND CINCHOCAINE Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g .............................................................................. 6.35 30 g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg .................................................................................... 2.66 12 FLUOROMETHOLONE Eye drops 0.1% – 1% DV Dec-12 to 2015 .......................................................3.80 5 ml

Ultraproct Ultraproct Flucon

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

33


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

FLUOROURACIL SODIUM Crm 5% – 1% DV Feb-13 to 2015 .................................................................25.16 Inj 25 mg per ml, 20 ml ...................................................................................55.60 Inj 25 mg per ml, 100 ml .................................................................................13.55 Inj 50 mg per ml, 10 ml – 1% DV Nov-10 to 2013..........................................26.25 Inj 50 mg per ml, 20 ml – 1% DV Nov-10 to 2013............................................7.50 Inj 50 mg per ml, 50 ml – 1% DV Nov-10 to 2013..........................................18.00 Inj 50 mg per ml, 100 ml – 1% DV Nov-10 to 2013........................................34.50 FLUOXETINE HYDROCHLORIDE Tab dispersible 20 mg, scored – 1% DV Sep-10 to 2013.................................2.50 Cap 20 mg – 1% DV Sep-10 to 2013...............................................................2.70 FLUPENTHIXOL DECANOATE Inj 20 mg per ml, 1 ml .....................................................................................13.14 Inj 20 mg per ml, 2 ml .....................................................................................20.90 Inj 100 mg per ml, 1 ml ...................................................................................40.87 FLUPHENAZINE DECANOATE Inj 12.5 mg per 0.5 ml, 0.5 ml .........................................................................17.60 Inj 25 mg per ml, 1 ml .....................................................................................27.90 Inj 100 mg per ml, 1 ml .................................................................................154.50 FLUTAMIDE Tab 250 mg – 1% DV Nov-10 to 2013 ...........................................................55.00 FLUTICASONE Aerosol inhaler, 50 µg per dose CFC-free ........................................................7.50 Powder for inhalation, 50 µg per dose ..............................................................8.67 Powder for inhalation, 100 µg per dose ..........................................................13.87 Aerosol inhaler, 125 µg per dose CFC-free ....................................................13.60 Aerosol inhaler, 250 µg per dose CFC-free ....................................................27.20 Powder for inhalation, 250 µg per dose ..........................................................24.51 FLUTICASONE PROPIONATE Metered aqueous nasal spray, 50 µg per dose – 1% DV Apr-13 to 2015 .........2.30 FLUTICASONE WITH SALMETEROL Aerosol inhaler 50 µg with salmeterol 25 µg ..................................................37.48 Powder for inhalation 100 µg with salmeterol 50 µg ......................................37.48 Aerosol inhaler 125 µg with salmeterol 25 µg ................................................49.69 Powder for inhalation 250 µg with salmeterol 50 µg ......................................49.69 FOLIC ACID Oral liq 50 µg per ml .......................................................................................24.00 FUROSEMIDE Tab 40 mg – 1% DV Sep-12 to 2015 .............................................................10.25 Tab 500 mg – 1% DV Feb-13 to 2015............................................................25.00 Inj 10 mg per ml, 2 ml – 1% DV Nov-10 to 2013..............................................1.30 FUSIDIC ACID Tab 250 mg .....................................................................................................34.50 Crm 2% – 1% DV Sep-10 to 2013 ...................................................................3.25 Eye drops 1% ...................................................................................................4.50 Oint 2% – 1% DV Sep-10 to 2013 ...................................................................3.25

20 g 10 1 5 1 1 1 30 84 5 5 5 5 5 5 100 120 dose 60 dose 60 dose 120 dose 120 dose 60 dose 120 dose

Efudix Mayne Mayne Fluorouracil Ebewe Fluorouracil Ebewe Fluorouracil Ebewe Fluorouracil Ebewe Fluox Fluox Fluanxol Fluanxol Fluanxol Modecate Modecate Modecate Flutamin Flixotide Flixotide Accuhaler Flixotide Accuhaler Flixotide Flixotide Flixotide Accuhaler Flixonase Hayfever & Allergy Seretide Seretide Accuhaler Seretide Seretide Accuhaler Biomed Diurin 40 Urex Forte Frusemide-Claris Fucidin Foban Fucithalmic Foban

120 dose 60 dose 120 dose 60 dose 25 ml 1,000 50 5 12 15 g 5g 15 g

34

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

GABAPENTIN Cap 100 mg ......................................................................................................7.16 Cap 300 mg ....................................................................................................11.50 Cap 400 mg ....................................................................................................14.75 GADOBENDATE DIMEGLUMINE Inj 0.5 g per litre, 10 ml .................................................................................324.74 Inj 0.5 g per litre, 20 ml .................................................................................636.28 GADOBUTROL Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5 ml prefilled syringe ................................................................................................... 253.10 GADODIAMIDE Inj 287 mg per ml, 10 ml ...............................................................................180.00 Inj 287 mg per ml, 10 ml prefilled syringe .....................................................220.00 Inj 287 mg per ml, 15 ml ...............................................................................270.00 Inj 287 mg per ml, 15 ml prefilled syringe .....................................................330.00 Inj 287 mg per ml, 20 ml prefilled syringe .....................................................440.00 GANCICLOVIR Inj 500 mg vial ..............................................................................................380.00 GEFITINIB Tab 250 mg ................................................................................................1,700.00 GELATIN PLASMA REPLACER Inf 3.5%, 500 ml bag .........................................................................................9.75 Inf 4% per 500 ml bag ....................................................................................92.50 108.00 GEMCITABINE HYDROCHLORIDE Inj 200 mg – 1% DV Sep-10 to 2013 .............................................................12.50 Inj 1 g – 1% DV Sep-10 to 2013 ....................................................................62.50

100 100 100 10 10

Nupentin Nupentin Nupentin Multihance Multihance

5 10 10 10 10 10 5 30 500 ml 10

Gadovist Omniscan Omniscan Omniscan Omniscan Omniscan Cymevene Iressa Haemaccel Gelafusal Gelofusine Gemcitabine Actavis 200 Gemcitabine Ebewe DBL Gemcitabine Gemcitabine Actavis 1000 Gemcitabine Ebewe Lipazil Genoptic Mayne Pfizer Apo-Gliclazide Minidiab Glucagen Hypokit

1 1

GEMFIBROZIL Tab 600 mg – 1% DV Feb-11 to 2013............................................................14.00 GENTAMICIN SULPHATE Eye drops 0.3% ..............................................................................................11.40 Inj 10 mg per ml, 1 ml .......................................................................................8.56 Inj 40 mg per ml, 2 ml – 1% DV Sep-12 to 2015..............................................6.50 GLICLAZIDE Tab 80 mg – 1% DV Sep-11 to 2014 .............................................................17.60 GLIPIZIDE Tab 5 mg – 1% DV Dec-12 to 2015 .................................................................3.00 GLUCAGON HYDROCHLORIDE Inj 1 mg syringe kit .........................................................................................32.00

60 5 ml 5 10 500 100 1

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

35


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

GLUCOSE Inf 5% ...............................................................................................................2.87 2.84 3.87 1.77 1.80 Inf 10% .............................................................................................................3.70 5.29 Inf 50% .............................................................................................................6.84 GLUCOSE WITH SODIUM, POTASSIUM, MAGNESIUM, CHLORIDE AND ACETATE Inf 50 g with 40 mmol/L sodium, 13 mmol/L potassium, 1.5 mmol/L magnesium, 40 mmol/L chloride, and 16 mmol/L acetate ......................... 4.50

50 ml 100 ml 250 ml 500 ml 1,000 ml 500 ml 1,000 ml 500 ml

Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter

500 ml

Baxter

GLUCOSE WITH SODIUM, POTASSIUM, MAGNESIUM, CHLORIDE, ACETATE AND GLUCONATE Inf 50 g with 140 mmol/L sodium, 5 mmol/L potassium, 1.5 mmol/L magnesium, 98 mmol/L chloride, 27 mmol/L acetate and 23 mmol/L gluconate ...................................................................................... 7.00 1,000 ml GLYCERIN WITH SODIUM SACCHARIN Suspension .....................................................................................................35.50 GLYCERIN WITH SUCROSE Suspension .....................................................................................................35.50 GLYCEROL Liquid ..............................................................................................................19.80 Suppos 3.6 g – 1% DV Jan-13 to 2015 ...........................................................6.50 GLYCERYL TRINITRATE Tab 600 µg – 1% DV Sep-11 to 2014 ..............................................................8.00 Inj 1 mg per ml, 5 ml – 1% DV Dec-12 to 2015..............................................22.70 Inj 1 mg per ml, 50 ml – 1% DV Dec-12 to 2015............................................86.60 Inj 5 mg per ml, 10 ml .....................................................................................40.00 Aerosol spray 400 µg per dose – 1% DV Mar-12 to 2014 ...............................4.45 TDDS 5 mg – 1% DV Sep-11 to 2014 ...........................................................16.56 TDDS 10 mg – 1% DV Sep-11 to 2014 .........................................................19.50 GLYCINE Soln 1.5% for irrigation ...................................................................................11.38 14.44 GOSERELIN ACETATE Inj 3.6 mg ......................................................................................................166.20 Inj 10.8 mg ....................................................................................................443.76 HALOPERIDOL Tab 500 µg – 1% DV Nov-10 to 2013 ..............................................................5.42 Tab 1.5 mg – 1% DV Nov-10 to 2013 ..............................................................8.20 Tab 5 mg – 1% DV Nov-10 to 2013 ...............................................................25.84 Oral liq 2 mg per ml – 1% DV Nov-10 to 2013...............................................19.87 Inj 5 mg per ml, 1 ml – 1% DV Nov-10 to 2013..............................................18.74 HALOPERIDOL DECANOATE Inj 50 mg per ml, 1 ml .....................................................................................28.39 Inj 100 mg per ml, 1 ml ...................................................................................55.90 473 ml 473 ml 2,000 ml 20 100 10 10 5 250 dose 30 30 2,000 ml 3,000 ml 1 1 100 100 100 100 ml 10 5 5

Baxter Ora-Sweet SF Ora-Sweet ABM PSM Lycinate Nitronal Nitronal Mayne Glytrin Nitroderm TTS 5 Nitroderm TTS 10 Baxter Baxter Zoladex Zoladex Serenace Serenace Serenace Serenace Serenace Haldol Haldol Concentrate

36

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

HEPARIN SODIUM Inj 1,000 iu per ml, 1 ml ..................................................................................66.80 Inj 1,000 iu per ml, 5 ml ..................................................................................11.44 46.30 Inj 5,000 iu per ml, 1 ml ..................................................................................14.20 Inj 5,000 iu per ml, 5 ml ................................................................................182.00 HEPARINISED SALINE Inj 10 iu per ml, 5 ml .......................................................................................32.50 HIGH FAT LOW CARBOHYDRATE FORMULA Powder (vanilla) ..............................................................................................35.50 HYDRALAZINE Inj 20 mg per ml, 1 ml .....................................................................................25.90 HYDROCORTISONE Tab 5 mg – 1% DV Nov-12 to 2015 .................................................................8.10 Tab 20 mg – 1% DV Nov-12 to 2015 .............................................................20.32 Crm 1%, 14.2 g ................................................................................................2.48 Powder – 1% DV Nov-11 to 2014 ..................................................................44.00 Crm 1%, 100 g .................................................................................................3.75 Crm 1%, 500 g – 1% DV Nov-11 to 2014 ......................................................14.00 Note: DV Limit applies to pack sizes of greater than 100 g. Inj 50 mg per ml, 2 ml – 1% DV Nov-10 to 2013..............................................3.99 HYDROCORTISONE ACETATE Rectal foam 10%, CFC-Free (14 applications) – 1% DV Jan-13 to 2015 .........25.30 HYDROCORTISONE BUTYRATE Lipocream 0.1% – 1% DV Mar-13 to 2015.......................................................2.30 6.85 Oint 0.1% – 1% DV Mar-13 to 2015.................................................................6.85 Milky emul 0.1% – 1% DV Mar-13 to 2015 ......................................................6.85 Scalp lotn 0.1% – 1% DV Mar-13 to 2015........................................................3.65 HYDROCORTISONE WITH CINCHOCAINE Oint 5 mg with cinchocaine hydrochloride 5 mg per g ....................................15.00 Suppos 5 mg with cinchocaine hydrochloride 5 mg per g ................................9.90 HYDROCORTISONE WITH MICONAZOLE Crm 1% with miconazole nitrate 2% .................................................................2.20 HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN Crm 1% with natamycin 1% and neomycin sulphate 0.5% ..............................2.79 Oint 1% with natamycin 1% and neomycin sulphate 0.5% ...............................2.79 HYDROGEN PEROXIDE Crm 1% ............................................................................................................8.56 HYDROXOCOBALAMIN Inj 1 mg per ml, 1 ml – 1% DV Sep-12 to 2015................................................5.10 HYDROXYCHLOROQUINE SULPHATE Tab 200 mg – 1% DV Nov-12 to 2015 ...........................................................18.00

50 10 50 5 50 50 300 g 5 100 100 14.2 g 25 g 100 g 500 g 1 21.1 g 30 g 100 g 100 g 100 ml 100 ml 30 g 12 15 g 15 g 15 g 15 g 3

Mayne Pfizer Pfizer Mayne Pfizer Pfizer KetoCal Apresoline Douglas Douglas AFT ABM Pharmacy Health Pharmacy Health Solu-Cortef Colifoam Locoid Lipocream Locoid Lipocream Locoid Locoid Crelo Locoid Proctosedyl Proctosedyl Micreme H Pimafucort Pimafucort Crystaderm ABM Hydroxocobalamin

100

Plaquenil

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

37


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

HYDROXYETHYL STARCH 130/0.4 WITH MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE AND SODIUM CHLORIDE Inj 6% with magnesium chloride 0.03%, potassium chloride 0.03%, sodium acetate 0.463% and sodium chloride 0.6%, 500 ml .................. 198.00 20 Volulyte 6% HYDROXYETHYL STARCH 130/0.4 WITH SODIUM CHLORIDE Inj 6% with sodium chloride 0.9%, 500 ml ....................................................198.00 HYDROXYUREA Cap 500 mg ....................................................................................................31.76 HYOSCINE (SCOPOLAMINE) Patches 1.5 mg ...............................................................................................11.95 HYOSCINE HYDROBROMIDE Inj 400 µg per ml, 1 ml ......................................................................................6.66 HYOSCINE N-BUTYLBROMIDE Tab 10 mg – 1% DV Sep-11 to 2014 ...............................................................1.48 Inj 20 mg per ml, 1 ml – 1% DV Nov-11 to 2014..............................................9.57 HYPROMELLOSE Eye drops 0.5% ................................................................................................3.92 IBUPROFEN Tab long-acting 800 mg – 1% DV Oct-11 to 2014 ...........................................8.12 Oral liq 100 mg per 5 ml – 1% DV Sep-10 to 2013..........................................2.69 IDARUBICIN HYDROCHLORIDE Cap 5 mg ......................................................................................................115.00 Cap 10 mg ....................................................................................................144.50 Inj 5 mg – 1% DV Sep-12 to 2015 ...............................................................100.00 Inj 10 mg – 1% DV Sep-12 to 2015 .............................................................200.00 IFOSFAMIDE Inj 1 g ..............................................................................................................96.00 Inj 2 g ............................................................................................................180.00 ILOPROST Inf 100 µg per ml, 0.5 ml ..............................................................................925.00 Nebuliser soln 10 µg per ml, 2 ml ..............................................................1,185.00 IMATINIB MESYLATE Tab 100 mg ................................................................................................2,400.00 IMIPENEM WITH CILASTATIN Inj 500 mg with cilastatin 500 mg – 1% DV Dec-12 to 2014 ..........................18.37 IMIPRAMINE HYDROCHLORIDE Tab 10 mg .........................................................................................................5.48 Tab 25 mg .........................................................................................................8.80 IMIQUIMOD Crm 5%, sachet – 1% DV Nov-11 to 2014 ....................................................62.00 INDAPAMIDE Tab 2.5 mg – 1% DV Oct-10 to 2013 ...............................................................2.95 INFLIXIMAB Powder for inj 100 mg ................................................................................1,227.00 INSULIN ASPART WITH INSULIN ASPART PROTAMINE Inj 100 iu per ml, 3 ml prefilled pen .................................................................52.15 20 100 2 5 20 5 15 ml 30 200 ml 1 1 1 1 1 1 5 30 60 1 50 50 12 90 1 5 Voluven Hydrea Scopoderm TTS Mayne Gastrosoothe Buscopan Methopt Brufen SR Fenpaed Zavedos Zavedos Zavedos Zavedos Holoxan Holoxan Ilomedin Ventavis Glivec Primaxin Tofranil Tofranil Aldara Dapa-Tabs Remicade NovoMix 30 FlexPen

38

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

INSULIN GLARGINE Inj 100 u per ml, 3 ml ......................................................................................94.50 Inj 100 u per ml, 10 ml ....................................................................................63.00 INSULIN GLULISINE Inj 100 iu per ml, 10 ml ...................................................................................27.03 Inj 100 iu per ml, 3 ml .....................................................................................46.07 Inj 100 iu per ml, 3 ml disposable pen ............................................................46.07 INSULIN LISPRO WITH INSULIN LISPRO PROTAMINE Inj lispro 25% with insulin lispro protamine 75%, 100 u per ml, 3 ml ..............52.15 Inj lispro 50% with insulin lispro protamine 50%, 100 u per ml, 3 ml ..............52.15 INSULIN PEN NEEDLES 29 g × 12.7 mm .............................................................................................10.50 31 g × 5 mm ...................................................................................................11.75 31 g × 6 mm ...................................................................................................10.50 31 g × 8 mm ...................................................................................................10.50 32 g × 4 mm ...................................................................................................10.50 (ABM 29 g × 12.7 mm to be delisted 1 May 2013) INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE Syringe 0.3 ml with 29 g × 12.7 mm needle .................................................13.00 Syringe 0.3 ml with 31 g × 8 mm needle .......................................................13.00 Syringe 0.5 ml with 29 g × 12.7 mm needle .................................................13.00 Syringe 0.5 ml with 31 g × 8 mm needle ......................................................13.00 Syringe 1 ml with 29 g × 12.7 mm needle .....................................................13.00 Syringe 1 ml with 31 g × 8 mm needle ..........................................................13.00 (ABM Syringe 0.3 ml with 29 g × 12.7 mm needle to be delisted 1 May 2013) (ABM Syringe 0.5 ml with 29 g × 12.7 mm needle to be delisted 1 May 2013) (ABM Syringe 0.5 ml with 31 g × 8 mm needle to be delisted 1 May 2013) IODINE WITH ALCOHOL Soln 1% with 70% alcohol, 100 ml ...................................................................9.30 IODIXANOL Inj 270 mg per ml (iodine equivalent), 50 ml .................................................223.50 Inj 270 mg per ml (iodine equivalent), 100 ml ...............................................447.00 Inj 320 mg per ml (iodine equivalent), 50 ml .................................................223.50 Inj 320 mg per ml (iodine equivalent), 100 ml ...............................................447.00 Inj 320 mg per ml (iodine equivalent), 150 ml ...............................................670.50 Inj 320 mg per ml (iodine equivalent), 200 ml ...............................................565.56 894.00

5 1 1 5 5 5 5 100 100 100 100 100

Lantus Lantus SoloStar Lantus Apidra Apidra Apidra Solostar Humalog Mix 25 Humalog Mix 50 ABM B-D Micro-Fine B-D Micro-Fine ABM ABM B-D Micro-Fine B-D Micro-Fine

100 100 100 100 100 100

ABM B-D Ultra Fine ABM B-D Ultra Fine II ABM B-D Ultra Fine ABM B-D Ultra Fine II ABM B-D Ultra Fine ABM B-D Ultra Fine II

1 10 10 10 10 10 6 10

healthE Visipaque Visipaque Visipaque Visipaque Visipaque Visipaque Visipaque

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

39


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

IOHEXOL Note: Iomeron, Isovue, Optiray, Ultraject and Ultravist are DV Pharmaceuticals. Inj 240 mg per ml (iodine equivalent), 50 ml ...................................................77.80 Inj 300 mg per ml (iodine equivalent), 20 ml ...................................................24.00 Inj 300 mg per ml (iodine equivalent), 50 ml ...................................................77.80 Inj 300 mg per ml (iodine equivalent), 100 ml ...............................................155.60 Inj 300 mg per ml (iodine equivalent), 500 ml ...............................................468.00 Inj 350 mg per ml (iodine equivalent), 20 ml ...................................................24.00 Inj 350 mg per ml (iodine equivalent), 50 ml ...................................................77.80 Inj 350 mg per ml (iodine equivalent), 75 ml .................................................116.70 Inj 350 mg per ml (iodine equivalent), 100 ml ...............................................155.60 Inj 350 mg per ml (iodine equivalent), 200 ml ...............................................186.70 Inj 350 mg per ml (iodine equivalent), 500 ml ...............................................780.00 IPRATROPIUM BROMIDE Nebuliser soln, 250 µg per ml, 1 ml – 1% DV Oct-10 to 2013 .........................3.79 Nebuliser soln, 250 µg per ml, 2 ml – 1% DV Oct-10 to 2013 .........................4.06 IRINOTECAN Inj 20 mg per ml, 2 ml – 1% DV Nov-12 to 2015..............................................9.34 Inj 20 mg per ml, 5 ml – 1% DV Nov-12 to 2015............................................23.34 IRON POLYMALTOSE Inj 50 mg per ml, 2 ml – 1% DV Oct-11 to 2014 ............................................19.90 IRON SUCROSE Inj 20 mg per ml, 5 ml ...................................................................................100.00 ISOFLURANE Liq 250 ml bottle – 1% DV Dec-12 to 2015...............................................1,020.00 ISONIAZID Tab 100 mg – 1% DV Mar-13 to 2015............................................................20.00 ISOPROPYL ALCOHOL Soln 70%, 500 ml .............................................................................................5.65 5.00 ISOSORBIDE MONONITRATE Tab 20 mg – 1% DV Jun-11 to 2014..............................................................17.10 Tab long-acting 40 mg – 1% DV Jun-11 to 2014 .............................................7.50 Tab long-acting 60 mg ......................................................................................3.94 ISOTRETINOIN Cap 10 mg – 1% DV Jan-13 to 2015 .............................................................18.71 Cap 20 mg – 1% DV Jan-13 to 2015 .............................................................28.91 ITRACONAZOLE Cap 100 mg – 1% DV Feb-11 to 2013.............................................................4.25 IVERMECTIN Tab 3 mg .........................................................................................................17.20 KETOCONAZOLE Shampoo 2% – 1% DV Sep-11 to 2014...........................................................3.08 KETONE BLOOD BETA-KETONE ELECTRODES Test strips .......................................................................................................15.50

10 6 10 10 6 6 10 10 10 6 10 20 20 1 1 5 5 6 100 1

Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Univent Univent Irinotecan Actavis 40 Irinotecan Actavis 100 Ferrum H Venofer Aerrane PSM healthE PSM Ismo-20 Corangin Duride Oratane Oratane Itrazole Stromectol Sebizole Freestyle Optium Ketone

100 30 90 120 120 15 4 100 ml 10 strip

40

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

KETOPROFEN Cap long-acting 100 mg .................................................................................21.56 Cap long-acting 200 mg .................................................................................43.12 LABETALOL Tab 50 mg .........................................................................................................8.23 Tab 100 mg .....................................................................................................10.06 Tab 200 mg .....................................................................................................17.55 LACOSAMIDE Tab 50 mg .......................................................................................................25.04 Tab 100 mg .....................................................................................................50.06 200.24 Tab 150 mg .....................................................................................................75.10 300.40 Tab 200 mg ...................................................................................................400.55 LACTULOSE Oral liq 10 g per 15 ml – 1% DV Mar-11 to 2013 .............................................7.68 LAMIVUDINE Tab 100 mg – 1% DV Dec-12 to 2014 ...........................................................32.50 LAMOTRIGINE Tab dispersible 2 mg .........................................................................................6.74 Tab dispersible 5 mg .........................................................................................9.64 15.00 Tab dispersible 25 mg .....................................................................................20.40 29.09 19.38 20.40 Tab dispersible 50 mg .....................................................................................34.70 47.89 32.97 34.70 Tab dispersible 100 mg ...................................................................................59.90 79.16 56.91 59.90 LANSOPRAZOLE Cap 15 mg – 1% DV Jan-13 to 2015 ...............................................................2.00 Cap 30 mg – 1% DV Jan-13 to 2015 ...............................................................2.32 LAPATINIB DITOSYLATE Tab 250 mg ................................................................................................1,899.00 LATANOPROST Eye drops 50 µg per ml – 1% DV Sep-12 to 2015...........................................1.99 LEFLUNOMIDE Tab 10 mg .......................................................................................................55.00 Tab 20 mg .......................................................................................................76.00 Tab 100 mg .....................................................................................................54.44 LETROZOLE Tab 2.5 mg – 1% DV Oct-12 to 2015 ...............................................................4.85

100 100 100 100 100 14 14 56 14 56 56 1,000 ml 28 30 30 56 56

Oruvail SR Oruvail SR Hybloc Hybloc Hybloc Vimpat Vimpat Vimpat Vimpat Vimpat Vimpat Laevolac Zetlam Lamictal Lamictal Arrow-Lamotrigine Arrow-Lamotrigine Lamictal Logem Mogine Arrow-Lamotrigine Lamictal Logem Mogine Arrow-Lamotrigine Lamictal Logem Mogine Solox Solox Tykerb Hysite Arava Arava Arava Letraccord

56

56

28 28 70 2.5 ml 30 30 3 30

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

41


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

LEUPRORELIN Inj 3.75 mg ....................................................................................................221.60 Inj 3.75 mg prefilled syringe .........................................................................221.60 Inj 7.5 mg ......................................................................................................166.20 Inj 11.25 mg ..................................................................................................591.68 Inj 11.25 mg prefilled syringe .......................................................................591.68 Inj 22.5 mg ....................................................................................................443.76 Inj 30 mg .......................................................................................................591.68 Inj 30 mg prefilled syringe .........................................................................1,109.40 Inj 45 mg .......................................................................................................832.05 LEVETIRACETAM Tab 250 mg .....................................................................................................24.03 Tab 500 mg .....................................................................................................28.71 Tab 750 mg .....................................................................................................45.23 LEVOBUNOLOL Eye drops 0.25% ..............................................................................................7.00 Eye drops 0.5% ................................................................................................7.00 LEVODOPA WITH BENSERAZIDE Tab dispersible 50 mg with benserazide 12.5 mg ...........................................10.00 Cap 50 mg with benserazide 12.5 mg ..............................................................8.00 Cap 100 mg with benserazide 25 mg .............................................................12.50 Cap long-acting 100 mg with benserazide 25 mg ..........................................17.00 Cap 200 mg with benserazide 50 mg .............................................................25.00 LEVODOPA WITH CARBIDOPA Tab 100 mg with carbidopa 25 mg ..................................................................20.00 Tab long-acting 200 mg with carbidopa 50 mg ...............................................47.50 Tab 250 mg with carbidopa 25 mg ..................................................................40.00 LEVONORGESTREL Tab 750 µg .....................................................................................................12.50 Subdermal implant (2 × 75 mg rods) ...........................................................133.65 LIGNOCAINE Gel 2% – 1% DV Oct-12 to 2015 .....................................................................3.40 Gel 2%, 10 ml urethral syringe .......................................................................43.26 LIGNOCAINE HYDROCHLORIDE Pump spray 10%, 50 ml CFC-free – 1% DV Nov-10 to 2013 ........................75.00 Viscous soln 2% – 1% DV Sep-11 to 2014....................................................55.00 Inj 1%, 2 ml .....................................................................................................57.60 Inj 1%, 5 ml .....................................................................................................35.00 Inj 1%, 20 ml ...................................................................................................20.00 Inj 2%, 2 ml .....................................................................................................62.40 Inj 2%, 5 ml .....................................................................................................23.00 Inj 2%, 20 ml ...................................................................................................15.00 LIGNOCAINE HYDROCHLORIDE WITH ADRENALINE Inj 1% with 1:100,000 of adrenaline 5 ml – 1% DV Nov-10 to 2013 ..............27.00 Inj 1% with 1:200,000 of adrenaline 20 ml – 1% DV Nov-10 to 2013 ............50.00 Inj 2% with 1:200,000 of adrenaline 20 ml – 1% DV Nov-10 to 2013 ............60.00 LIGNOCAINE WITH CHLORHEXIDINE Gel 2% with 0.05% chlorhexidine ...................................................................43.26

1 1 1 1 1 1 1 1 1 60 60 60 5 ml 5 ml 100 100 100 100 100 100 100 100 2 1 20 ml 10 50 ml 200 ml 50 50 5 50 50 5 10 5 5 10

Lucrin Depot Lucrin Depot PDS Eligard Lucrin Depot Lucrin Depot PDS Eligard Eligard Lucrin Depot PDS Eligard Levetiracetam-Rex Levetiracetam-Rex Levetiracetam-Rex Betagan Betagan Madopar Dispersible Madopar 62.5 Madopar 125 Madopar HBS Madopar 250 Sinemet Sinemet CR Sinemet Next Choice Jadelle Orion Pfizer Xylocaine Xylocaine Viscous Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Pfizer

42

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

LIGNOCAINE WITH PRILOCAINE Crm 2.5% with prilocaine 2.5%, 30 g – 1% DV Nov-10 to 2013 ....................45.00 Patch 2.5% with prilocaine 2.5% – 1% DV Nov-10 to 2013.........................115.00 Crm 2.5% with prilocaine 2.5%, 5 g – 1% DV Nov-10 to 2013 ......................45.00 LISINOPRIL Tab 5 mg – 1% DV Jan-13 to 2015..................................................................3.58 Tab 10 mg – 1% DV Jan-13 to 2015................................................................4.08 Tab 20 mg – 1% DV Jan-13 to 2015................................................................4.88 LISURIDE HYDROGEN MALEATE Tab 200 µg .....................................................................................................25.00 LITHIUM CARBONATE Tab 250 mg – 1% DV Sep-12 to 2015 ...........................................................34.30 Tab 400 mg – 1% DV Sep-12 to 2015 ...........................................................12.83 Cap 250 mg – 1% DV Nov-11 to 2014.............................................................9.42 LOMUSTINE Cap 10 mg – 1% DV Sep-11 to 2014...........................................................132.59 Cap 40 mg – 1% DV Sep-11 to 2014...........................................................399.15 LOPERAMIDE HYDROCHLORIDE Cap 2 mg – 1% DV Dec-10 to 2013.................................................................8.95 LOPINAVIR WITH RITONAVIR Tab 100 mg with ritonavir 25 mg ...................................................................183.75 Tab 200 mg with ritonavir 50 mg ...................................................................735.00 Oral liq 80 mg with ritonavir 20 mg per ml ....................................................735.00 LORATADINE Tab 10 mg – 1% DV Sep-10 to 2013 ...............................................................2.09 Oral liq 1 mg per ml – 1% DV Sep-10 to 2013.................................................3.10 LORAZEPAM Tab 1 mg – 1% DV Dec-10 to 2013 ...............................................................16.42 Tab 2.5 mg – 1% DV Dec-10 to 2013 ............................................................11.17 LOSARTAN Tab 12.5 mg – 1% DV Dec-11 to 2014 ............................................................2.88 Tab 25 mg – 1% DV Dec-11 to 2014 ...............................................................3.20 Tab 50 mg – 1% DV Dec-11 to 2014 ...............................................................5.22 Tab 50 mg with hydrochlorothiazide 12.5 mg – 1% DV Dec-11 to 2014 ..........4.89 Tab 100 mg – 1% DV Dec-11 to 2014 .............................................................8.68 MACROGOL 3350 Powder 13.125 g, sachets – 1% DV Dec-12 to 2014.....................................10.00 MAGNESIUM SULPHATE Inj 2 mmol per ml, 5 ml – 1% DV Feb-13 to 2015 ..........................................18.35 MANNITOL Inf 10% ...........................................................................................................14.21 Inf 15% .............................................................................................................9.84 Inf 20% ...........................................................................................................10.80 MASK FOR SPACER DEVICE Size 2 ................................................................................................................2.99

30 g 20 5 90 90 90 30 500 100 100 20 20 400 60 120 300 ml 100 100 ml 250 100 90 90 90 30 90 30 10 1,000 ml 500 ml 500 ml 1

EMLA EMLA EMLA Arrow-Lisinopril Arrow-Lisinopril Arrow-Lisinopril Dopergin Lithicarb FC Lithicarb FC Douglas Ceenu Ceenu Diamide Relief Kaletra Kaletra Kaletra Loraclear Hayfever Relief Lorapaed Ativan Ativan Lostaar Lostaar Lostaar Arrow-Losartan & Hydrochlorothiazide Lostaar Lax-Sachets Martindale Baxter Baxter Baxter EZ-fit Paediatric Mask

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

43


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

MEBENDAZOLE Tab 100 mg – 1% DV Nov-11 to 2014 ...........................................................24.19 MEBEVERINE HYDROCHLORIDE Tab 135 mg – 1% DV Sep-11 to 2014 ...........................................................18.00 MEDROXYPROGESTERONE ACETATE Tab 2.5 mg – 1% DV Jul-10 to 2013 ................................................................3.09 Tab 5 mg – 1% DV Jul-10 to 2013 .................................................................13.06 Tab 10 mg – 1% DV Jul-10 to 2013 .................................................................6.85 Tab 100 mg – 1% DV Jul-10 to 2013 .............................................................96.50 Tab 200 mg – 1% DV Jul-10 to 2013 .............................................................70.50 Inj 150 mg per ml, 1 ml syringe – 1% DV Jul-10 to 2013 ................................7.15 MEGESTROL ACETATE Tab 160 mg – 1% DV Jan-13 to 2015............................................................51.55 MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml ...............21.00 Oral soln 660 mg per ml, with sodium amidotrizoate 100 mg per ml, 100 ml .................................................................................................... 210.00 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml prefilled syringe ........................................................................................................ 92.00 Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml vial ......................184.00 MERCAPTOPURINE Tab 50 mg – 1% DV Dec-10 to 2013 .............................................................47.06 MEROPENEM Inj 500 mg – 1% DV Mar-12 to 2014..............................................................10.50 Inj 1 g – 1% DV Mar-12 to 2014.....................................................................21.00 MESALAZINE Tab 400 mg .....................................................................................................49.50 Tab EC 500 mg ...............................................................................................49.50 Tab long-acting 500 mg ..................................................................................59.05 Enema 1 g per 100 ml – 1% DV Sep-12 to 2015...........................................44.12 Suppos 500 mg – 1% DV Sep-11 to 2014 .....................................................22.80 Suppos 1 g .....................................................................................................50.96 MESNA Tab 400 mg – 1% DV Nov-10 to 2013 .........................................................210.65 Tab 600 mg – 1% DV Nov-10 to 2013 .........................................................314.40 Inj 100 mg per ml, 4 ml – 1% DV Nov-10 to 2013........................................137.04 Inj 100 mg per ml, 10 ml – 1% DV Nov-10 to 2013......................................314.66 METFORMIN HYDROCHLORIDE Tab immediate-release 500 mg – 1% DV Oct-12 to 2015..............................12.30 Tab immediate-release 850 mg – 1% DV Oct-12 to 2015..............................10.10 METHADONE HYDROCHLORIDE Tab 5 mg – 1% DV Oct-10 to 2013 ..................................................................1.85 Oral liq 2 mg per ml – 1% DV Sep-12 to 2015.................................................5.55 Oral liq 5 mg per ml – 1% DV Sep-12 to 2015.................................................5.55 Oral liq 10 mg per ml – 1% DV Sep-12 to 2015...............................................6.55 Inj 10 mg per ml, 1 ml .....................................................................................61.00

24 90 30 100 30 100 30 1 30 100 ml 10

De-Worm Colofac Provera Provera Provera Provera Provera Depo-Provera Apo-Megestrol Gastrografin Gastrografin

5 10 25 1 1 100 100 100 7 20 28 50 50 15 15 1,000 500 10 200 ml 200 ml 200 ml 10

Magnevist Magnevist Purinethol Penembact Penembact Asacol Asamax Pentasa Pentasa Asacol Pentasa Uromitexan Uromitexan Uromitexan Uromitexan Apotex Apotex Methatabs Biodone Biodone Forte Biodone Extra Forte AFT

44

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

METHOTREXATE Tab 2.5 mg ........................................................................................................5.22 Tab 10 mg .......................................................................................................40.93 Inj 25 mg per ml, 40 ml ...................................................................................25.00 Inj 25 mg per ml, 2 ml – 1% DV Nov-10 to 2013............................................48.00 Inj 25 mg per ml, 20 ml – 1% DV Nov-10 to 2013..........................................90.00 Inj 100 mg per ml, 10 ml – 1% DV Nov-08 to 2014........................................25.00 Inj 100 mg per ml, 50 ml – 1% DV Nov-08 to 2014......................................125.00 METHYLCELLULOSE Powder ............................................................................................................14.00 Suspension .....................................................................................................35.50 METHYLCELLULOSE WITH GLYCERIN AND SODIUM SACCHARIN Suspension .....................................................................................................35.50 METHYLCELLULOSE WITH GLYCERIN AND SUCROSE Suspension .....................................................................................................35.50 METHYLDOPA Tab 125 mg .....................................................................................................14.25 Tab 250 mg .....................................................................................................15.10 Tab 500 mg .....................................................................................................23.15 METHYLPHENIDATE HYDROCHLORIDE Tab immediate-release 5 mg ............................................................................3.20 Tab immediate-release 10 mg ..........................................................................3.00 Tab immediate-release 20 mg ..........................................................................7.85 Tab sustained-release 20 mg .........................................................................10.95 50.00 METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE Tab extended-release 18 mg ..........................................................................58.96 Tab extended-release 27 mg ..........................................................................65.44 Tab extended-release 36 mg ..........................................................................71.93 Tab extended-release 54 mg ..........................................................................86.24 Cap modified-release 10 mg ..........................................................................19.50 Cap modified-release 20 mg ..........................................................................25.50 Cap modified-release 30 mg ..........................................................................31.90 Cap modified-release 40 mg ..........................................................................38.25 METHYLPREDNISOLONE Tab 4 mg – 1% DV Oct-12 to 2015 ................................................................60.00 Tab 100 mg – 1% DV Oct-12 to 2015 ..........................................................166.52 METHYLPREDNISOLONE ACEPONATE Crm 0.1% .........................................................................................................4.95 Oint 0.1% ..........................................................................................................4.95 METHYLPREDNISOLONE ACETATE Inj 40 mg per ml, 1 ml – 1% DV Oct-12 to 2015 ..............................................6.70 METHYLPREDNISOLONE ACETATE WITH LIGNOCAINE Inj 40 mg per ml with lignocaine 10 mg per ml, 1 ml – 1% DV Oct-12 to 2015 ....................................................................................................... 7.50

30 50 1 5 1 1 1 100 g 473 ml 473 ml 473 ml 100 100 100 30 30 30 30 100 30 30 30 30 30 30 30 30 100 20 15 g 15 g 1

Methoblastin Methoblastin DBL Methotrexate Hospira Hospira Methotrexate Ebewe Methotrexate Ebewe ABM Ora-Plus Ora-Blend SF Ora-Blend Prodopa Prodopa Prodopa Rubifen Ritalin Rubifen Rubifen Rubifen SR Ritalin SR Concerta Concerta Concerta Concerta Ritalin LA Ritalin LA Ritalin LA Ritalin LA Medrol Medrol Advantan Advantan Depo-Medrol

1

Depo-Medrol with Lidocaine

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

45


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

METHYLPREDNISOLONE SODIUM SUCCINATE Inj 40 mg per ml, 1 ml – 1% DV Oct-12 to 2015 ..............................................7.50 Inj 62.5 mg per ml, 2 ml – 1% DV Oct-12 to 2015 .........................................18.50 Inj 500 mg – 1% DV Oct-12 to 2015 ..............................................................18.00 Inj 1 g – 1% DV Oct-12 to 2015 .....................................................................37.50 METOCLOPRAMIDE HYDROCHLORIDE Tab 10 mg – 1% DV Jun-11 to 2014................................................................3.95 Inj 5 mg per ml, 2 ml – 1% DV Sep-11 to 2014................................................4.50 METOPROLOL SUCCINATE Tab long-acting 23.75 mg – 1% DV Sep-12 to 2015........................................0.96 Tab long-acting 47.5 mg – 1% DV Sep-12 to 2015..........................................1.41 Tab long-acting 95 mg – 1% DV Sep-12 to 2015.............................................2.42 Tab long-acting 190 mg – 1% DV Sep-12 to 2015...........................................4.66 METOPROLOL TARTRATE Tab 50 mg – 1% DV Aug-12 to 2015 .............................................................16.00 Tab 100 mg – 1% DV Aug-12 to 2015 ...........................................................21.00 Tab long-acting 200 mg – 1% DV Aug-12 to 2015.........................................18.00 Inj 1 mg per ml, 5 ml – 1% DV Dec-12 to 2015..............................................24.00 METRONIDAZOLE Tab 200 mg .....................................................................................................10.45 Tab 400 mg .....................................................................................................18.15 Oral liq 200 mg per 5 ml .................................................................................25.00 Inj 500 mg, 100 ml ............................................................................................2.46 12.30 Suppos 500 mg ..............................................................................................24.48 MEXILETINE HYDROCHLORIDE Cap 250 mg ..................................................................................................102.00 Cap 150 mg ....................................................................................................65.00 MICONAZOLE Oral gel 20 mg per g – 1% DV Feb-13 to 2015................................................4.95 MICONAZOLE NITRATE Crm 2% – 1% DV Nov-11 to 2014 ...................................................................0.46 Powder 2% .......................................................................................................8.50 MIDAZOLAM Inj 1 mg per ml, 5 ml .......................................................................................10.75 10.00 Inj 5 mg per ml, 3 ml .......................................................................................11.90 MINOXIDIL Tab 10 mg .......................................................................................................70.00 MIRTAZAPINE Tab 30 mg – 1% DV Sep-12 to 2015 ...............................................................8.78 Tab 45 mg – 1% DV Sep-12 to 2015 .............................................................13.95 MITOMYCIN C Inj 5 mg ...........................................................................................................72.75

1 1 1 1 100 10 30 30 30 30 100 60 28 5 100 100 100 ml 1 5 10 100 100

Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Metamide Pfizer Metoprolol - AFT CR Metoprolol - AFT CR Metoprolol - AFT CR Metoprolol - AFT CR Lopresor Lopresor Slow-Lopresor Lopresor Trichozole Trichozole Flagyl-S Baxter AFT Flagyl Mexiletine Hydrochloride USP Mexiletine Hydrochloride USP Decozol Multichem Daktarin Hypnovel Pfizer Hypnovel Pfizer Loniten Avanza Avanza Arrow

40 g 15 g 30 g 10 5

100 30 30 1

46

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

MITOZANTRONE Inj 2 mg per ml, 5 ml .....................................................................................110.00 Inj 2 mg per ml, 10 ml – 1% DV Sep-10 to 2013..........................................100.00 Inj 2 mg per ml, 12.5 ml ................................................................................407.50 MIVACURIUM Inj 10 mg per 5 ml ...........................................................................................33.92 Inj 20 mg per 10 ml .........................................................................................67.17 MOCLOBEMIDE Tab 150 mg – 1% DV Apr-13 to 2015 ............................................................81.83 Tab 300 mg – 1% DV Apr-13 to 2015 ............................................................29.51 MOMETASONE FUROATE Crm 0.1% – 1% DV Sep-12 to 2015 ................................................................1.78 3.42 Oint 0.1% – 1% DV Sep-12 to 2015 ................................................................1.78 3.42 MONTELUKAST Tab 10 mg .......................................................................................................18.48 Tab 4 mg .........................................................................................................18.48 Tab 5 mg .........................................................................................................18.48 MORPHINE HYDROCHLORIDE Oral liq 1 mg per ml – 1% DV Oct-12 to 2015..................................................8.84 Oral liq 2 mg per ml – 1% DV Oct-12 to 2015................................................11.62 Oral liq 5 mg per ml – 1% DV Oct-12 to 2015................................................14.65 Oral liq 10 mg per ml – 1% DV Oct-12 to 2015..............................................21.55 MORPHINE SULPHATE Tab immediate-release 10 mg ..........................................................................2.80 Tab long-acting 10 mg – 1% DV Aug-11 to 2013.............................................1.98 Tab immediate-release 20 mg ..........................................................................5.52 Tab long-acting 30 mg – 1% DV Aug-11 to 2013.............................................3.15 Tab long-acting 60 mg – 1% DV Aug-11 to 2013.............................................7.20 Tab long-acting 100 mg – 1% DV Aug-11 to 2013...........................................7.85 Cap long-acting 10 mg – 1% DV Nov-10 to 2013 ............................................2.22 Cap long-acting 30 mg – 1% DV Nov-10 to 2013 ............................................3.20 Cap long-acting 60 mg – 1% DV Nov-10 to 2013 ............................................6.90 Cap long-acting 100 mg – 1% DV Nov-10 to 2013 ..........................................8.05 Inf 1 mg per ml, 100 ml premixed bag – 1% DV Dec-11 to 2014.................165.00 Inj 1 mg per ml, 10 ml prefilled syringe – 1% DV Dec-11 to 2014 .................39.50 Inj 1 mg per ml, 30 ml prefilled syringe ...........................................................75.00 Inj 1 mg per ml, 50 ml prefilled syringe – 1% DV Dec-11 to 2014 .................79.50 Inj 2 mg per ml, 30 ml prefilled syringe – 1% DV Dec-11 to 2014 ...............135.00 Inj 5 mg per ml, 1 ml – 1% DV Nov-11 to 2014................................................5.51 Inj 10 mg per ml, 1 ml – 1% DV Nov-11 to 2014..............................................4.79 Inj 15 mg per ml, 1 ml – 1% DV Nov-11 to 2014..............................................5.01 Inj 30 mg per ml, 1 ml – 1% DV Nov-11 to 2014..............................................5.30

1 1 1 5 5 500 100 15 g 45 g 15 g 45 g 28 28 28 200 ml 200 ml 200 ml 200 ml 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 5 5 5 5

Mitozantrone Ebewe Mitozantrone Ebewe Onkotrone Mivacron Mivacron Apo-Moclobemide Apo-Moclobemide m-Mometasone m-Mometasone m-Mometasone m-Mometasone Singulair Singulair Singulair RA-Morph RA-Morph RA-Morph RA-Morph Sevredol Arrow-Morphine LA Sevredol Arrow-Morphine LA Arrow-Morphine LA Arrow-Morphine LA m-Eslon m-Eslon m-Eslon m-Eslon Biomed Biomed Biomed Biomed Biomed DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

47


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

MORPHINE TARTRATE Inj 80 mg per ml, 1.5 ml – 1% DV Nov-10 to 2013.........................................30.00 Inj 80 mg per ml, 5 ml – 1% DV Nov-10 to 2013............................................75.00 MOXIFLOXACIN Tab 400 mg .....................................................................................................52.00 Soln for inf 1.6 mg per ml, 250 ml ...................................................................70.00 MUCILAGINOUS LAXATIVES Dry – 1% DV Nov-10 to 2013 ..........................................................................6.02 MYCOPHENOLATE MOFETIL Tab 500 mg .....................................................................................................70.00 60.00 Cap 250 mg ....................................................................................................30.00 70.00 60.00 Pwd for oral liq 1 g per 5 ml ..........................................................................285.00 Inj 500 mg vial ..............................................................................................133.33 NADOLOL Tab 40 mg – 1% DV Apr-13 to 2015 ..............................................................15.57 Tab 80 mg – 1% DV Apr-13 to 2015 ..............................................................23.74 NALOXONE HYDROCHLORIDE Inj 400 µg per ml, 1 ml ....................................................................................33.00 NALTREXONE HYDROCHLORIDE Tab 50 mg – 1% DV Jun-11 to 2013............................................................123.00 NAPHAZOLINE HYDROCHLORIDE Eye drops 0.1 % – 1% DV Sep-11 to 2014 ......................................................4.15 NAPROXEN Tab 250 mg – 1% DV Jan-13 to 2015............................................................21.25 Tab 500 mg – 1% DV Jan-13 to 2015............................................................22.25 NEOSTIGMINE METHYLSULPHATE Inj 2.5 mg per ml, 1 ml – 1% DV Sep-11 to 2014.........................................140.00 NEVIRAPINE Tab 200 mg – 1% DV Jan-13 to 2015............................................................95.94 Oral suspension 10 mg per ml ......................................................................134.55 NICORANDIL Tab 10 mg .......................................................................................................27.95 Tab 20 mg .......................................................................................................33.28

5 5 5 1 500 g 50

Hospira Hospira Avelox Avelox IV 400 Konsyl-D CellCept Ceptolate Myaccord Ceptolate CellCept Myaccord CellCept CellCept Apo-Nadolol Apo-Nadolol Mayne Naltraccord Naphcon Forte Noflam 250 Noflam 500 AstraZeneca Nevirapine Alphapharm Viramune Suspension Ikorel Ikorel

50 100 165 ml 4 100 100 5 30 15 ml 500 250 50 60 240 ml 60 60

48

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

NICOTINE Patch 7 mg – 5% DV Jul-11 to 2014..............................................................18.13 Patch 14 mg – 5% DV Jul-11 to 2014............................................................18.81 Patch 21 mg – 5% DV Jul-11 to 2014............................................................19.14 Lozenge 1 mg – 5% DV Jul-11 to 2014 .........................................................19.94 Lozenge 2 mg – 5% DV Jul-11 to 2014 .........................................................24.27 Gum 2 mg (classic) – 5% DV Oct-11 to 2014................................................36.47 Gum 2 mg (fruit) – 5% DV Oct-11 to 2014.....................................................36.47 Gum 2 mg (mint) – 5% DV Oct-11 to 2014....................................................36.47 Gum 4 mg (classic) – 5% DV Oct-11 to 2014................................................42.04 Gum 4 mg (fruit) – 5% DV Oct-11 to 2014.....................................................42.04 Gum 4 mg (mint) – 5% DV Oct-11 to 2014....................................................42.04 NIFEDIPINE Tab long-acting 20 mg ......................................................................................7.30 Tab long-acting 30 mg ......................................................................................8.56 Tab long-acting 60 mg ....................................................................................12.28 NORADRENALINE ACID TARTRATE Inj 1:1,000 per 2 ml .........................................................................................42.00 NORETHISTERONE Tab 5 mg – 1% DV Nov-11 to 2014 ...............................................................26.50 NORFLOXACIN Tab 400 mg – 1% DV Sep-11 to 2014 ...........................................................15.45 NORTRIPTYLINE HYDROCHLORIDE Tab 10 mg .........................................................................................................6.69 Tab 25 mg .......................................................................................................14.77 NYSTATIN Tab 500,000 u – 1% DV Nov-10 to 2013 .......................................................14.16 Cap 500,000 u – 1% DV Nov-10 to 2013.......................................................12.81 Oral liq 100,000 u per ml – 1% DV Sep-11 to 2014.........................................3.19 OCTREOTIDE Inj LAR, 10 mg prefilled syringe ................................................................1,772.50 Inj LAR, 20 mg prefilled syringe ................................................................2,358.75 Inj LAR, 30 mg prefilled syringe ................................................................2,951.25 Inj 50 µg per ml, 1 ml – 1% DV May-12 to 2014 ............................................19.24 Inj 100 µg per ml, 1 ml – 1% DV May-12 to 2014 ..........................................36.38 Inj 500 µg per ml, 1 ml – 1% DV May-12 to 2014 ........................................131.25 OIL IN WATER EMULSION Crm – 1% DV Dec-12 to 2015 .........................................................................2.63 Crm 100 g .........................................................................................................1.60 OLANZAPINE Orodispersible tab 5 mg – 5% DV Aug-11 to 2013..........................................6.36 Orodispersible tab 10 mg – 5% DV Aug-11 to 2013........................................8.76 Tab 2.5 mg – 5% DV Aug-11 to 2013 ..............................................................2.00 Tab 5 mg – 5% DV Aug-11 to 2013 .................................................................3.85 Tab 10 mg – 5% DV Aug-11 to 2013 ...............................................................6.35

28 28 28 216 216 384 384 384 384 384 384 100 30 30

Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Nyefax Retard Adefin XL Arrow-Nifedipine XR Adefin XL Arrow-Nifedipine XR Levophed Primolut N Arrow-Norfloxacin Norpress Norpress Nilstat Nilstat Nilstat Sandostatin LAR Sandostatin LAR Sandostatin LAR Octreotide MaxRx Octreotide MaxRx Octreotide MaxRx healthE Fatty Cream healthE Olanzine-D Olanzine-D Olanzine Olanzine Olanzine

6 100 100 100 180 50 50 24 ml 1 1 1 5 5 5 500 g 1 28 28 28 28 28

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

49


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

OLANZAPINE PAMOATE MONOHYDRATE Inj 210 mg .....................................................................................................280.00 Inj 300 mg .....................................................................................................460.00 Inj 405 mg .....................................................................................................560.00 OMEPRAZOLE Cap 10 mg – 1% DV Oct-11 to 2014 ...............................................................2.91 Cap 20 mg – 1% DV Oct-11 to 2014 ...............................................................3.78 Cap 40 mg – 1% DV Oct-11 to 2014 ...............................................................5.57 Powder – 1% DV Sep-11 to 2014 ..................................................................42.50 Inf 40 mg – 1% DV Sep-11 to 2014 ...............................................................19.00 Inj 40 mg – 1% DV Sep-11 to 2014 ...............................................................28.65 ONDANSETRON Tab 4 mg – 1% DV Feb-11 to 2013..................................................................5.10 Tab disp 4 mg ...................................................................................................0.68 1.70 17.18 Tab 8 mg – 1% DV Feb-11 to 2013..................................................................1.70 Tab disp 8 mg – 5% DV May-11 to 2013..........................................................2.00 Inj 2 mg per ml, 2 ml .........................................................................................2.64 14.40 Inj 2 mg per ml, 4 ml .........................................................................................2.98 23.20 (Zofran Inj 2 mg per ml, 2 ml to be delisted 1 April 2013) (Zofran Inj 2 mg per ml, 4 ml to be delisted 1 April 2013) ORAL ELEMENTAL FEED 1KCAL/ML Powder (unflavoured) .......................................................................................4.50 Liquid (vanilla) ..................................................................................................4.95 ORAL FEED 1.5KCAL/ML Liquid (banana) .................................................................................................1.26 Liquid (chocolate) .............................................................................................1.26 1.33 Liquid (fruit of the forest) ...................................................................................1.26 Liquid (strawberry) ............................................................................................1.33 Liquid (vanilla) ..................................................................................................1.26 1.33 ORAL FEED 2KCAL/ML Liquid (vanilla) ..................................................................................................2.25 ORNIDAZOLE Tab 500 mg .....................................................................................................16.50 OXALIPLATIN Inj 50 mg – 1% DV Aug-12 to 2015 ...............................................................15.32 Inj 100 mg – 1% DV Aug-12 to 2015 .............................................................25.01 OXYBUTYNIN Tab 5 mg .........................................................................................................44.79 Oral liq 5 mg per 5 ml .....................................................................................50.40

1 1 1 90 90 90 5g 5 5 30 4 10 10 10 5 5

Zyprexa Relprevv Zyprexa Relprevv Zyprexa Relprevv Omezol Relief Omezol Relief Omezol Relief Midwest Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron Zofran Zydis Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron Ondanaccord Zofran Ondanaccord Zofran

80.4 g 237 ml 200 ml 200 ml 237 ml 200 ml 237 ml 200 ml 237 ml 237 ml 10 1 1 500 473 ml

Vivonex TEN Peptamen OS 1.0 Ensure Plus Ensure Plus Ensure Plus Ensure Plus Ensure Plus Ensure Plus Ensure Plus Two Cal HN Arrow-Ornidazole Oxaliplatin Actavis 50 Oxaliplatin Actavis 100 Apo-Oxybutynin Apo-Oxybutynin

50

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

OXYCODONE HYDROCHLORIDE Tab controlled-release 5 mg .............................................................................7.51 Tab controlled-release 10 mg .........................................................................11.14 Tab controlled-release 20 mg .........................................................................18.93 Tab controlled-release 40 mg .........................................................................33.29 Tab controlled-release 80 mg .........................................................................58.03 Cap 5 mg ..........................................................................................................2.83 Cap 10 mg ........................................................................................................5.58 Cap 20 mg ........................................................................................................9.77 Oral liq 5 mg per 5 ml .....................................................................................11.20 Inj 10 mg per ml, 1 ml – 1% DV Dec-12 to 2015............................................10.08 Inj 10 mg per ml, 2 ml – 1% DV Dec-12 to 2015............................................19.87 inj 50 mg per ml, 1 ml – 1% DV May-13 to 2015............................................60.00 OXYTOCIN Inj 5 iu per ml, 1 ml ...........................................................................................5.94 Inj 10 iu per ml, 1 ml .........................................................................................7.48 Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml – 1% DV Oct-12 to 2015 ..................................................................................................... 11.13 PACLITAXEL Inj 30 mg – 1% DV Oct-08 to 2014 ..............................................................137.50 Inj 100 mg – 1% DV Oct-08 to 2014 ..............................................................91.67 Inj 150 mg – 1% DV Oct-08 to 2014 ............................................................137.50

20 20 20 20 20 20 20 20 250 ml 5 5 5 5 5 5 5 1 1

OxyContin OxyContin OxyContin OxyContin OxyContin OxyNorm OxyNorm OxyNorm OxyNorm Oxycodone Orion Oxycodone Orion OxyNorm Syntocinon Syntocinon Syntometrine Paclitaxel Ebewe Paclitaxel Actavis Paclitaxel Ebewe Anzatax Paclitaxel Actavis Paclitaxel Ebewe Anzatax Paclitaxel Actavis Paclitaxel Ebewe Paclitaxel Ebewe Pediasure Pediasure RTH Nutrini Low Energy Multi Fibre Nutrini Energy Multi Fibre Pediasure Pediasure Pediasure Pediasure Pamisol Pamidronate BNM Pamidronate BNM Pamidronate BNM

Inj 300 mg – 1% DV Oct-08 to 2014 ............................................................275.00

1

Inj 600 mg – 1% DV Oct-08 to 2014 ............................................................550.00 PAEDIATRIC ORAL FEED Powder (vanilla) ..............................................................................................20.00 PAEDIATRIC ENTERAL FEED 1 KCAL/ML Liquid ................................................................................................................2.68 PAEDIATRIC ENTERAL FEED WITH FIBRE 0.75 KCAL/ML Liquid ................................................................................................................4.00 PAEDIATRIC ENTERAL FEED WITH FIBRE 1.5 KCAL/ML Liquid ................................................................................................................6.00 PAEDIATRIC ORAL FEED 1 KCAL/ML Liquid (chocolate) .............................................................................................1.07 Liquid (strawberry) ............................................................................................1.07 Liquid (vanilla) ..................................................................................................1.07 1.27 PAMIDRONATE DISODIUM Inj 3 mg per ml, 5 ml .......................................................................................18.75 Inj 3 mg per ml, 10 ml – 1% DV Feb-13 to 2014............................................16.00 Inj 6 mg per ml, 10 ml – 1% DV Feb-13 to 2014............................................32.00 Inj 9 mg per ml, 10 ml – 1% DV Feb-13 to 2014............................................48.00

1 900 g 500 ml 500 ml

500 ml 200 ml 200 ml 200 ml 237 ml 1 1 1 1

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

51


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PANCURONIUM BROMIDE Inj 2 mg per ml, 2 ml – 1% DV Jan-13 to 2015 ............................................260.00 PANTOPRAZOLE Tab 20 mg – 1% DV Sep-10 to 2013 ...............................................................1.23 Tab 40 mg – 1% DV Sep-10 to 2013 ...............................................................1.54 PAPAVERINE HYDROCHLORIDE Inj 12 mg per ml, 10 ml ...................................................................................73.12 PARACETAMOL Oral liq 120 mg per 5 ml – 20% DV Dec-11 to 2014........................................2.21 Oral liq 250 mg per 5 ml – 20% DV Sep-11 to 2014........................................6.70 Inj 10 mg per ml, 100 ml – 1% DV Apr-13 to 2014 ........................................22.50 Suppos 25 mg ................................................................................................56.35 Suppos 50 mg ................................................................................................56.35 Suppos 125 mg ................................................................................................7.49 Suppos 250 mg ..............................................................................................14.40 Suppos 500 mg – 1% DV Jan-13 to 2015 .....................................................20.70 PARACETAMOL WITH CODEINE Tab paracetamol 500 mg with codeine phosphate 8 mg – 1% DV Nov11 to 2014 .................................................................................................. 2.70

50 28 28

AstraZeneca Dr Reddy’s Pantoprazole Dr Reddy’s Pantoprazole Mayne Ethics Paracetamol Paracare Double Strength Paracetamol-AFT Biomed Biomed Panadol Panadol Paracare

5 500 ml 1,000 ml 10 20 20 20 20 50

100

Paracetamol + Codeine (Relieve)

PARAFFIN White soft – 1% DV Feb-13 to 2015 ................................................................0.92 10 g healthE Note: DV Limit applies to pack sizes of 30 g or less, and to white soft paraffin and yellow soft paraffin. PARECOXIB Inj 40 mg .......................................................................................................100.00 10 Dynastat PAROXETINE HYDROCHLORIDE Tab 20 mg – 1% DV Sep-10 to 2013 ...............................................................2.38 PAZOPANIB Tab 200 mg ................................................................................................1,334.70 Tab 400 mg ................................................................................................2,669.40 PEAK FLOW METER Low Range .....................................................................................................11.44 Normal Range ................................................................................................11.44 PEGFILGRASTIM Inj 6 mg per 0.6 ml prefilled syringe ..........................................................1,395.00 PENICILLAMINE Tab 125 mg .....................................................................................................61.93 Tab 250 mg .....................................................................................................98.98 PERGOLIDE Tab 0.25 mg – 1% DV Sep-11 to 2014 ..........................................................48.00 Tab 1 mg – 1% DV Sep-11 to 2014 .............................................................170.00 PERHEXILINE MALEATE Tab 100 mg .....................................................................................................62.90 30 30 30 1 1 1 100 100 100 100 100 Loxamine Votrient Votrient Breath-Alert Breath-Alert Neulastim D-Penamine D-Penamine Permax Permax Pexsig

52

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PERMETHRIN Crm 5% – 1% DV Sep-11 to 2014 ...................................................................4.20 Lotn 5% – 1% DV Sep-11 to 2014 ...................................................................3.24 PETHIDINE HYDROCHLORIDE Tab 50 mg – 1% DV Mar-13 to 2015................................................................3.95 Tab 100 mg – 1% DV Mar-13 to 2015..............................................................5.80 Inj 50 mg per ml, 1 ml – 1% DV Nov-11 to 2014..............................................5.51 Inj 50 mg per ml, 2 ml – 1% DV Nov-11 to 2014..............................................5.83 PHENOBARBITONE Tab 15 mg – 1% DV Mar-13 to 2015..............................................................28.00 Tab 30 mg – 1% DV Mar-13 to 2015..............................................................29.00 PHENOXYMETHYLPENICILLIN (PENICILLIN V) Cap potassium salt 250 mg – 1% DV Nov-10 to 2013.....................................9.71 Cap potassium salt 500 mg – 1% DV Nov-10 to 2013...................................11.70 Grans for oral liq 125 mg per 5 ml – 1% DV Sep-10 to 2013...........................1.68 Grans for oral liq 250 mg per 5 ml – 1% DV Sep-10 to 2013...........................1.78 PHENYLEPHRINE HYDROCHLORIDE Inj 1%, 1 ml ...................................................................................................115.50 PHYTOMENADIONE Inj 2 mg per 0.2 ml ............................................................................................8.00 Inj 10 mg per ml, 1 ml .......................................................................................9.21 PINDOLOL Tab 5 mg ...........................................................................................................5.40 Tab 10 mg .........................................................................................................9.19 Tab 15 mg .......................................................................................................13.80 PIOGLITAZONE Tab 15 mg – 1% DV Sep-12 to 2015 ...............................................................1.50 Tab 30 mg – 1% DV Sep-12 to 2015 ...............................................................2.50 Tab 45 mg – 1% DV Sep-12 to 2015 ...............................................................3.50 PIPERACILLIN SODIUM WITH TAZOBACTAM SODIUM Inj 4 g with tazobactam sodium 500 mg – 1% DV Jun-10 to 2013 ................12.00 PIZOTIFEN Tab 500 µg – 1% DV Mar-13 to 2015 ............................................................23.21 PODOPHYLLOTOXIN Soln 0.5% .......................................................................................................33.60 POLOXAMER Oral drops 10% – 1% DV Sep-11 to 2014 .......................................................3.78 POLYETHYLENE GLYCOL WITH SODIUM SULPHATE Powder, sachets .............................................................................................14.31 POLYVINYL ALCOHOL Eye drops 1.4% ................................................................................................3.62 2.95 Eye drops 3% ...................................................................................................3.88 3.80

30 g 30 ml 10 10 5 5

Lyderm A-Scabies PSM PSM DBL Pethidine Hydrochloride DBL Pethidine Hydrochloride PSM PSM Cilicaine VK Cilicaine VK AFT AFT Neosynephrine HCL Konakion MM Konakion MM Apo-Pindolol Apo-Pindolol Apo-Pindolol Pizaccord Pizaccord Pizaccord Tazocin EF Sandomigran Condyline Coloxyl Klean Prep Liquifilm Tears Vistil Liquifilm Forte Vistil Forte

500 500 50 50 100 ml 100 ml 25 5 5 100 100 100 28 28 28 1 100 3.5 ml 30 ml 4 15 ml 15 ml

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

53


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PORACTANT ALFA Inj 80 mg per ml, 1.5 ml ................................................................................425.00 Inj 80 mg per ml, 3 ml ...................................................................................695.00 POSACONAZOLE Oral liq 40 mg per ml ....................................................................................761.13 POTASSIUM CHLORIDE Tab long-acting 600 mg – 1% DV Oct-12 to 2015 ...........................................7.42 POTASSIUM CHLORIDE WITH GLUCOSE Inf 20 mmol/L with 5% glucose .........................................................................7.36 POTASSIUM CHLORIDE WITH GLUCOSE AND SODIUM CHLORIDE Inf 20 mmol/L with 2.5% glucose and 0.45% sodium chloride .........................4.95 Inf 20 mmol/L with 4% glucose and 0.18% sodium chloride ............................3.45 4.30 Inf 30 mmol/L with 4% glucose and 0.18% sodium chloride ............................3.62 POTASSIUM CHLORIDE WITH SODIUM CHLORIDE Inf 20 mmol/L with 0.9% sodium chloride .........................................................3.85 Inf 30 mmol/L with 0.9% sodium chloride .........................................................2.59 Inf 40 mmol/L with 0.9% sodium chloride .........................................................6.62 POTASSIUM CITRATE Oral liq 3 mmol per ml ....................................................................................30.00 POVIDONE IODINE Oint 10% ...........................................................................................................3.27 Alcohol skin preparation 10% with 30% alcohol .............................................10.00 Antiseptic soln 10% ..........................................................................................2.95 6.20 PRAMIPEXOLE HYDROCHLORIDE Tab 0.125 mg – 1% DV Jun-12 to 2013...........................................................1.95 Tab 0.25 mg – 1% DV Jun-12 to 2013.............................................................2.40 Tab 0.5 mg ........................................................................................................4.20 Tab 1 mg ...........................................................................................................7.20 PRASUGREL Tab 5 mg .......................................................................................................108.00 Tab 10 mg .....................................................................................................120.00 PRAVASTATIN Tab 20 mg – 1% DV Nov-11 to 2014 ...............................................................5.44 Tab 40 mg – 1% DV Nov-11 to 2014 ...............................................................9.28 PRAZOSIN HYDROCHLORIDE Tab 1 mg ...........................................................................................................5.53 Tab 2 mg ...........................................................................................................7.00 Tab 5 mg .........................................................................................................11.70 PREDNISOLONE SODIUM PHOSPHATE Oral liq 5 mg per ml ........................................................................................10.45

1 1 105 ml 200 1,000 ml 500 ml 500 ml 1,000 ml 1,000 ml 1,000 ml 1,000 ml 1,000 ml 200 ml 25 g 500 ml 100 ml 500 ml

Curosurf Curosurf Noxafil Span-K Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter Biomed Betadine Betadine Skin Prep Riodine Riodine Betadine Dr Reddy’s Pramipexole Dr Reddy’s Pramipexole Dr Reddy’s Pramipexole Dr Reddy’s Pramipexole Effient Effient Cholvastin Cholvastin Apo-Prazo Apo-Prazo Apo-Prazo Redipred

30 30 30 30 28 28 30 30 100 100 100 30 ml

54

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PREDNISONE Tab 1 mg .........................................................................................................10.68 Tab 2.5 mg ......................................................................................................12.09 Tab 5 mg .........................................................................................................11.09 Tab 20 mg .......................................................................................................29.03 PREGNANCY TEST – HCG URINE Cassette .........................................................................................................22.80

500 500 500 500 40 test

Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone Innovacon hCG One Step Pregnancy Test S26LBW Gold RTF S-26 Gold Premgro Citanest Citanest Cilicaine Natulan Antinaus Allersoothe Allersoothe Allersoothe Mayne Diprivan Fresofol 1% Provive MCT-LCT 1% Diprivan Fresofol 1% Provive MCT-LCT 1% Diprivan Diprivan Fresofol 1% Provive MCT-LCT 1% Diprivan Apo-Propranolol Apo-Propranolol Cardinol LA ABM PTU

PREMATURE BIRTH FORMULA Liquid ................................................................................................................0.75 PRETERM POST-DISCHARGE INFANT FORMULA Powder ............................................................................................................15.25 PRILOCAINE HYDROCHLORIDE Inj 0.5%, 50 ml – 1% DV Nov-10 to 2013 ....................................................100.00 Inj 2%, 5 ml – 1% DV Nov-10 to 2013 ...........................................................55.00 PROCAINE PENICILLIN Inj 1.5 mega u – 1% DV Nov-11 to 2014 .....................................................123.50 PROCARBAZINE HYDROCHLORIDE Cap 50 mg ....................................................................................................225.00 PROCHLORPERAZINE Tab 5 mg .........................................................................................................16.85 PROMETHAZINE HYDROCHLORIDE Tab 10 mg – 1% DV Sep-12 to 2015 ...............................................................1.99 Tab 25 mg – 1% DV Sep-12 to 2015 ...............................................................2.99 Oral liq 5 mg per 5 ml – 1% DV Feb-13 to 2015 ..............................................2.79 Inj 25 mg per ml, 2 ml .....................................................................................11.00 PROPOFOL Inj 1%, 20 ml ...................................................................................................42.00 7.60 Inj 1%, 50 ml ...................................................................................................25.00 4.00 Inj 1%, 50 ml prefilled syringe ........................................................................47.00 Inj 1%, 100 ml .................................................................................................30.00 7.60 Inj 2%, 50 ml prefilled syringe ........................................................................60.00 PROPRANOLOL Tab 10 mg .........................................................................................................3.65 Tab 40 mg .........................................................................................................4.65 Cap long-acting 160 mg .................................................................................16.06 PROPYLENE GLYCOL Liq ...................................................................................................................12.00 PROPYLTHIOURACIL Tab 50 mg .......................................................................................................35.00

100 ml 400 g 5 10 5 50 500 50 50 100 ml 5 5

1

1 1

1 100 100 100 500 ml 100

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

55


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PROTEIN SUPPLEMENT Powder ..............................................................................................................8.95 PYRIDOSTIGMINE BROMIDE Tab 60 mg – 1% DV Sep-11 to 2014 .............................................................38.90 PYRIDOXINE HYDROCHLORIDE Tab 25 mg – 1% DV Sep-11 to 2014 ...............................................................2.20 Tab 50 mg – 1% DV Sep-11 to 2014 .............................................................12.16 QUETIAPINE Tab 25 mg .........................................................................................................7.00 10.50 Tab 100 mg .....................................................................................................14.00 21.00 Tab 200 mg .....................................................................................................24.00 36.00 Tab 300 mg .....................................................................................................40.00 60.00 QUINAPRIL Tab 5 mg – 1% DV Apr-13 to 2015 .................................................................1.60 3.44 Tab 10 mg – 1% DV Apr-13 to 2015 ...............................................................1.75 4.64 Tab 20 mg – 1% DV Apr-13 to 2015 ...............................................................2.35 6.34 (Accupril Tab 5 mg to be delisted 1 April 2013) (Accupril Tab 10 mg to be delisted 1 April 2013) (Accupril Tab 20 mg to be delisted 1 April 2013) QUINAPRIL WITH HYDROCHLOROTHIAZIDE Tab 10 mg with hydrochlorothiazide 12.5 mg – 1% DV Aug-12 to 2015..........3.37 Tab 20 mg with hydrochlorothiazide 12.5 mg – 1% DV Aug-12 to 2015..........4.57 QUININE SULPHATE Tab 300 mg .....................................................................................................54.06 RALOXIFENE HYDROCHLORIDE Tab 60 mg .......................................................................................................53.76 RALTEGRAVIR POTASSIUM Tab 400 mg ................................................................................................1,090.00 RANITIDINE HYDROCHLORIDE Tab 150 mg – 1% DV Sep-11 to 2014 .............................................................6.79 Tab 300 mg – 1% DV Sep-11 to 2014 .............................................................9.34 Oral liq 150 mg per 10 ml – 1% DV Sep-11 to 2014........................................5.92 Inj 25 mg per ml, 2 ml .......................................................................................8.75

227 g 100 90 500 60 90 60 90 60 90 60 90 30 90 30 90 30 90

Resource Beneprotein Mestinon PyridoxADE Apo-Pyridoxine Dr Reddy’s Quetiapine Seroquel Quetapel Dr Reddy’s Quetiapine Seroquel Quetapel Dr Reddy’s Quetiapine Seroquel Quetapel Dr Reddy’s Quetiapine Seroquel Quetapel Accupril Arrow-Quinapril 5 Accupril Arrow-Quinapril 10 Accupril Arrow-Quinapril 20

30 30 500 28 60 250 250 300 ml 5

Accuretic 10 Accuretic 20 Q 300 Evista Isentress Arrow-Ranitidine Arrow-Ranitidine Peptisoothe Zantac

56

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

RECOMBINANT COAGULATION FACTOR VIIA Combination pack (powder and diluent for inj) 1 mg Combination pack (powder and diluent for inj) 2 mg Combination pack (powder and diluent for inj) 5 mg Combination pack (powder and diluent for inj) 8 mg

.................................1,163.75 .................................2,327.50 .................................5,818.75 .................................9,310.00

1 1 1 1 1 1 1 1 1

NovoSeven RT NovoSeven RT NovoSeven RT NovoSeven RT BeneFIX BeneFIX BeneFIX BeneFIX Advate Kogenate FS Xyntha Advate Kogenate FS Xyntha Advate Kogenate FS Xyntha Advate Advate Kogenate FS Xyntha Advate Kogenate FS Xyntha Remifentanil-AFT Remifentanil-AFT Nepro RTH Nepro Nepro Novasource Renal PSM healthE Mycobutin

RECOMBINANT FACTOR IX Inj 250 IU ......................................................................................................310.00 Inj 500 IU ......................................................................................................620.00 Inj 1,000 IU ................................................................................................1,240.00 Inj 2,000 IU ................................................................................................2,480.00 RECOMBINANT FACTOR VIII Inj 250 IU ......................................................................................................237.50 250.00 225.00 Inj 500 IU ......................................................................................................475.00 500.00 450.00 Inj 1,000 IU ...................................................................................................950.00 1,000.00 900.00 Inj 1,500 IU ................................................................................................1,425.00 Inj 2,000 IU ................................................................................................1,900.00 2,000.00 1,800.00 Inj 3,000 IU ................................................................................................2,850.00 3,000.00 2,700.00 REMIFENTANIL HYDROCHLORIDE Inj 1 mg vial – 1% DV Feb-12 to 2014 ...........................................................27.95 Inj 2 mg vial – 1% DV Feb-12 to 2014 ...........................................................41.80 RENAL ENTERAL FEED 2 KCAL/ML Liquid ................................................................................................................6.08 RENAL ORAL FEED 2 KCAL/ML Liquid (strawberry) ............................................................................................2.43 Liquid (vanilla) ..................................................................................................2.43 3.31 RETINOL PALMITATE Oint 25 g ...........................................................................................................2.00 Oint 50 g ...........................................................................................................2.86 RIFABUTIN Cap 150 mg – 1% DV Sep-10 to 2013.........................................................213.19

1

1

1 1

1

5 5 500 ml 200 ml 200 ml 237 ml 1 1 30

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

57


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

RISPERIDONE Orally-disintergrating tab 0.5 mg ....................................................................21.42 Tab 0.5 mg ........................................................................................................2.86 3.51

28 20 60

Orally-disintergrating tab 1 mg .......................................................................42.84 Tab 1 mg ...........................................................................................................6.00

28 60

16.92 Orally-disingergrating tab 2 mg ......................................................................85.71 Tab 2 mg .........................................................................................................11.00

28 60

33.84 Tab 3 mg .........................................................................................................15.00

60

50.78 Tab 4 mg .........................................................................................................20.00

60

67.68 Oral liq 1 mg per ml ........................................................................................18.35 25.26 18.35 Inj 25 mg per 2 ml .........................................................................................175.00 Inj 37.5 mg per 2 ml ......................................................................................230.00 Inj 50 mg per 2 ml .........................................................................................280.00 RITONAVIR Tab 100 mg – 1% DV Oct-12 to 2015 ............................................................43.31 RITUXIMAB Inj 100 mg per 10 ml vial ...........................................................................1,075.50 Inj 500 mg per 50 ml vial ...........................................................................2,688.30 RIVAROXABAN Tab 10 mg .....................................................................................................153.00 RIZATRIPTAN Tab orodispersible 10 mg – 1% DV May-12 to 2014......................................18.00 ROCURONIUM BROMIDE Inj 10 mg per ml, 5 ml – 1% DV Sep-12 to 2015............................................38.25 ROPINIROLE HYDROCHLORIDE Tab 0.25 mg – 1% DV Sep-10 to 2013 ............................................................6.20 Tab 1 mg – 1% DV Sep-10 to 2013 ...............................................................15.95 Tab 2 mg – 1% DV Sep-10 to 2013 ...............................................................24.95 Tab 5 mg – 1% DV Sep-10 to 2013 ...............................................................38.00

30 ml

1 1 1 30 2 1 15 30 10

Risperdal Quicklet Risperdal Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Quicklet Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Risperdal Quicklet Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Apo-Risperidone Risperdal Risperon Risperdal Consta Risperdal Consta Risperdal Consta Norvir Mabthera Mabthera Xarelto Rizamelt DBL Rocuronium Bromide Ropin Ropin Ropin Ropin

84 84 84 84

58

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ROPIVACAINE HYDROCHLORIDE Inj 2 mg per ml, 20 ml .....................................................................................75.00 Inf 2 mg per ml, 100 ml .................................................................................200.00 Inf 2 mg per ml, 200 ml .................................................................................265.00 Inj 7.5 mg per ml, 10 ml ..................................................................................45.00 Inj 7.5 mg per ml, 20 ml ..................................................................................84.00 Inj 10 mg per ml, 10 ml ...................................................................................54.00 ROPIVACAINE HYDROCHLORIDE WITH FENTANYL Inf 2 mg per ml with 2 µg of fentanyl per ml, 100 ml – 1% DV Nov-10 to 2013 ................................................................................................... 198.50 Inf 2 mg per ml with 2 µg of fentanyl per ml, 200 ml – 1% DV Nov-10 to 2013 ................................................................................................... 270.00 ROXITHROMYCIN Tab 150 mg – 1% DV Sep-12 to 2015 .............................................................7.48 Tab 300 mg – 1% DV Sep-12 to 2015 ...........................................................14.40 SALBUTAMOL Oral liq 2 mg per 5 ml .......................................................................................1.20 1.99 Aerosol inhaler 100 µg per dose, CFC-free .....................................................4.00 Inhaler 100 µg dose, 200 doses .......................................................................6.00 Nebuliser soln, 1 mg per ml, 2.5 ml – 1% DV Nov-12 to 2015.........................3.25 Nebuliser soln, 2 mg per ml, 2.5 ml – 1% DV Nov-12 to 2015.........................3.44 SALBUTAMOL WITH IPRATROPIUM BROMIDE Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml – 1% DV Nov-12 to 2015 ..................................................................... 3.75 SALMETEROL Aerosol inhaler CFC-free, 25 µg per dose .....................................................26.46 Powder for inhalation, breath activated 50 µg per dose .................................26.46 SERTRALINE Tab 50 mg – 1% DV Feb-11 to 2013................................................................5.40 Tab 100 mg – 1% DV Feb-11 to 2013..............................................................9.60 SEVOFLURANE Liq 250 ml bottle – 1% DV Dec-12 to 2015...............................................1,230.00 SILDENAFIL Tab 25 mg – 1% DV May-13 to 2014 ...............................................................1.85 Tab 50 mg – 1% DV May-13 to 2014 ...............................................................1.85 Tab 100 mg – 1% DV May-13 to 2014 .............................................................7.45 SILVER SULPHADIAZINE Crm 1% ..........................................................................................................12.30 SIMVASTATIN Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg – 1% DV Sep-11 to 2014 ...............................................................1.40 – 1% DV Sep-11 to 2014 ...............................................................1.95 – 1% DV Sep-11 to 2014 ...............................................................3.18 – 1% DV Sep-11 to 2014 ...............................................................9.31

5 5 5 5 5 5

Naropin Naropin Naropin Naropin Naropin Naropin

5 5 50 50 90 ml 150 ml 200 dose 200 dose 20 20

Naropin Naropin Arrow-Roxithromycin Arrow-Roxithromycin Broncolin Salapin Salamol Ventolin Asthalin Asthalin

20 120 dose 60 dose 90 90 6 4 4 4 50 g 90 90 90 90

Duolin Serevent Serevent Accuhaler Arrow-Sertraline Arrow-Sertraline Baxter Silagra Silagra Silagra Flamazine Arrow-Simva Arrow-Simva Arrow-Simva Arrow-Simva

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

59


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

SIROLIMUS Tab 1 mg .......................................................................................................813.00 Tab 2 mg ....................................................................................................1,626.00 Oral liq 1 mg per ml ......................................................................................487.80 SODIUM ACID PHOSPHATE Enema 16% with sodium phosphate 8% ..........................................................2.50 SODIUM ALGINATE Oral liq 500 mg with sodium bicarbonate 267 mg and calcium carbonate 160 mg per 10 ml ................................................................................. 4.95 SODIUM BICARBONATE Cap 840 mg ......................................................................................................8.52 Inf 5% .............................................................................................................19.06 Inj 8.4%, 50 ml ................................................................................................19.95 Inj 8.4%, 100 ml ..............................................................................................20.50 SODIUM CHLORIDE Soln 0.9% for irrigation .....................................................................................2.49 2.88 2.96 10.00 12.67 Soln 7% ..........................................................................................................23.50 Inf 0.45% ..........................................................................................................5.50 Inf 0.9% ............................................................................................................3.01 2.28 3.60 1.77 1.80 1.70 1.71 Inf 3% ...............................................................................................................5.69 Soln 0.9% for irrigation, 30 ml – 1% DV Nov-11 to 2014 ...............................19.50 Inj 0.9%, 5 ml ..................................................................................................10.85 15.50 Inj 0.9%, 10 ml ................................................................................................11.50 15.50 Inj 0.9%, 20 ml ..................................................................................................8.41 Inj 23.4%, 20 ml – 1% DV Nov-10 to 2013 ....................................................31.25 SODIUM CHLORIDE WITH GLUCOSE Inf 0.18% with glucose 4% ...............................................................................1.77 1.80 Inf 0.45% with glucose 2.5% ............................................................................4.95 Inf 0.45% with glucose 5% ...............................................................................9.87 5.80 Inf 0.9% with glucose 5% .................................................................................4.54 SODIUM CITRATE WITH SODIUM LAURYL SULPHOACETATE Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml – 1% DV Oct-10 to 2013............................................................................. 25.00 SODIUM CITRO-TARTRATE Gran eff 4 g sachets .........................................................................................2.75

100 100 60 ml 1

Rapamune Rapamune Rapamune Fleet Phosphate Enema

500 ml 100 500 ml 1 1 100 ml 500 ml 1,000 ml 2,000 ml 3,000 ml 90 ml 500 ml 50 ml 100 ml 250 ml 500 ml 1,000 ml 500 ml 1,000 ml 1,000 ml 30 50 50 20 5 500 ml 1,000 ml 500 ml 500 ml 1,000 ml 1,000 ml

Acidex Sodibic Baxter Biomed Biomed Baxter Baxter Baxter Baxter Baxter Biomed Baxter Baxter Baxter Baxter Baxter Baxter Freeflex Freeflex Baxter Pfizer Multichem Pfizer Multichem Pfizer Multichem Biomed Baxter Baxter Baxter Baxter Baxter Baxter

50 28

Micolette Ural

60

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

SODIUM DIOTRIZOATE Powder for oral soln 3.705 g, 10 ml sachet ..................................................156.12 SODIUM FLUORESCEIN Inj 100 mg per ml, 5 ml – 1% DV Nov-10 to 2013........................................125.00 SODIUM HYALURONATE Ophthalmic soln 10 mg per ml, 1 ml – 1% DV Oct-12 to 2015 ......................30.00 Ophthalmic inj 14 mg per ml – 1% DV Oct-12 to 2015 ..................................50.00 Inj 10 mg per ml, 0.4 ml; and inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.35 ml .............................................................................. 64.00 Inj 10 mg per ml, 0.55 ml; and inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.5 ml – 1% DV Sep-11 to 2014 ............................ 74.00 SODIUM NITROPRUSSIDE Test strip ...........................................................................................................6.00 SOFT WHITE PARAFFIN WITH PARAFFIN LIQUID Oint 50% with 50% paraffin liquid, 100 g ..........................................................3.10 SOLIFENACIN SUCCINATE Tab 5 mg .........................................................................................................56.50 Tab 10 mg .......................................................................................................56.50 SORBOLENE WITH GLYCERIN Crm with 10% glycerine, 100 g .........................................................................2.10 2.00 3.20 Crm with 10% glycerine, 500 ml .......................................................................4.50 7.30 Crm with 10% glycerine, 1,000 ml ....................................................................6.50 SOTALOL Tab 80 mg .......................................................................................................27.50 Tab 160 mg .....................................................................................................10.50 Inj 10 mg per ml, 4 ml .....................................................................................65.39 SPACER DEVICE 800 ml ...............................................................................................................8.50 230 ml (single patient) ......................................................................................4.72 SPIRONOLACTONE Tab 25 mg – 1% DV Sep-10 to 2013 ...............................................................4.60 Tab 100 mg – 1% DV Sep-10 to 2013 ...........................................................15.15 Oral liq 5 mg per ml ........................................................................................30.00 STANDARD SUPPLEMENT ORAL FEED (POWDER) Powder (chocolate) .........................................................................................13.00 10.22 Powder (vanilla) ..............................................................................................13.00 9.50 10.22

50 12 1 1 1 1 50 strip 1 30 30 1

Ioscan Fluorescite Provisc Healon GV Duovisc Duovisc Accu-Chek Ketur-Test healthE Vesicare Vesicare Pharmacy Health Pharmacy Health healthE Pharmacy Health healthE Pharmacy Health Mylan Mylan Sotacor Volumatic Space Chamber Plus Spirotone Spirotone Biomed Ensure Sustagen Hospital Formula Ensure Fortisip Sustagen Hospital Formula

1 1 500 100 5 1 1 100 100 25 ml 900 g

900 g

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

61


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

STANDARD SUPPLEMENT ORAL FEED 1.4 KCAL/ML Liquid (chocolate) .............................................................................................4.00 Liquid (vanilla) ..................................................................................................4.00 STREPTOKINASE Inj 250,000 IU ...............................................................................................117.70 Inj 1,500,000 IU ............................................................................................188.10 SULPHASALAZINE Tab 500 mg .....................................................................................................11.68 Tab EC 500 mg ...............................................................................................12.89 SUMATRIPTAN Tab 50 mg – 1% DV Apr-10 to 2013 ..............................................................38.83 Tab 100 mg – 1% DV Apr-10 to 2013 ............................................................77.66 Inj 12 mg per ml, 0.5 ml – 1% DV Jun-11 to 2013 .........................................36.00 SUNITINIB Cap 12.5 mg ..............................................................................................2,315.38 Cap 25 mg .................................................................................................4,630.77 Cap 50 mg .................................................................................................9,261.54 SUNSCREENS, PROPRIETARY Lotn ..................................................................................................................2.55 5.10 SUXAMETHONIUM CHLORIDE Inj 50 mg per ml, 2 ml ...................................................................................130.00 SYRUP (PHARMACEUTICAL GRADE) Liq ...................................................................................................................21.75 TACROLIMUS Cap 0.5 mg ...................................................................................................214.00 Cap 1 mg ......................................................................................................428.00 Cap 5 mg ...................................................................................................1,070.00 TAMOXIFEN CITRATE Tab 10 mg .......................................................................................................17.50 Tab 20 mg – 1% DV Jun-11 to 2014................................................................8.75 TAMSULOSIN HYDROCHLORIDE Cap 400 µg – 1% DV Oct-10 to 2013..............................................................5.98 TAR WITH TRIETHANOLAMINE LAURYL SULPHATE AND FLUORESCEIN Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium – 1% DV Nov-11 to 2014 ........................................................................... 3.05 5.82 TEMAZEPAM Tab 10 mg – 1% DV Nov-11 to 2014 ...............................................................1.27

237 ml 237 ml

Impact Advanced Recovery Impact Advanced Recovery Streptase Streptase Salazopyrin Salazopyrin EN Arrow-Sumatriptan Arrow-Sumatriptan Arrow-Sumatriptan Sutent Sutent Sutent Marine Blue Lotion SPF 30+ Marine Blue Lotion SPF 30+ AstraZeneca Midwest Prograf Prograf Prograf Genox Genox Tamsulosin-Rex

1 1 100 100 100 100 2 28 28 28 100 g 200 g

50 2,000 ml 100 100 50 100 100 30

500 ml 1,000 ml 25

Pinetarsol Pinetarsol Normison

62

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

TEMOZOLOMIDE Cap 5 mg – 1% DV Mar-12 to 2013 ...............................................................16.00 Cap 20 mg – 1% DV Mar-12 to 2013 .............................................................72.00 Cap 100 mg – 1% DV Mar-12 to 2013 .........................................................350.00 Cap 250 mg – 1% DV Mar-12 to 2013 .........................................................820.00 TENOFOVIR DISOPROXIL FUMARATE Tab 300 mg ...................................................................................................531.00 TENOXICAM Inj 20 mg – 1% DV Jul-10 to 2013...................................................................9.95 TERBINAFINE Tab 250 mg – 1% DV Nov-11 to 2014 .............................................................1.78 TERIPARATIDE Inj 250 µg per ml, 2.4 ml ...............................................................................490.00 TERLIPRESSIN Inj 1 mg .........................................................................................................450.00 TESTOSTERONE Transdermal patch, 2.5 mg per day ................................................................80.00 TESTOSTERONE CYPIONATE Inj long-acting 100 mg per ml, 10 ml – 1% DV Feb-12 to 2014 .....................76.50 TESTOSTERONE UNDECANOATE Cap 40 mg – 1% DV Oct-12 to 2015 .............................................................31.17 Inj 250 mg per ml, 4 ml ...................................................................................86.00 TETRABENAZINE Tab 25 mg – 1% DV Jul-12 to 2015 .............................................................178.00 TETRACOSACTRIN Inj 1 mg per ml, 1 ml – 1% DV Sep-11 to 2014..............................................29.56 Inj 250 µg – 1% DV Sep-11 to 2014 ............................................................177.18 THALIDOMIDE Cap 50 mg ....................................................................................................504.00 Cap 100 mg ...............................................................................................1,008.00 TIAPROFENIC ACID Tab 300 mg .....................................................................................................19.26 TIMOLOL MALEATE Eye drops 0.25%, gel forming ..........................................................................3.30 Eye drops 0.5%, gel forming ............................................................................3.78 TIOTROPIUM BROMIDE Powder for inhalation 18 µg per dose .............................................................70.00 TIROFIBAN HYDROCHLORIDE Inj 0.25 mg per ml, 50 ml ..............................................................................370.00 TOBRAMYCIN Eye oint 0.3% – 1% DV Sep-11 to 2014 ........................................................10.45 Eye drops 0.3% – 1% DV Sep-11 to 2014 .....................................................11.48 Inj 40 mg per ml, 2 ml – 1% DV Sep-11 to 2014............................................29.32 TOLCAPONE Tab 100 mg – 1% DV Sep-11 to 2014 .........................................................126.20

5 5 5 5 30 1 14 1 5 60 1 60 1 112 1 10 28 28 60 2.5 ml 2.5 ml 30 dose 1 3.5 g 5 ml 5 100

Temaccord Temaccord Temaccord Temaccord Viread AFT Dr Reddy’s Terbinafine Forteo Glypressin Androderm Depo-Testosterone Andriol Testocaps Reandron 1000 Motetis Synacthen Depot Synacthen Thalomid Thalomid Surgam Timoptol XE Timoptol XE Spiriva Aggrastat Tobrex Tobrex DBL Tobramycin Tasmar

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

63


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

TOLTERODINE Tab 1 mg .........................................................................................................14.56 Tab 2 mg .........................................................................................................14.56 TOPIRAMATE Tab 25 mg .......................................................................................................11.07 26.04 Tab 50 mg .......................................................................................................18.81 44.26 Tab 100 mg .....................................................................................................31.99 75.25 Tab 200 mg .....................................................................................................55.19 129.85 Sprinkle cap 15 mg .........................................................................................20.84 Sprinkle cap 25 mg .........................................................................................26.04 TRAMADOL HYDROCHLORIDE Tab sustained-release 100 mg .........................................................................2.14 Tab sustained-release 150 mg .........................................................................3.21 Tab sustained-release 200 mg .........................................................................4.28 Cap 50 mg – 1% DV Sep-11 to 2014...............................................................4.95 Inj 50 mg per ml, 1 ml .......................................................................................4.50 Inj 50 mg per ml, 2 ml .......................................................................................4.50 TRANEXAMIC ACID Tab 500 mg – 1% DV Jun-10 to 2013............................................................32.92 Inj 100 mg per ml, 5 ml .................................................................................124.73 TRASTUZUMAB Inj 150 mg vial ...........................................................................................1,350.00 Inj 440 mg vial ...........................................................................................3,875.00 TRETINOIN Cap 10 mg ....................................................................................................435.90 TRIAMCINOLONE ACETONIDE 0.1% in dental paste USP – 1% DV Sep-11 to 2014 .......................................4.34 Crm 0.02% – 1% DV Sep-11 to 2014 ..............................................................6.63 Oint 0.02% – 1% DV Sep-11 to 2014 ..............................................................6.69 Inj 10 mg per ml, 1 ml – 1% DV Jun-12 to 2014 ............................................21.90 Inj 40 mg per ml, 1 ml – 1% DV Jun-12 to 2014 ............................................53.79 TRIAMCINOLONE ACETONIDE WITH GRAMICIDIN, NEOMYCIN AND NYSTATIN Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g ...................................................................... 5.16 TRICLOSAN Soln 1% ............................................................................................................4.50 TRIMETHOPRIM Tab 300 mg .......................................................................................................9.28 TROPICAMIDE Eye drops 0.5% – 1% DV Sep-11 to 2014 .......................................................7.15 Eye drops 1% – 1% DV Sep-11 to 2014 ..........................................................8.66

56 56 60 60 60 60 60 60 20 20 20 100 5 5 100 10 1 1 100 5g 100 g 100 g 5 5

Arrow-Tolterodine Arrow-Tolterodine Arrow-Topiramate Topamax Arrow-Topiramate Topamax Arrow-Topiramate Topamax Arrow-Topiramate Topamax Topamax Topamax Tramal SR 100 Tramal SR 150 Tramal SR 200 Arrow-Tramadol Tramal 50 Tramal 100 Cyklokapron Cyklokapron Herceptin Herceptin Vesanoid Oracort Aristocort Aristocort Kenacort-A Kenacort-A40

7.5 ml 500 ml 50 15 ml 15 ml

Kenacomb Pharmacy Health TMP Mydriacyl Mydriacyl

64

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

TROPISETRON Cap 5 mg ........................................................................................................77.41 Inj 1 mg per ml, 2 ml .......................................................................................19.20 Inj 1 mg per ml, 5 ml .......................................................................................38.40 URSODEOXYCHOLIC ACID Cap 250 mg – 1% DV May-12 to 2014 ..........................................................71.50 VALACICLOVIR Tab 500 mg ...................................................................................................102.72 VALGANCICLOVIR Tab 450 mg ................................................................................................3,000.00 VANCOMYCIN HYDROCHLORIDE Inj 500 mg – 1% DV Sep-11 to 2014 ...............................................................3.58 VARENICLINE TARTRATE Tab 0.5 mg × 11 and 1 mg × 14 ....................................................................60.48 Tab 1 mg .........................................................................................................67.74 135.48 VENLAFAXINE Cap 37.5 mg ...................................................................................................15.84 Tab 37.5 mg ....................................................................................................12.67 Cap 75 mg ......................................................................................................31.67 Tab 75 mg .......................................................................................................19.00 Cap 150 mg ....................................................................................................38.82 Tab 150 mg .....................................................................................................23.41 Tab 225 mg .....................................................................................................35.12 VERAPAMIL HYDROCHLORIDE Tab long-acting 120 mg ..................................................................................15.20 Tab 40 mg – 1% DV Sep-11 to 2014 ...............................................................7.01 Tab 80 mg – 1% DV Sep-11 to 2014 .............................................................11.74 Tab long-acting 240 mg ..................................................................................25.00 Inj 2.5 mg per ml, 2 ml ......................................................................................7.54 VINBLASTINE SULPHATE Inj 10 mg .......................................................................................................137.50 VINCRISTINE SULPHATE Inj 1 mg per ml, 1 ml – 1% DV Aug-10 to 2013 ...........................................108.00 Inj 1 mg per ml, 2 ml – 1% DV Aug-10 to 2013 ...........................................116.00 VINORELBINE Inj 10 mg per ml, 1 ml – 1% DV Sep-12 to 2015............................................12.85 Inj 10 mg per ml, 5 ml – 1% DV Sep-12 to 2015............................................64.25 VORICONAZOLE Tab 50 mg .....................................................................................................730.00 Tab 200 mg ................................................................................................2,930.00 Powder for suspension, 40 mg per ml ..........................................................730.00 Inj 200 mg .....................................................................................................185.00

5 1 1 100 30 60 1 25 28 56 28 28 28 28 28 28 28 250 100 100 250 5 5 5 5 1 1 56 56 70 ml 1

Navoban Navoban Navoban Ursosan Valtrex Valcyte Mylan Champix Champix Champix Efexor XR Arrow-Venlafaxine XR Efexor XR Arrow-Venlafaxine XR Efexor XR Arrow-Venlafaxine XR Arrow-Venlafaxine XR Verpamil SR Isoptin Isoptin Verpamil SR Isoptin Mayne Hospira Hospira Navelbine Navelbine Vfend Vfend Vfend Vfend

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

65


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

WATER Inf .....................................................................................................................4.50 Soln for irrigation ..............................................................................................2.68 2.61 2.75 9.71 15.80 Purified for inj 5 ml ..........................................................................................10.25 Purified for inj 10 ml ........................................................................................11.25 Purified for inj 20 ml ..........................................................................................6.50 WATER WITH SODIUM, POTASSIUM, CALCIUM AND CHLORIDE Inf 147 mmol/L sodium, 4 mmol/L potassium, 2.2 mmol/L calcium and 156 mmol/L chloride .................................................................................. 5.13 WATER WITH SODIUM, POTASSIUM, CALCIUM, BICARBONATE AND CHLORIDE Inf 131 mmol/L sodium, 5 mmol/L potassium, 2 mmol/L calcium, 29 mmol/L bicarbonate and 111 mmol/L chloride .......................................... 1.77 1.80

1,000 ml 100 ml 500 ml 1,000 ml 2,000 ml 3,000 ml 50 50 20

Baxter Baxter Baxter Baxter Baxter Baxter Multichem Multichem Multichem

1,000 ml

Baxter

500 ml 1,000 ml

Baxter Baxter

WATER WITH SODIUM, POTASSIUM, CALCIUM, BICARBONATE, CHLORIDE AND GLUCOSE Inf 131 mmol/L sodium, 5 mmol/L potassium, 2 mmol/L calcium, 29 mmol/L bicarbonate, 111 mmol/L chloride and glucose 5% ...................... 5.38 1,000 ml WATER WITH SODIUM, POTASSIUM, MAGNESIUM, CHLORIDE, ACETATE AND GLUCONATE Inf 140 mmol/L sodium, 5 mmol/L potassium, 1.5 mmol/L magnesium, 98 mmol/L chloride, 27 mmol/L acetate and 23 mmol/L gluconate ........... 5.00 500 ml 3.10 1,000 ml ZIDOVUDINE [AZT] Cap 100 mg – 1% DV Jun-10 to 2013 .........................................................145.00 Oral liq 10 mg per ml – 1% DV Jun-10 to 2013 .............................................29.00 ZIDOVUDINE [AZT] WITH LAMIVUDINE Tab 300 mg with lamivudine 150 mg – 1% DV Dec-12 to 2014.....................63.50 ZINC AND CASTOR OIL Crm – 1% DV Apr-12 to 2014..........................................................................1.63 ZINC SULPHATE Cap 137.4 mg (50 mg elemental) – 1% DV Nov-11 to 2014..........................11.00 ZIPRASIDONE Cap 20 mg Cap 40 mg Cap 60 mg Cap 80 mg ......................................................................................................87.88 ....................................................................................................164.78 ....................................................................................................247.17 ....................................................................................................329.56 100 200 ml 60 20 g 100 60 60 60 60 100 ml 1 30 5

Baxter

Baxter Baxter Retrovir Retrovir Alphapharm Orion Zincaps Zeldox Zeldox Zeldox Zeldox Aclasta Zometa Apo-Zopiclone Clopixol

ZOLEDRONIC ACID Soln for inf 5 mg in 100 ml ............................................................................600.00 Soln for inf 4 mg, 5 ml ...................................................................................550.00 ZOPICLONE Tab 7.5 mg – 1% DV Jan-12 to 2014...............................................................1.90 ZUCLOPENTHIXOL DECANOATE Depot inj 200 mg per ml, 1 ml .........................................................................19.80

66

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.


Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ZUCLOPENTHIXOL HYDROCHLORIDE Tab 10 mg .......................................................................................................31.45

100

Clopixol

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

67


Part III: Discretionary Community Supply Pharmaceuticals

ALBENDAZOLE Tab 200 mg Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 8 weeks. CEFEPIME HYDROCHLORIDE Inj 1 g, 15 ml Inj 2 g, 77 ml For any indication approved by the hospital service, with review at 6 weeks. CEFOTAXIME SODIUM Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. CEFOXITIN SODIUM Powder for injection 1 g For any indication approved by the hospital service, with review at 6 weeks. CEFTAZIDIME Inj 500 mg Inj 1 g Inj 2 g For any indication approved by the hospital service, with review at 6 weeks. CEFTRIAXONE SODIUM Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. CEFUROXIME AXETIL Tab 250 mg Oral liq 125 mg per 5 ml Up to 2 weeks supply for any appropriate indication CEFUROXIME SODIUM Inj 250 mg Inj 750 mg Inj 1.5 g For any indication approved by the hospital service, with review at 6 weeks. CHLORHEXIDINE Eye drops 0.02% For a period of 3 months for treatment of acanthamoeba keratitis. CIPROFLOXACIN Oral liq 5% Oral liq 10% Up to 6 weeks supply for any appropriate indication

Albenza Zentel Indefinite supply to cover treatment of hydatid disease, strongyloidiasis, toxocariasis, ancylostomiasis, neurocysticerosis and schistosomiasis (where first line treatment has failed) until NPPA funding is approved (Section 29) AMIKACIN SULPHATE Inj 250 mg per ml, 2 ml For any indication approved by the hospital service, with review at 6 weeks AMOXYCILLIN CLAVULANATE Inj 600 mg Inj 1.2 g For any indication approved by the hospital service, with review at 6 weeks AMPHOTERICIN B Inj 50 mg Oral liq 100 mg per ml (nonliposomal only) Up to 6 weeks supply for any appropriate indication AZTREONAM Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. BACLOFEN Inj 10 mg Lioresal Intrathecal Indefinite supply for patients with severe chronic spasticity of cerebral origin or due to multiple sclerosis, spinal cord injury or spinal cord disease, where oral antispastic agents have failed or have caused unacceptable side effects. BENZATHINE PENICILLIN Inj 1.2 mega u per 2 ml For prophylaxis of endocarditis BENZYLPENICILLIN SODIUM (PENICILLIN G) Inj 1 mega u For any indication approved by the hospital service, with review at 8 weeks. CEFAMANDOLE NAFATE Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 8 weeks. CEFAZOLIN SODIUM

68


CLOPIDOGREL Tab 75 mg Up to 4 weeks supply post stenting. Not to be funded for acute coronary syndrome or transient ischaemic attacks DALTEPARIN SODIUM Inj 2,500 IU per 0.2 ml Fragmin Inj 5,000 IU per 0.2 ml Fragmin Inj 7,500 IU per 0.75 ml Fragmin Inj 10,000 IU per 0.4 ml Fragmin Inj 10,000 IU per 1 ml Fragmin Inj 12,500 IU per 0.5 ml Fragmin Inj 15,000 IU per 0.6 ml Fragmin Inj 18,000 IU per 0.72 ml Fragmin For the treatment of venous thromboembolism (VTE) for a maximum of 14 days or until a stabilised therapeutic INR is established. For a maximum treatment period from the time of diagnosis to 8 weeks post partum for a confirmed thromboembolic event during pregnancy. For prophylaxis of thromboembolism for patients considered high risk after consultation with a specialist from diagnosis of pregnancy to 8 weeks post partum. For a maximum treatment period from diagnosis of pregnancy to 8 weeks post partum for women normally maintained on long-term oral anticoagulation who are at very high risk of thromboembolism. For the treatment for a maximum of 7 days pre and post operatively for patients on oral anticoagulants requiring surgical intervention in a public hospital or until an appropriate therapeutic INR level is reached. For a maximum of 14 days treatment in high-risk patients post pelvic, colo-rectal and major orthopaedic surgery. For a maximum of 7 days treatment for patients with an acute coronary syndrome (ACS) awaiting further hospital intervention. For a maximum of 14 days treatment post cardioversion in non anticoagulated patients with atrial fibrillation or until appropriate therapeutic INR level is reached. For treatment of malignancy - associated venous thromboembolism. DEMECLOCYCLINE Cap 150 mg Ledermycin Indefinite supply for SIADH (syndrome of inappropriate anti diuretic hormone) (Section 29) DEXTROSE Inj 5%, 10 ml Where required for antibiotic treatment funded under DCS or NPPA

ENOXAPARIN SODIUM Inj 20 mg per 0.2 ml Clexane Inj 40 mg per 0.4 ml Clexane Inj 60 mg per 0.6 ml Clexane Inj 80 mg per 0.8 ml Clexane Inj 100 mg per ml Clexane Inj 120 mg per 0.8 ml Clexane Inj 150 mg per ml Clexane For the treatment of venous thromboembolism (VTE) for a maximum of 14 days or until a stabilised therapeutic INR is established. For a maximum treatment period from the time of diagnosis to 8 weeks post partum for a confirmed thromboembolic event during pregnancy. For prophylaxis of thromboembolism for patients considered high risk after consultation with a specialist from diagnosis of pregnancy to 8 weeks post partum. For a maximum treatment period from diagnosis of pregnancy to 8 weeks post partum for women normally maintained on long-term oral anticoagulation who are at very high risk of thromboembolism. For the treatment for a maximum of 7 days pre and post operatively for patients on oral anticoagulants requiring surgical intervention in a public hospital or until an appropriate therapeutic INR level is reached. For a maximum of 14 days treatment in high-risk patients post pelvic, colo-rectal and major orthopaedic surgery. For a maximum of 7 days treatment for patients with an acute coronary syndrome (ACS) awaiting further hospital intervention. For a maximum of 14 days treatment post cardioversion in non anticoagulated patients with atrial fibrillation or until appropriate therapeutic INR level is reached. For treatment of malignancy - associated venous thromboembolism. ERTAPENEM SODIUM Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. FILGRASTIM Inj 300 µg per 0.5 ml prefilled syringe Inj 300 µg per 1 ml vial Inj 480 µg per 0.5 ml prefilled syringe Neupogen Zario Neupogen Neupogen Zario

69


Discretionary Community Supply Pharmaceuticals

FLUCLOXACILLIN SODIUM Inj 250 mg Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 8 weeks. FLUCONAZOLE Inj 100 mg per 50 ml For any indication approved by the hospital service, with review at 6 weeks. FORTIFIED EYE DROPS Up to 4 weeks supply of proprietary eyedrops fortified with any appropriate anti-infective agent for the treatment of severe corneal or eye surface infections FOSCARNET Inj 24 mg per ml IV soln Indefinite supply for any appropriate indication GANCICLOVIR Inj 500 mg Cymevene For prophylaxis and treatment of CMV-associated disease in immunocompromised patients and following organ transplant. GENTAMICIN SULPHATE Inj 40 mg per ml, 2 ml Indefinite supply for any indication approved by the hospital service. HEPARINISED SALINE Inj 10 iu per ml, 5 ml Inj 100 iu per ml, 5 ml For the maintenance of IV lines HYDRALAZINE Tab 25 mg S29 For patients with congestive heart failure: 1) who have not responded to treatment with ACE inhibitors and/or ARBs; or 2) in whom treatment with ACE inhibitors and/or ARBs is not tolerated due to renal impairment HYOSCINE (SCOPOLAMINE) Patches 1.5 mg Scopoderm TTS Up to 6 months supply for symptom control in terminally ill patients IMIPENEM WITH CILASTATIN Inj 500 mg with cilastin 500 mg For any indication approved by the hospital service, with review at 6 weeks. INDOMETHACIN Cap 25 mg S29 Cap 50 mg S29 Cap long-acting 75 mg S29 Supp 100 mg S29 For any indication approved by the hospital service ITRACONAZOLE Oral liq 10 mg per ml Up to 3 months supply for use in liver transplant patients IVERMECTIN Tab 6 mg Indefinite supply for the treatment of filaricides, cutaneous larva migrans (creeping eruption) and Strongyloidiasis (Section 29) LENOGRASTIM Inj 13.4 million iu vial Granocyte Inj 33.6 million iu vial Granocyte Indefinite supply for any appropriate indication for the management of patients with cancer. L-ORNITHINE L-ASPARTATE (LOLA) S29 Sach 5 mg For patients with chronic hepatic encephalopathy who have not responded to treatment with lactulose MEROPENEM Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. METHOXSALEN Cap 10 mg Oxsoralen Tab 10 mg Methoxypsaralen Indefinite supply for PUVA – psoralen plus ultraviolet a (UVA) therapy for severe, disabling psoriasis prephototherapy. METOLAZONE S29 Tab 5 mg For patients with congestive heart failure: 1) who have not responded to treatment with ACE inhibitors and/or ARBs; or 2) in whom treatment with ACE inhibitors and/or ARBs is not tolerated due to renal impairment

70


Discretionary Community Supply Pharmaceuticals

MOLGRAMOSTIM Inj 300 µg Leucomax Indefinite supply for any appropriate indication for the management of patients with cancer. NETILMICIN Inj 150 mg per 1.5 ml Up to 2 weeks supply for any appropriate indication (extension for up to 6 weeks supply for endocarditis should be applied for under Hospital NPPA) NIMODIPINE Tab 30 mg Up to 21 days supply post sub-arachnoid haemorrhage PEGFILGRASTIM Inj 6 mg per 0.6 ml prefilled syringe Indefinite supply for any appropriate indication for the management of patients with cancer. PENTAMIDINE Inj 300 mg Indefinite supply for any appropriate indication PHENINDIONE Tab 10 mg Tab 25 mg Tab 50 mg Indefinite supply for warfarin resistance anti-coagulation therapy (Section 29) PIPERACILLIN SODIUM Inj 2 g Inj 4 g For any indication approved by the hospital service, with review at 6 weeks. PIPERACILLIN WITH TAZOBACTAM Inj 4 g with tazobactam 500 mg For any indication approved by the hospital service, with review at 6 weeks. POLYHEXAMETHYLENE BIGUANIDE Eye drops 0.02% For a period of 3 months for treatment of acanthamoeba keratitis. PRAZIQUANTEL Cysticide Tab 500 mg S29 For the treatment of worm infestations (Section 29) PRIMAQUINE Tab 2.5 mg Tab 5 mg Tab 7.5 mg Indefinite supply for any appropriate indication (Section 29) PYRIMETHAMINE Tab 25 mg S29 For the treatment of toxoplasmosis in patients with HIV for a period of 3 months; For pregnant patients for the term of the pregnancy; For infants with congenital toxoplasmosis until 12 months of age. SODIUM CHLORIDE Tab 600 mg Slow Sodium Indefinite supply for salt wasting nephropathy (Section 29) Inj 0.9% Where required for injection of antibiotic treatment funded under DCS or NPPA SPECIAL FOOD SUPPLEMENT Liquid, 237 ml (Vanilla,Chocolate) Impact Advanced Recovery Three packs of 237 mls per days for 5 to 7 days prior to major gastrointestinal or head or neck surgery. Powder 1kcal/ml, 900 g Sustagen Hospital Formula Ensure Liquid 1.5kcal/ml, 200 ml Ensure Plus Fortisip Liquid 1.5kcal/ml, 237 ml Ensure Plus Liquid 1.5kcal/ml with fibre, 200 ml Fortisip Multi Fibre For use in community/non-hospitalised patients for 10 days prior to hospitalisation and 30 days following discharge.

SULPHADIAZINE Tab 500 mg S29 For the treatment of toxoplasmosis in patients with HIV for a period of 3 months; For pregnant patients for the term of the pregnancy; For infants with congenital toxoplasmosis until 12 months of age.

71


Discretionary Community Supply Pharmaceuticals

TEICOPLANIN Inj 400 mg For any indication approved by the hospital service, with review at 6 weeks. TICARCILLIN DISODIUM WITH CLAVULANIC ACID Inj 3 g with clavulanic acid 0.1 g For any indication approved by the hospital service, with review at 6 weeks. TINZAPARIN SODIUM Inj 3,500 anti-Xa IU/0.35 ml Innohep Inj 4,500 anti-Xa IU/0.45 ml Innohep Inj 10,000 anti-Xa IU/0.5 ml Innohep Inj 14,000 anti-Xa IU/0.7 ml Innohep Inj 18,000 anti-Xa IU/0.9 ml Innohep Inj 20,000 anti-Xa IU/ml, 2 ml Innohep For the treatment of venous thromboembolism (VTE) for a maximum of 14 days or until a stabilised therapeutic INR is established. For a maximum treatment period from the time of diagnosis to 8 weeks post partum for a confirmed thromboembolic event during pregnancy. For prophylaxis of thromboembolism for patients considered high risk after consultation with a specialist from diagnosis of pregnancy to 8 weeks post partum. For a maximum treatment period from diagnosis of pregnancy to 8 weeks post partum for women normally maintained on long-term oral anticoagulation who are at very high risk of thromboembolism. For the treatment for a maximum of 7 days pre and post operatively for patients on oral anticoagulants requiring surgical intervention in a public hospital or until an appropriate therapeutic INR level is reached. For a maximum of 14 days treatment in high-risk patients post pelvic, colo-rectal and major orthopaedic surgery. For a maximum of 7 days treatment for patients with an acute coronary syndrome (ACS) awaiting further hospital intervention. For a maximum of 14 days treatment post cardioversion in non anticoagulated patients with atrial fibrillation or until appropriate therapeutic INR level is reached. For treatment of malignancy - associated venous thromboembolism. TOBRAMYCIN Inj 40 mg per ml, 2 ml Indefinite supply for any indication approved by the hospital service. TRIMETHOPRIM Tab 100 mg Indefinite supply for any appropriate indication (Section 29) VANCOMYCIN HYDROCHLORIDE Inj 500 mg For any indication approved by the hospital service, with review at 6 weeks. WATER Purified for inj Where required for injection of antibiotic treatment funded under DCS or NPPA

72


INDEX Generic Chemicals and Brands

Amiloride ........................................16 Amino acid formula .........................16 Aminoacid without phenylalanine ............................ 16 Aminophylline .................................16 Amisulpride .....................................16 Amitrip ............................................16 Amitriptyline ....................................16 Amlodipine ......................................16 Amoxycillin ......................................17 Amoxycillin clavulanate Contracted ..................................17 DCS ............................................68 Amphotericin B Contracted ..................................17 DCS ............................................68 Anastrozole .....................................17 Andriol Testocaps ...........................63 Androderm ......................................63 Anexate ..........................................33 Antabuse ........................................29 Antinaus ..........................................55 Antithymocyte globulin (equine) ..................................... 17 Anzatax ...........................................51 Apidra .............................................39 Apidra Solostar ...............................39 Apo-Allopurinol ...............................16 Apo-Amlodipine ..............................16 Apo-Azithromycin ...........................18 Apo-Clarithromycin .........................24 Apo-Clomipramine ..........................25 Apo-Clopidogrel ..............................25 Apo-Diclo ........................................28 Apo-Diltiazem CD ...........................28 Apo-Doxazosin ...............................29 Apo-Gliclazide ................................35 Apo-Megestrol ................................44 Apo-Moclobemide ...........................47 Apo-Nadolol ....................................48 Apo-Oxybutynin ..............................50 Apo-Pindolol ...................................53 Apo-Prazo .......................................54 Apo-Prednisone ..............................55 Apo-Propranolol ..............................55 Apo-Pyridoxine ...............................56 Apo-Risperidone .............................58 Apo-Zopiclone ................................66 Apomine .........................................17 Apomorphine hydrochloride ...........17 Aprepitant .......................................17 Apresoline .......................................37 Aqueous cream ..............................17 Arava ..............................................41 Aremed ...........................................17 Aripiprazole .....................................17 Aristocort ........................................64 Aromasin ........................................32 Arrow-Amitriptyline .........................16 Arrow-Bendrofluazide .....................19 Arrow-Brimonidine ..........................20 Arrow-Calcium ................................21 Arrow-Citalopram ............................24 Arrow-Diazepam .............................28 Arrow-Doxorubicin ..........................29 Arrow-Etidronate .............................32 Arrow-Lamotrigine ..........................41 Arrow-Lisinopril ...............................43 Arrow-Losartan & Hydrochlorothiazide ................... 43 Arrow-Morphine LA ........................47 Arrow-Nifedipine XR .......................49 Arrow-Norfloxacin ...........................49 Arrow-Ornidazole ............................50 Arrow-Quinapril 10 ..........................56 Arrow-Quinapril 20 ..........................56 Arrow-Quinapril 5 ............................56 Arrow-Ranitidine .............................56 Arrow-Roxithromycin ......................59 Arrow-Sertraline .............................59 Arrow-Simva ...................................59 Arrow-Sumatriptan ..........................62 Arrow-Tolterodine ...........................64 Arrow-Topiramate ...........................64 Arrow-Tramadol ..............................64 Arrow-Venlafaxine XR .....................65 Arsenic trioxide ...............................17 Asacol .............................................44 Asamax ...........................................44 Ascorbic acid ..................................17 Aspen Adrenaline ...........................15 Aspen Ceftriaxone ..........................23 Aspen Ciprofloxacin ........................24 Asthalin ...........................................59 Atazanavir sulphate ........................17 Atenolol ...........................................18 Atenolol AFT ...................................18 ATGAM ...........................................17 Ativan ..............................................43 Atomoxetine hydrochloride .............18 Atorvastatin ....................................18 Atracurium besylate ........................18

-AA-Scabies .......................................53 Abacavir sulphate ...........................15 Abacavir sulphate with lamivudine ................................. 15 Abciximab .......................................15 Abilify ..............................................17 ABM Hydroxocobalamin .................37 Acarbose ........................................15 Accarb ............................................15 Accu-Chek Ketur-Test .....................61 Accu-Chek Performa ................19, 20 Accupril ...........................................56 Accuretic 10 ....................................56 Accuretic 20 ....................................56 Acetadote .......................................15 Acetazolamide ................................15 Acetylcysteine .................................15 Aciclovir ..........................................15 Acidex .............................................60 Acitretin ...........................................15 Aclasta ............................................66 Activated charcoal ..........................15 Adalimumab ....................................15 Adefin XL ........................................49 Adefovir dipivoxil .............................15 Adrenaline ......................................15 Advantan ........................................45 Advate ............................................57 Aerrane ...........................................40 Aggrastat ........................................63 Alanase ...........................................19 Albendazole ....................................68 Albenza ...........................................68 Aldara .............................................38 Alendronate sodium ........................15 Alendronate sodium with cholecalciferol ............................ 15 Alfacalcidol .....................................15 Alitraq .............................................30 Allersoothe ......................................55 Allopurinol .......................................16 Alphamox ........................................17 Alphapharm ....................................66 Alprostadil .......................................16 Amantadine hydrochloride ..............16 AmBisome ......................................17 Ambrisentan ...................................16 Amikacin sulphate Contracted ..................................16 DCS ............................................68

73


INDEX Generic Chemicals and Brands

Atripla .............................................29 Atropine sulphate ............................18 Atropt ..............................................18 Augmentin ......................................17 Avanza ............................................46 Avelox .............................................48 Avelox IV 400 ..................................48 Azactam ..........................................18 Azathioprine ...................................18 Azithromycin ...................................18 Azol .................................................27 AZT .................................................66 Aztreonam Contracted ..................................18 DCS ............................................68 -BB-D Micro-Fine ...............................39 B-D Ultra Fine .................................39 B-D Ultra Fine II ..............................39 Bacillus calmette-guerin (BCG) vaccine ...................................... 18 Baclofen Contracted ..................................18 DCS ............................................68 Baraclude .......................................30 Barium sulphate .............................18 Basiliximab .....................................18 Beclazone 100 ................................19 Beclazone 250 ................................19 Beclazone 50 ..................................19 Beclomethasone dipropionate ............................... 19 Bendrofluazide ................................19 BeneFIX ..........................................57 Benzathine benzylpenicillin ............19 Benzathine penicillin .......................68 Benztrop .........................................19 Benztropine mesylate .....................19 Benzylpenicillin sodium (penicillin G) Contracted ..................................19 DCS ............................................68 Beractant ........................................19 Beta Scalp ......................................19 Betadine .........................................54 Betadine Skin Prep .........................54 Betagan ..........................................42 Betahistine dihydrochloride ............19 Betamethasone dipropionate with calcipotriol .......................... 19 Betamethasone valerate .................19 Bezafibrate .....................................19 Bezalip ............................................19 Bezalip Retard ................................19 Bicalaccord .....................................19 Bicalutamide ...................................19 Bicillin LA ........................................19 Biodone ..........................................44 Biodone Extra Forte ........................44 Biodone Forte .................................44 Bisacodyl ........................................19 Bisoprolol fumarate .........................19 Blood glucose diagnostic test meter ......................................... 19 Blood glucose diagnostic test strip ............................................ 20 Blood ketone diagnostic test meter ......................................... 20 Bortezomib .....................................20 Bosentan ........................................20 Bosvate ...........................................19 Botox ..............................................25 Breath-Alert ....................................52 Brimonidine tartrate ........................20 Broncolin .........................................59 Brufen SR .......................................38 Budenocort .....................................20 Budesonide .....................................20 Bumetanide ....................................20 Bupafen ..........................................20 Bupivacaine hydrochloride .............20 Bupivacaine hydrochloride with adrenaline .................................. 20 Bupivacaine hydrochloride with fentanyl ...................................... 20 Buprenorphrine with naloxone .................................... 21 Bupropion hydrochloride .................21 Burinex ...........................................20 Buscopan ........................................38 Buspirone hydrochloride .................21 Busulphan .......................................21 Butacort Aqueous ...........................20 -CCabergoline ....................................21 Caffeine citrate ...............................21 Cal-d-Forte .....................................24 Calamine ........................................21 Calcipotriol ......................................21 Calcitonin ........................................21 Calcitriol ..........................................21 Calcitriol-AFT ..................................21 Calcium carbonate ..........................21 Calcium folinate ..............................21 Calcium Folinate Ebewe .................21 Calcium gluconate ..........................22 Calcium polystyrene sulphonate ................................. 22 Calcium Resonium .........................22 Calsource .......................................21 Cancidas .........................................22 Candesartan ...................................22 Candestar .......................................22 Capecitabine ...................................22 Capoten ..........................................22 Capsaicin ........................................22 Captopril .........................................22 Carbaccord .....................................22 Carboplatin .....................................22 Carboplatin Ebewe .........................22 Carbosorb-X ...................................15 Cardinol LA .....................................55 CareSens ........................................20 CareSens II .....................................19 CareSens N ..............................19, 20 CareSens N POP ...........................19 Carvedilol .......................................22 Caspofungin ...................................22 Catapres .........................................25 Catapres-TTS-1 ..............................25 Catapres-TTS-2 ..............................25 Catapres-TTS-3 ..............................25 Ceenu .............................................43 Cefaclor monohydrate ....................22 Cefalexin Sandoz ............................23 Cefamandole nafate .......................68 Cefazolin sodium Contracted ..................................22 DCS ............................................68 Cefepime hydrochloride Contracted ..................................22 DCS ............................................68 Cefotaxime .....................................22 Cefotaxime Sandoz ........................22 Cefotaxime sodium .........................68 Cefoxitin sodium Contracted ..................................23 DCS ............................................68 Ceftazidime Contracted ..................................23 DCS ............................................68 Ceftriaxone sodium Contracted ..................................23 DCS ............................................68 Cefuroxime axetil Contracted ..................................23 DCS ............................................68 Cefuroxime sodium Contracted ..................................23

74


INDEX Generic Chemicals and Brands

DCS ............................................68 Celiprolol .........................................23 CellCept ..........................................48 Celol ...............................................23 Cephalexin ABM .............................23 Cephalexin monohydrate ................23 Ceptolate ........................................48 Cetirizine - AFT ..............................23 Cetirizine hydrochloride ..................23 Cetomacrogol .................................23 Champix .........................................65 Chlorafast .......................................23 Chloramphenicol .............................23 Chlorhexidine Contracted ..................................23 DCS ............................................68 Chlorhexidine gluconate .................23 Chlorhexidine in alcohol .................24 Chlorhexidine with cetrimide ...........24 Chlorothiazide .................................24 Chlorsig ..........................................23 Chlorthalidone ................................24 Cholecalciferol ................................24 Cholvastin .......................................54 Cilazapril with hydrochlorothiazide ................... 24 Cilicaine ..........................................55 Cilicaine VK ....................................53 Cipflox .............................................24 Ciprofloxacin Contracted ..................................24 DCS ............................................68 Cisplatin ..........................................24 Cisplatin Ebewe ..............................24 Citalopram hydrobromide ...............24 Citanest ..........................................55 Cladribine .......................................24 Clarithromycin .................................24 Clexane Contracted ..................................30 DCS ............................................69 Clindamycin ....................................24 Clindamycin ABM ...........................24 Clobetasol propionate .....................25 Clomazol .........................................25 Clomiphene citrate ..........................25 Clomipramine hydrochloride ...........25 Clonazepam ...................................25 Clonidine .........................................25 Clonidine hydrochloride ..................25 Clopidogrel Contracted ..................................25 DCS ............................................69 Clopine ...........................................25 Clopixol .....................................66, 67 Clostridum botulinum ......................25 Clotrimazole ....................................25 Clozapine ........................................25 Clozaril ...........................................25 Co-trimoxazole ...............................25 Cocaine ..........................................25 Codeine phosphate ........................26 Cogentin .........................................19 Colaspase (L-asparaginase) ..........26 Colchicine .......................................26 Colgout ...........................................26 Colifoam .........................................37 Colistin sulphomethate ...................26 Colistin-Link ....................................26 Colofac ...........................................44 Coloxyl ............................................53 Concerta .........................................45 Condyline ........................................53 Corangin .........................................40 Cord oral feed 1.5 kcal/ml ...............26 Cosopt ............................................29 Crotamiton ......................................26 Crystaderm .....................................37 CT Plus+ .........................................18 Curam Duo .....................................17 Curosurf ..........................................54 Cyclizine hydrochloride ...................26 Cyclizine lactate ..............................26 Cycloblastin ....................................26 Cyclophosphamide .........................26 Cyclosporin .....................................26 Cyklokapron ....................................64 Cymevene Contracted ..................................35 DCS ............................................70 Cyproterone acetate .......................26 Cysticide .........................................71 Cytarabine ......................................26 -DD-Penamine ....................................52 Dabigatran ......................................26 Dacarbazine ...................................26 Daivobet .........................................19 Daivonex .........................................21 Daktarin ..........................................46 Dalacin C ........................................24 Dalteparin sodium Contracted ..................................27 DCS ............................................69 Danazol ..........................................27 Danthron with polaxamer ................27 Dantrium .........................................27 Dantrium IV ....................................27 Dantrolene sodium .........................27 Dantrolene sodium hemiheptahydrate ...................... 27 Dapa-Tabs ......................................38 Darunavir ........................................27 Dasatinib .........................................27 Daunorubicin ..................................27 DBL Aminophylline .........................16 DBL Cefepime ................................22 DBL Cefotaxime .............................22 DBL Ceftazidime .............................23 DBL Epirubicin Hydrochloride .........31 DBL Ergometrine ............................31 DBL Gemcitabine ...........................35 DBL Leucovorin Calcium ................21 DBL Methotrexate ...........................45 DBL Morphine Sulphate .................47 DBL Pethidine Hydrochloride .........53 DBL Rocuronium Bromide ..............58 DBL Tobramycin .............................63 De-Worm ........................................44 Decozol ...........................................46 Deferiprone .....................................27 Demeclocycline ..............................69 Depo-Medrol ...................................45 Depo-Medrol with Lidocaine ...........45 Depo-Provera .................................44 Depo-Testosterone .........................63 Deprim ............................................25 Dermol ............................................25 Desferrioxamine mesylate ..............27 Desflurane ......................................27 Desmopressin .................................27 Desmopressin-PH&T ......................27 Dexamethasone .............................27 Dexamethasone sodium phosphate .................................. 28 Dexamphetamine sulphate .............28 Dextran 70 with sodium chloride ...................................... 28 Dextrose Contracted ..................................28 DCS ............................................69 DHC Continus .................................28 Diabetic enteral feed 1 kcal/ml ....................................... 28 Diabetic oral feed 1 kcal/ml ............28 Diamide Relief ................................43 Diamox ...........................................15 Diazepam .......................................28

75


INDEX Generic Chemicals and Brands

Diclax SR ........................................28 Diclofenac sodium ..........................28 Diflucan ...........................................33 Dihydrocodeine tartrate ..................28 Dilatrend .........................................22 Diltiazem hydrochloride ..................28 Dilzem .............................................28 Dinoprostone ..................................28 Diprivan ..........................................55 Dipyridamole ...................................28 Disulfiram ........................................29 Diurin 40 .........................................34 Dixarit .............................................25 Docetaxel ........................................29 Docetaxel Ebewe ............................29 Docusate sodium ............................29 Docusate sodium with sennosides ................................ 29 Domperidone ..................................29 Donepezil hydrochloride .................29 Donepezil-Rex ................................29 Dopamine hydrochloride .................29 Dopergin .........................................43 Dopress ..........................................29 Doribax ...........................................29 Doripenem ......................................29 Dornase alfa ...................................29 Dorzolamide hydrochloride with timolol maleate .......................... 29 Dostinex ..........................................21 Dothiepin hydrochloride ..................29 Doxazosin mesylate .......................29 Doxine ............................................29 Doxorubicin .....................................29 Doxycycline hydrochloride ..............29 DP-Anastrozole ..............................17 Dr Reddy’s Omeprazole .................50 Dr Reddy’s Ondansetron ................50 Dr Reddy’s Pantoprazole ................52 Dr Reddy’s Pramipexole .................54 Dr Reddy’s Quetiapine ...................56 Dr Reddy’s Risperidone ..................58 Dr Reddy’s Terbinafine ...................63 Dulcolax ..........................................19 Duolin .............................................59 Duovisc ...........................................61 Duride .............................................40 Dynastat .........................................52 Dysport ...........................................25 -EE-Mycin ...........................................31 Efavirenz .........................................29 Efavirenz with emtricitabine with tenofovir disoproxil fumarate .................................... 29 Efexor XR .......................................65 Effient .............................................54 Efudix ..............................................34 Elecare ...........................................16 Elecare LCP ...................................16 Eligard ............................................42 Emend Tri-Pack ..............................17 EMLA ..............................................43 Emtricitabine ...................................29 Emtricitabine with tenofovir disoproxil fumarate .................... 29 Emtriva ...........................................29 Emulsifying ointment ......................30 Enalapril .........................................30 Enbrel .............................................31 Endoxan .........................................26 Enfuvirtide ......................................30 Enoxaparin sodium Contracted ..................................30 DCS ............................................69 Ensure Contracted ..................................61 DCS ............................................71 Ensure Plus Contracted ..................................50 DCS ............................................71 Ensure Plus HN ..............................30 Ensure Plus RTH ............................30 Entacapone ....................................30 Entapone ........................................30 Entecavir .........................................30 Enteral feed 1 kcal/ml .....................30 Enteral Feed 1.5 kcal/ml .................30 Enteral Feed 2 kcal/ml ....................30 Enteral feed with fibre 1 kcal/ml ....................................... 30 Enteral feed with fibre 1.5 kcal/ml ....................................... 30 Enteral/oral elemental feed 1 kcal/ml ....................................... 30 Enteral/oral feed 1 kcal/ml ..............30 Ephedrine hydrochloride .................30 Epirubicin ........................................31 Epirubicin Ebewe ............................31 Eprex ..............................................31 Eptifibatide ......................................31 Ergometrine maleate ......................31 Erlotinib hydrochloride ....................31 Ertapenem sodium Contracted ..................................31 DCS ............................................69 Erythrocin IV ...................................31 Erythromycin ethyl succinate ..........31 Erythromycin lactobionate ..............31 Erythropoietin alpha .......................31 Erythropoietin beta .........................31 Escitalopram ...................................31 Etanercept ......................................31 Ethambutol hydrochloride ...............32 Ethics Paracetamol .........................52 Ethinyloestradiol with levonorgestrel ............................ 32 Etidronate disodium ........................32 Etopophos ......................................32 Etoposide ........................................32 Etoposide phosphate ......................32 Etravirine ........................................32 Evista ..............................................56 Exemestane ....................................32 EZ-fit Paediatric Mask ....................43 -FFactor eight inhibitors bypassing agent ......................................... 32 Fat free arginine supplement ..........32 FEIBA .............................................32 Felodipine .......................................32 Fenpaed .........................................38 Fentanyl ..........................................32 Fentanyl citrate ...............................32 Ferodan ..........................................33 Ferriprox .........................................27 Ferro-F-Tabs ...................................32 Ferro-tab .........................................32 Ferrous fumarate ............................32 Ferrous fumarate with folic acid ............................................ 32 Ferrous sulphate .............................33 Ferrum H ........................................40 Filgrastim Contracted ..................................33 DCS ............................................69 Finasteride ......................................33 Flagyl ..............................................46 Flagyl-S ..........................................46 Flamazine .......................................59 Flecainide acetate ..........................33 Fleet Phosphate Enema .................60 Flixonase Hayfever & Allergy ..........34 Flixotide ..........................................34 Flixotide Accuhaler .........................34 Florinef ...........................................33 Fluanxol ..........................................34 Flucloxacillin sodium Contracted ..................................33

76


INDEX Generic Chemicals and Brands

DCS ............................................70 Flucloxin .........................................33 Flucon .............................................33 Fluconazole Contracted ..................................33 DCS ............................................70 Fluconazole-Claris ..........................33 Fludara Oral ....................................33 Fludarabine Ebewe .........................33 Fludarabine phosphate ...................33 Fludrocortisone acetate ..................33 Flumazenil ......................................33 Fluocortolone caproate with fluocortolone pivalate and cinchocaine ................................ 33 Fluorescite ......................................61 Fluorometholone .............................33 Fluorouracil Ebewe .........................34 Fluorouracil sodium ........................34 Fluox ...............................................34 Fluoxetine hydrochloride .................34 Flupenthixol decanoate ..................34 Fluphenazine decanoate ................34 Flutamide ........................................34 Flutamin ..........................................34 Fluticasone .....................................34 Fluticasone propionate ...................34 Fluticasone with salmeterol ............34 Foban .............................................34 Folic acid ........................................34 Forteo .............................................63 Fortified eye drops ..........................70 Fortisip Contracted ..................................61 DCS ............................................71 Fortisip Multi Fibre ..........................71 Fortum ............................................23 Fosamax .........................................15 Fosamax Plus .................................15 Foscarnet ........................................70 Fragmin Contracted ..................................27 DCS ............................................69 Freeflex ...........................................60 FreeStyle Lite ...........................19, 20 Freestyle Optium ............................20 Freestyle Optium Ketone ................40 Fresofol 1% .....................................55 Frusemide-Claris ............................34 Fucidin ............................................34 Fucithalmic .....................................34 Fungilin ...........................................17 Furosemide .....................................34 Fusidic acid .....................................34 Fuzeon ............................................30 -GGabapentin .....................................35 Gadobendate dimeglumine ............35 Gadobutrol ......................................35 Gadodiamide ..................................35 Gadovist .........................................35 Ganciclovir Contracted ..................................35 DCS ............................................70 Gastrografin ....................................44 Gastrosoothe ..................................38 Gefitinib ..........................................35 Gelafusal ........................................35 Gelatin plasma replacer ..................35 Gelofusine ......................................35 Gemcitabine Actavis 1000 ..............35 Gemcitabine Actavis 200 ................35 Gemcitabine Ebewe .......................35 Gemcitabine hydrochloride .............35 Gemfibrozil .....................................35 Genoptic .........................................35 Genox .............................................62 Gentamicin sulphate Contracted ..................................35 DCS ............................................70 Gliclazide ........................................35 Glipizide ..........................................35 Glivec ..............................................38 Glucagen Hypokit ...........................35 Glucagon hydrochloride ..................35 Glucerna Select ..............................28 Glucerna Select RTH ......................28 Glucose ..........................................36 Glucose with sodium, potassium, magnesium, chloride and acetate ....................................... 36 Glucose with sodium, potassium, magnesium, chloride, acetate and gluconate ............................ 36 Glycerin with sodium saccharin ................................... 36 Glycerin with sucrose .....................36 Glycerol ..........................................36 Glyceryl trinitrate ............................36 Glycine ............................................36 Glypressin .......................................63 Glytrin .............................................36 Goserelin acetate ...........................36 Granocyte .......................................70 -HHabitrol ...........................................49 Haemaccel ......................................35 Haldol .............................................36 Haldol Concentrate .........................36 Haloperidol .....................................36 Haloperidol decanoate ...................36 Healon GV ......................................61 healthE Fatty Cream .......................49 Heparin sodium ..............................37 Heparinised saline Contracted ..................................37 DCS ............................................70 Heparon Junior ...............................30 Hepsera ..........................................15 Herceptin ........................................64 High fat low carbohydrate formula ....................................... 37 Holoxan ..........................................38 Humalog Mix 25 ..............................39 Humalog Mix 50 ..............................39 Humira ............................................15 HumiraPen ......................................15 Hybloc .............................................41 Hydralazine Contracted ..................................37 DCS ............................................70 Hydrea ............................................38 Hydrocortisone ...............................37 Hydrocortisone acetate ..................37 Hydrocortisone butyrate .................37 Hydrocortisone with cinchocaine ................................ 37 Hydrocortisone with miconazole ................................ 37 Hydrocortisone with natamycin and neomycin ............................ 37 Hydrogen peroxide .........................37 Hydroxocobalamin ..........................37 Hydroxychloroquine sulphate .........37 Hydroxyethyl Starch 130/0.4 with magnesium chloride, potassium chloride, sodium acetate and sodium chloride ...................................... 38 Hydroxyethyl starch 130/0.4 with sodium chloride ......................... 38 Hydroxyurea ...................................38 Hygroton .........................................24 Hyoscine (scopolamine) Contracted ..................................38 DCS ............................................70

77


INDEX Generic Chemicals and Brands

Hyoscine hydrobromide ..................38 Hyoscine n-butylbromide ................38 Hypnovel .........................................46 Hypromellose ..................................38 Hysite ..............................................41 -IIbiamox ...........................................17 Ibuprofen ........................................38 Idarubicin hydrochloride .................38 Ifosfamide .......................................38 Igroton ............................................24 Ikorel ...............................................48 Ilomedin ..........................................38 Iloprost ............................................38 Imatinib mesylate ............................38 Imipenem with cilastatin Contracted ..................................38 DCS ............................................70 Imipramine hydrochloride ...............38 Imiquimod .......................................38 Impact Advanced Recovery Contracted ..................................62 DCS ............................................71 Imuprine .........................................18 Imuran ............................................18 Indapamide .....................................38 Indomethacin ..................................70 Infliximab ........................................38 Inhibace Plus ..................................24 Innohep ..........................................72 Innovacon hCG One Step Pregnancy Test .......................... 55 Insulin aspart with insulin aspart protamine ................................... 38 Insulin glargine ...............................39 Insulin glulisine ...............................39 Insulin lispro with insulin lispro protamine ................................... 39 Insulin pen needles .........................39 Insulin syringes, disposable with attached needle ......................... 39 Integrilin ..........................................31 Intelence .........................................32 Invanz .............................................31 Iodine with alcohol ..........................39 Iodixanol .........................................39 Iohexol ............................................40 Ioscan .............................................61 Ipratropium bromide .......................40 Iressa ..............................................35 Irinotecan ........................................40 Irinotecan Actavis 100 ....................40 Irinotecan Actavis 40 ......................40 Iron polymaltose .............................40 Iron sucrose ....................................40 Isentress .........................................56 Ismo-20 ...........................................40 Isoflurane ........................................40 Isoniazid .........................................40 Isopropyl alcohol .............................40 Isoptin .............................................65 Isosorbide mononitrate ...................40 Isotretinoin ......................................40 Itch-Soothe .....................................26 Itraconazole Contracted ..................................40 DCS ............................................70 Itrazole ............................................40 Ivermectin Contracted ..................................40 DCS ............................................70 -JJadelle ............................................42 Jevity ..............................................30 Jevity HiCal RTH ............................30 Jevity RTH ......................................30 -KKaletra ............................................43 Kenacomb ......................................64 Kenacort-A ......................................64 Kenacort-A40 ..................................64 KetoCal ...........................................37 Ketoconazole ..................................40 Ketone blood beta-ketone electrodes .................................. 40 Ketoprofen ......................................41 Kivexa .............................................15 Klacid ..............................................24 Klean Prep ......................................53 Kogenate FS ...................................57 Konakion MM ..................................53 Konsyl-D .........................................48 -LL-ornithine l-aspartate (lola) S29 ........................................... 70 Labetalol .........................................41 Lacosamide ....................................41 Lactulose ........................................41 Laevolac .........................................41 Lamictal ..........................................41 Lamivudine .....................................41 Lamotrigine .....................................41 Lansoprazole ..................................41 Lantus .............................................39 Lantus SoloStar ..............................39 Lapatinib ditosylate .........................41 Latanoprost .....................................41 Lax-Sachets ....................................43 Lax-Tabs .........................................19 Laxofast 120 ...................................29 Laxofast 50 .....................................29 Laxsol .............................................29 Ledermycin .....................................69 Leflunomide ....................................41 Lenograstim ....................................70 Letraccord .......................................41 Letrozole .........................................41 Leucomax .......................................71 Leunase ..........................................26 Leuprorelin ......................................42 Leustatin .........................................24 Levetiracetam .................................42 Levetiracetam-Rex ..........................42 Levobunolol ....................................42 Levodopa with benserazide ............42 Levodopa with carbidopa ................42 Levonorgestrel ................................42 Levophed ........................................49 Lignocaine ......................................42 Lignocaine hydrochloride ................42 Lignocaine hydrochloride with adrenaline .................................. 42 Lignocaine with chlorhexidine .........42 Lignocaine with prilocaine ..............43 Lioresal Intrathecal Contracted ..................................18 DCS ............................................68 Lipazil .............................................35 Liquifilm Forte .................................53 Liquifilm Tears .................................53 Lisinopril .........................................43 Lisuride hydrogen maleate .............43 Lithicarb FC ....................................43 Lithium carbonate ...........................43 Locoid .............................................37 Locoid Crelo ...................................37 Locoid Lipocream ...........................37 Logem .............................................41 Lomustine .......................................43 Loniten ............................................46 Loperamide hydrochloride ..............43 Lopinavir with ritonavir ....................43 Lopresor .........................................46 Loraclear Hayfever Relief ...............43 Lorapaed ........................................43 Loratadine .......................................43 Lorazepam ......................................43 Losartan .........................................43

78


INDEX Generic Chemicals and Brands

Lostaar ............................................43 Lovir ................................................15 Loxalate ..........................................31 Loxamine ........................................52 Lucrin Depot ...................................42 Lucrin Depot PDS ...........................42 Lycinate ..........................................36 Lyderm ............................................53 -Mm-Amoxiclav ...................................17 m-Captopril .....................................22 m-Cefuroxime .................................23 m-Enalapril .....................................30 m-Eslon ..........................................47 m-Mometasone ...............................47 Mabthera ........................................58 Macrogol 3350 ................................43 Madopar 125 ..................................42 Madopar 250 ..................................42 Madopar 62.5 .................................42 Madopar Dispersible .......................42 Madopar HBS .................................42 Magnesium sulphate ......................43 Magnevist .......................................44 Mannitol ..........................................43 Marcain ...........................................20 Marcain Heavy ................................20 Marcain Isobaric .............................20 Marcain with Adrenaline .................20 Marine Blue Lotion SPF 30+ ..........62 Martindale Acetylcysteine ...............15 Mask for spacer device ...................43 Max Health .....................................30 Maxidex ..........................................27 Mebendazole ..................................44 Mebeverine hydrochloride ..............44 Medrol .............................................45 Medroxyprogesterone acetate ....................................... 44 Megestrol acetate ...........................44 Meglumine diatrizoate with sodium amidotrizoate ................ 44 Meglumine gadopentetate ..............44 Mercaptopurine ..............................44 Meropenem Contracted ..................................44 DCS ............................................70 Mesalazine .....................................44 Mesna .............................................44 Mestinon .........................................56 Metamide ........................................46 Metformin hydrochloride .................44 Methadone hydrochloride ...............44 Methatabs .......................................44 Methoblastin ...................................45 Methopt ...........................................38 Methotrexate ...................................45 Methotrexate Ebewe .......................45 Methoxsalen ...................................70 Methoxypsaralen ............................70 Methylcellulose ...............................45 Methylcellulose with glycerin and sodium saccharin ...................... 45 Methylcellulose with glycerin and sucrose ...................................... 45 Methyldopa .....................................45 Methylphenidate hydrochloride ............................. 45 Methylphenidate hydrochloride extended-release ....................... 45 Methylprednisolone ........................45 Methylprednisolone aceponate .................................. 45 Methylprednisolone acetate ............45 Methylprednisolone acetate with lignocaine .................................. 45 Methylprednisolone sodium succinate ................................... 46 Metoclopramide hydrochloride ............................. 46 Metolazone S29 .............................70 Metoprolol - AFT CR .......................46 Metoprolol succinate .......................46 Metoprolol tartrate ..........................46 Metronidazole .................................46 Mexiletine hydrochloride .................46 Mexiletine Hydrochloride USP ........................................... 46 Miacalcic .........................................21 Micolette .........................................60 Miconazole .....................................46 Miconazole nitrate ..........................46 Micreme H ......................................37 Microgynon 50 ED ..........................32 Midazolam ......................................46 Minidiab ..........................................35 Minirin .............................................27 Minoxidil ..........................................46 Mirtazapine .....................................46 Mitomycin C ....................................46 Mitozantrone ...................................47 Mitozantrone Ebewe .......................47 Mivacron .........................................47 Mivacurium .....................................47 Moclobemide ..................................47 Modecate ........................................34 Mogine ............................................41 Molgramostim .................................71 Mometasone furoate .......................47 Montelukast ....................................47 Morphine hydrochloride ..................47 Morphine sulphate ..........................47 Morphine tartrate ............................48 Motetis ............................................63 Moxifloxacin ....................................48 Mucilaginous laxatives ....................48 Multihance ......................................35 Myaccord ........................................48 Myambutol ......................................32 Mycobutin .......................................57 Mycophenolate mofetil ....................48 Mydriacyl ........................................64 Mylan Atenolol ................................18 Mylan Fentanyl Patch .....................32 Myleran ...........................................21 -NNadolol ...........................................48 Naloxone hydrochloride ..................48 Naltraccord .....................................48 Naltrexone hydrochloride ................48 Naphazoline hydrochloride .............48 Naphcon Forte ................................48 Naproxen ........................................48 Naropin ...........................................59 Natulan ...........................................55 Nausicalm .......................................26 Navelbine ........................................65 Navoban .........................................65 Neocate Advance ...........................16 Neocate Gold ..................................16 Neoral .............................................26 NeoRecormon ................................31 Neostigmine methylsulphate ..........48 Neosynephrine HCL .......................53 Neotigason .....................................15 Nepro ..............................................57 Nepro RTH .....................................57 Netilmicin ........................................71 Neulastim ........................................52 Neupogen Contracted ..................................33 DCS ............................................69 Nevirapine ......................................48 Nevirapine Alphapharm ..................48 Next Choice ....................................42 Nicorandil ........................................48 Nicotine ...........................................49

79


INDEX Generic Chemicals and Brands

Nifedipine ........................................49 Nilstat ..............................................49 Nimodipine ......................................71 Nitroderm TTS 10 ...........................36 Nitroderm TTS 5 .............................36 Nitronal ...........................................36 Noflam 250 .....................................48 Noflam 500 .....................................48 Noradrenaline acid tartrate .............49 Norethisterone ................................49 Norfloxacin ......................................49 Normison ........................................62 Norpress .........................................49 Nortriptyline hydrochloride ..............49 Norvir ..............................................58 Novasource Renal ..........................57 Novatretin .......................................15 NovoMix 30 FlexPen .......................38 NovoSeven RT ................................57 Noxafil .............................................54 Nupentin .........................................35 Nutrini Energy Multi Fibre ...............51 Nutrini Low Energy Multi Fibre .......................................... 51 Nutrison Concentrated ...................30 Nutrison Energy ..............................30 Nyefax Retard .................................49 Nystatin ...........................................49 -OOctreotide .......................................49 Octreotide MaxRx ...........................49 Oil in water emulsion ......................49 Olanzapine .....................................49 Olanzapine pamoate monohydrate .............................. 50 Olanzine .........................................49 Olanzine-D ......................................49 Omeprazole ....................................50 Omezol Relief .................................50 Omnipaque .....................................40 Omniscan .......................................35 On Call Advanced .....................19, 20 OncoTICE .......................................18 Ondanaccord ..................................50 Ondansetron ...................................50 One-Alpha ......................................15 Onkotrone .......................................47 Ora-Blend .......................................45 Ora-Blend SF ..................................45 Ora-Plus .........................................45 Ora-Sweet ......................................36 Ora-Sweet SF .................................36 Oracort ...........................................64 Oral elemental feed 1kcal/ml ..........50 Oral feed 1.5kcal/ml ........................50 Oral feed 2kcal/ml ...........................50 Oratane ...........................................40 Ornidazole ......................................50 Oruvail SR ......................................41 Osmolite .........................................30 Osmolite RTH .................................30 Ospamox ........................................17 Oxaliplatin .......................................50 Oxaliplatin Actavis 100 ...................50 Oxaliplatin Actavis 50 .....................50 Oxsoralen .......................................70 Oxybutynin ......................................50 Oxycodone hydrochloride ...............51 Oxycodone Orion ...........................51 OxyContin .......................................51 OxyNorm ........................................51 Oxytocin ..........................................51 Ozole ..............................................33 -PPacifen ............................................18 Pacific Buspirone ............................21 Paclitaxel ........................................51 Paclitaxel Actavis ............................51 Paclitaxel Ebewe ............................51 Paediatric enteral feed 1 kcal/ml ....................................... 51 Paediatric enteral feed with fibre 0.75 kcal/ml ............................... 51 Paediatric enteral feed with fibre 1.5 kcal/ml ................................. 51 Paediatric Oral Feed .......................51 Paediatric oral feed 1 kcal/ml ..........51 Pamidronate BNM ..........................51 Pamidronate disodium ....................51 Pamisol ...........................................51 Panadol ..........................................52 Pancuronium bromide ....................52 Pantoprazole ...................................52 Papaverine hydrochloride ...............52 Paracare .........................................52 Paracare Double Strength ..............52 Paracetamol ...................................52 Paracetamol + Codeine (Relieve) .................................... 52 Paracetamol with codeine ..............52 Paracetamol-AFT ...........................52 Paraffin ...........................................52 Parecoxib ........................................52 Paroxetine hydrochloride ................52 Paxam ............................................25 Pazopanib .......................................52 Peak flow meter ..............................52 Pediasure .......................................51 Pediasure RTH ...............................51 Pegfilgrastim Contracted ..................................52 DCS ............................................71 Penembact .....................................44 Penicillamine ..................................52 Pentamidine ....................................71 Pentasa ..........................................44 Peptamen OS 1.0 ...........................50 Peptisoothe .....................................56 Pergolide ........................................52 Perhexiline maleate ........................52 Permax ...........................................52 Permethrin ......................................53 Pethidine hydrochloride ..................53 Pexsig .............................................52 Phenindione ....................................71 Phenobarbitone ..............................53 Phenoxymethylpenicillin (penicillin V) ............................... 53 Phenylephrine hydrochloride ..........53 Phytomenadione .............................53 Pimafucort ......................................37 Pindolol ...........................................53 Pinetarsol ........................................62 Pinorax ...........................................27 Pinorax Forte ..................................27 Pioglitazone ....................................53 Piperacillin sodium ..........................71 Piperacillin sodium with tazobactam sodium ................... 53 Piperacillin with tazobactam ...........71 Pizaccord ........................................53 Pizotifen ..........................................53 PKU Anamix Junior LQ ...................16 Plaquenil .........................................37 Plendil ER .......................................32 Podophyllotoxin ..............................53 Poloxamer .......................................53 Polyethylene glycol with sodium sulphate ..................................... 53 Polyhexamethylene biguanide ................................... 71 Polyvinyl alcohol .............................53 Poractant alfa ..................................54 Posaconazole .................................54 Potassium chloride .........................54 Potassium chloride with glucose ...................................... 54 Potassium chloride with glucose and sodium chloride .................. 54

80


INDEX Generic Chemicals and Brands

Potassium chloride with sodium chloride ...................................... 54 Potassium citrate ............................54 Povidone iodine ..............................54 Pradaxa ..........................................26 Pramipexole hydrochloride .............54 Prasugrel ........................................54 Pravastatin ......................................54 Praziquantel ....................................71 Prazosin hydrochloride ...................54 Prednisolone sodium phosphate .................................. 54 Prednisone .....................................55 Pregnancy test – hCG Urine ..........55 Premature birth formula ..................55 Preterm post-discharge infant formula ....................................... 55 Prezista ...........................................27 Prilocaine hydrochloride .................55 Primaquine .....................................71 Primaxin .........................................38 Primolut N .......................................49 Procaine penicillin ...........................55 Procarbazine hydrochloride ............55 Prochlorperazine ............................55 Proctosedyl .....................................37 Prodopa ..........................................45 Prograf ............................................62 Prokinex ..........................................29 Promethazine hydrochloride ...........55 Propofol ..........................................55 Propranolol .....................................55 Propylene glycol .............................55 Propylthiouracil ...............................55 Prostin E2 .......................................28 Prostin VR ......................................16 Protein supplement .........................56 Provera ...........................................44 Provisc ............................................61 Provive MCT-LCT 1% .....................55 PTU ................................................55 Pulmocare ......................................26 Pulmozyme .....................................29 Purinethol .......................................44 Pyridostigmine bromide ..................56 PyridoxADE ....................................56 Pyridoxine hydrochloride ................56 Pyrimethamine ...............................71 Pytazen SR .....................................28 -QQ 300 ..............................................56 Quetapel .........................................56 Quetiapine ......................................56 Quinapril .........................................56 Quinapril with hydrochlorothiazide ................... 56 Quinine sulphate .............................56 -RRA-Morph .......................................47 Raloxifene hydrochloride ................56 Raltegravir potassium .....................56 Ranbaxy-Cefaclor ...........................22 Ranitidine hydrochloride .................56 Rapamune ......................................60 Reandron 1000 ...............................63 Recombinant coagulation factor VIIa ............................................ 57 Recombinant factor IX ....................57 Recombinant factor VIII ..................57 Redipred .........................................54 Remicade .......................................38 Remifentanil hydrochloride .............57 Remifentanil-AFT ............................57 Renal Enteral Feed 2 kcal/ml .........57 Renal oral feed 2 kcal/ml ................57 ReoPro ...........................................15 Resource Arginaid ..........................32 Resource Beneprotein ....................56 Resource Diabetic ..........................28 Retinol palmitate .............................57 Retrovir ...........................................66 Reyataz ..........................................17 Ridal ...............................................58 Rifabutin .........................................57 Riodine ...........................................54 Risperdal ........................................58 Risperdal Consta ............................58 Risperdal Quicklet ..........................58 Risperidone ....................................58 Risperon .........................................58 Ritalin ..............................................45 Ritalin LA ........................................45 Ritalin SR ........................................45 Ritonavir .........................................58 Rituximab ........................................58 Rivaroxaban ....................................58 Rivotril .............................................25 Rizamelt ..........................................58 Rizatriptan ......................................58 Rocaltrol .........................................21 Rocuronium bromide ......................58 Ropin ..............................................58 Ropinirole hydrochloride .................58 Ropivacaine hydrochloride .............59 Ropivacaine hydrochloride with fentanyl ...................................... 59 Roxane ...........................................21 Roxithromycin .................................59 Rubifen ...........................................45 Rubifen SR .....................................45 -SS-26 Gold Premgro .........................55 S26LBW Gold RTF .........................55 Salamol ...........................................59 Salapin ............................................59 Salazopyrin .....................................62 Salazopyrin EN ...............................62 Salbutamol ......................................59 Salbutamol with ipratropium bromide ...................................... 59 Salmeterol ......................................59 Sandimmun ....................................26 Sandomigran ..................................53 Sandostatin LAR .............................49 Scopoderm TTS Contracted ..................................38 DCS ............................................70 Sebizole ..........................................40 Serenace ........................................36 Seretide ..........................................34 Seretide Accuhaler .........................34 Serevent .........................................59 Serevent Accuhaler ........................59 Serophene ......................................25 Seroquel .........................................56 Sertraline ........................................59 Sevoflurane .....................................59 Sevredol .........................................47 Silagra ............................................59 Sildenafil .........................................59 Silver sulphadiazine ........................59 Simulect ..........................................18 Simvastatin .....................................59 Sinemet ..........................................42 Sinemet CR ....................................42 Singulair ..........................................47 Sirolimus .........................................60 Siterone ..........................................26 Slow Sodium ...................................71 Slow-Lopresor ................................46 Sodibic ............................................60 Sodium acid phosphate ..................60 Sodium alginate ..............................60 Sodium bicarbonate ........................60 Sodium chloride Contracted ..................................60 DCS ............................................71

81


INDEX Generic Chemicals and Brands

Sodium chloride with glucose .........60 Sodium citrate with sodium lauryl sulphoacetate ............................ 60 Sodium citro-tartrate .......................60 Sodium diotrizoate ..........................61 Sodium fluorescein .........................61 Sodium hyaluronate ........................61 Sodium nitroprusside ......................61 Soft white paraffin with paraffin liquid .......................................... 61 Solian ..............................................16 Solifenacin succinate ......................61 Solox ...............................................41 Solu-Cortef .....................................37 Solu-Medrol ....................................46 Sorbolene with glycerin ..................61 Sotacor ...........................................61 Sotalol .............................................61 Space Chamber Plus ......................61 Spacer device .................................61 Span-K ............................................54 Special food supplement ................71 Spiriva .............................................63 Spironolactone ................................61 Spirotone ........................................61 Sprycel ...........................................27 Standard supplement oral feed (powder) .................................... 61 Standard supplement oral feed 1.4 kcal/ml ................................. 62 Staphlex ..........................................33 Stesolid ...........................................28 Stocrin ............................................29 Strattera ..........................................18 Streptase ........................................62 Streptokinase ..................................62 Stromectol ......................................40 Suboxone .......................................21 Sulphadiazine .................................71 Sulphasalazine ...............................62 Sumatriptan ....................................62 Sunitinib ..........................................62 Sunscreens, proprietary .................62 Suprane ..........................................27 Surgam ...........................................63 Survanta .........................................19 Sustagen Hospital Formula Contracted ..................................61 DCS ............................................71 Sutent .............................................62 Suxamethonium chloride ................62 Symmetrel ......................................16 Synacthen .......................................63 Synacthen Depot ............................63 Syntocinon ......................................51 Syntometrine ..................................51 Syrup (pharmaceutical grade) ........................................ 62 -TTacrolimus ......................................62 Tambocor ........................................33 Tambocor CR ..................................33 Tamoxifen citrate .............................62 Tamsulosin hydrochloride ...............62 Tamsulosin-Rex ..............................62 Tar with triethanolamine lauryl sulphate and fluorescein ............ 62 Tarceva ...........................................31 Tasmar ............................................63 Tazocin EF ......................................53 Teicoplanin ......................................72 Temaccord ......................................63 Temazepam ....................................62 Temozolomide ................................63 Tenofovir disoproxil fumarate ..........63 Tenoxicam ......................................63 Terbinafine ......................................63 Teriparatide .....................................63 Terlipressin .....................................63 Testosterone ...................................63 Testosterone cypionate ...................63 Testosterone undecanoate .............63 Tetrabenazine .................................63 Tetracosactrin .................................63 Thalidomide ....................................63 Thalomid .........................................63 Tiaprofenic acid ..............................63 Ticarcillin disodium with clavulanic acid ........................... 72 Timolol maleate ..............................63 Timoptol XE ....................................63 Tinzaparin sodium ..........................72 Tiotropium bromide .........................63 Tirofiban hydrochloride ...................63 TMP ................................................64 Tobramycin Contracted ..................................63 DCS ............................................72 Tobrex .............................................63 Tofranil ............................................38 Tolcapone .......................................63 Tolterodine ......................................64 Topamax .........................................64 Topiramate ......................................64 Tracleer ...........................................20 Tracrium ..........................................18 Tramadol hydrochloride ..................64 Tramal 100 ......................................64 Tramal 50 ........................................64 Tramal SR 100 ................................64 Tramal SR 150 ................................64 Tramal SR 200 ................................64 Tranexamic acid ..............................64 Trastuzumab ...................................64 Tretinoin ..........................................64 Triamcinolone acetonide .................64 Triamcinolone acetonide with gramicidin, neomycin and nystatin ...................................... 64 Trichozole .......................................46 Triclosan .........................................64 Trimethoprim Contracted ..................................64 DCS ............................................72 Tropicamide ....................................64 Tropisetron ......................................65 Truvada ...........................................29 Two Cal HN .....................................50 Two Cal HN RTH ............................30 Tykerb .............................................41 -UUltraproct ........................................33 Univent ...........................................40 Ural .................................................60 Urex Forte .......................................34 Uromitexan .....................................44 Ursodeoxycholic acid ......................65 Ursosan ..........................................65 -VValaciclovir ......................................65 Valcyte ............................................65 Valganciclovir ..................................65 Valtrex .............................................65 Vancomycin hydrochloride Contracted ..................................65 DCS ............................................72 Varenicline tartrate .........................65 Velcade ...........................................20 Venlafaxine .....................................65 Venofer ...........................................40 Ventavis ..........................................38 Ventolin ...........................................59 Vepesid ...........................................32 Veracol ............................................23 Verapamil hydrochloride .................65 Vergo 16 .........................................19 Verpamil SR ...................................65 Vesanoid .........................................64

82


INDEX Generic Chemicals and Brands

Vesicare ..........................................61 Vfend ..............................................65 Vimpat ............................................41 Vinblastine sulphate .......................65 Vincristine sulphate ........................65 Vinorelbine ......................................65 Viramune Suspension ....................48 Viread .............................................63 Visipaque ........................................39 Vistil ................................................53 Vistil Forte ......................................53 Vital HN ..........................................30 Vitala-C ...........................................17 Vivonex Paediatric ..........................16 Vivonex TEN ...................................50 Volibris ............................................16 Voltaren ..........................................28 Voltaren Ophtha ..............................28 Volulyte 6% .....................................38 Volumatic ........................................61 Voluven ...........................................38 Voriconazole ...................................65 Votrient ...........................................52 -WWater Contracted ..................................66 DCS ............................................72 Water with sodium, potassium, calcium and chloride .................. 66 Water with sodium, potassium, calcium, bicarbonate and chloride ...................................... 66 Water with sodium, potassium, calcium, bicarbonate, chloride and glucose ............................... 66 Water with sodium, potassium, magnesium, chloride, acetate and gluconate ............................ 66 -XXarelto ............................................58 Xeloda ............................................22 Xylocaine ........................................42 Xylocaine Viscous ..........................42 Xyntha ............................................57 -ZZantac .............................................56 Zarator ............................................18 Zario ...............................................69 Zarzio ..............................................33 Zavedos ..........................................38 Zeldox .............................................66 Zentel ..............................................68 Zetlam .............................................41 Zetop ..............................................23 Ziagen .............................................15 Zidovudine [AZT] ............................66 Zidovudine [AZT] with lamivudine ................................. 66 Zinc and castor oil ..........................66 Zinc sulphate ..................................66 Zincaps ...........................................66 Zinnat ..............................................23 Ziprasidone .....................................66 Zithromax ........................................18 Zofran .............................................50 Zofran Zydis ....................................50 Zoladex ...........................................36 Zoledronic acid ...............................66 Zometa ...........................................66 Zopiclone ........................................66 Zostrix .............................................22 Zostrix HP .......................................22 Zovirax IV .......................................15 Zuclopenthixol decanoate ...............66 Zuclopenthixol hydrochloride ..........67 Zyban ..............................................21 Zyprexa Relprevv ............................50

83


Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-3694 (Print) ISSN 1179-3708 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

If Undelivered, Return To: PO Box 10-254, Wellington 6143, New Zealand

Metadata

Title

Section H - effective 1 March 2013

Abstract

Pharmaceutical Management Agency Section H for Hospital Pharmaceuticals Effective 1 March 2013 New Zealand Pharmaceutical Schedule Hospital Pharmaceuticals March 2013 Editors Sarah Le Leu & Donna Jennings email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.